Class Action Reports


Class Action Reports

OLO Class Action: Learn About the Olo Lawsuit

Levi & Korsinsky, LLP

September 30, 2022

Levi & Korsinsky, LLP announces that an OLO class action lawsuit has been filed on behalf of investors who purchased Olo Inc. (OLO) securities between August 11, 2021, and August 11, 2022.For more on the OLO Lawsuit please contact us today.

 

 

According to the Olo lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Subway was ending its contract with Olo; (2) Olo’s key business metric – active locations – could not continue to grow as defendants touted due to the loss of Subway’s business; and (3) as a result of the above, defendants’ statements about Olo’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE OLO CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Olo you have until November 28, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

YSG Class Action: Learn About the Yatsen Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a YSG class action lawsuit has been filed on behalf of investors who purchased Yatsen Holding Limited (YSG) This lawsuit is on behalf of a class consisting of all persons and entities who purchased Yatsen Holding Limited American Depository Shares (“ADS”) between November 19, 2020 and March 10, 2022, or acquired Yatsen ADS pursuant or traceable to documents issued in connection with Yatsen’s November 2020 initial public stock offering. For more on the YSG Lawsuit please contact us today.

 

 

According to the Yatsen lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: The filed complaint alleges that defendants made false statements and/or concealed that the registration statement and prospectus used to effectuate the Company’s initial public offering (“IPO”), Yatsen and the other named defendants misled investors into believing that Yatsen’s most significant brands, Perfect Diary and Little Ondine, were thriving, thereby driving Yatsen’s “healthy” top-line growth at the time of its IPO and quarter after quarter thereafter. In truth, however, cosmetic and skincare sales of Perfect Diary and Little Ondine products were declining in the period leading up to (and including at the time of) the IPO and throughout 2021. Moreover, as the truth about Yatsen’s business reached the market, the value of the Company’s shares declined dramatically, causing Yatsen investors to suffer significant damages.

 

TO LEARN MORE ABOUT THE YSG CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Yatsen you have until November 22, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

BCS Class Action: Learn About the Barclays Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a BCS class action lawsuit has been filed on behalf of investors who purchased Barclays PLC (BCS) This lawsuit is on behalf of persons who purchased or otherwise acquired Barclays American Depositary Receipts on a U.S. open market between February 18, 2021, and March 25, 2022. For more on the BCS Lawsuit please contact us today.

 

 

According to the Barclays lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: a) as of December 31, 2020, and February 18, 2021, Barclays had a material weakness in its internal control environment due to the fact that the over-issuance had occurred and was not immediately identified; and b) they failed to disclose that as of February 18, 2021 (i) Barclays Bank PLC (“BBPLC”) had and was selling unregistered securities in excess of the amounts registered by the August 2019 shelf registration statement, (ii) BBPLC was violating U.S. securities laws and/or the U.S. Securities and Exchange Commission regulations, subjecting Barclays to legal liability, and (iii) BBPLC was required to conduct a rescission offer for those unregistered securities.

 

TO LEARN MORE ABOUT THE BCS CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Barclays you have until November 22, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

FLGT Class Action: Learn About the Fulgent Lawsuit

Levi & Korsinsky, LLP

September 23, 2022

Levi & Korsinsky, LLP announces that an FLGT class action lawsuit has been filed on behalf of investors who purchased Fulgent Genetics, Inc. (FLGT) securities between March 22, 2019, and August 4, 2022. For more on the FLGT Lawsuit please contact us today.

 

 

 

 

According to the Fulgent lawsuit, throughout the Class Period defendants made false and misleading statements and failed to disclose that: (i) Fulgent had been conducting medically unnecessary laboratory testing, engaging in improper billing practices in relation to laboratory testing, and providing or receiving remuneration in violation of the Anti-Kickback Statute and Stark Law; (ii) accordingly, Fulgent was likely to become subject to enhanced legal and regulatory scrutiny; (iii) Fulgent’s revenues, to the extent they were derived from the foregoing unlawful conduct, were unsustainable; (iv) the foregoing, once revealed, was likely to subject the Company to significant financial and/or reputational harm; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE FLGT CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Fulgent you have until November 21, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

PLTR Class Action: Learn About the Palantir Lawsuit

Levi & Korsinsky, LLP

September 21, 2022

Levi & Korsinsky, LLP announces that a PLTR class action lawsuit has been filed on behalf of investors who purchased Palantir Technologies Inc. (PLTR) securities between November 9, 2021, and May 6, 2022. For more on the PLTR Lawsuit please contact us today.

 

 

 

According to the Palantir lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Palantir’s investments in marketable securities were having a significant negative impact on the Company’s earnings per share (“EPS”) results; (ii) Palantir overstated the sustainability of its government segment’s growth and revenues; (iii) Palantir was experiencing a significant slowdown in revenue growth, particularly among its government customers, despite ongoing global conflicts and market disruptions; (iv) as a result of all the foregoing, the Company was likely to miss consensus estimates for its first quarter 2022 EPS and second quarter 2022 sales outlook; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE PLTR CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Palantir you have until November 14, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Dindong (Cayman) Ltd Securities Class Action Lawsuit

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

TWTR Class Action: Learn About the Twitter Lawsuit

Levi & Korsinsky, LLP

September 15, 2022

Levi & Korsinsky, LLP announces that a TWTR class action lawsuit has been filed on behalf of investors who purchased Twitter, Inc. (TWTR) securities between August 3, 2020, and August 23, 2022. For more on the TWTR Lawsuit please contact us today.

 

 

According to the Twitter lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Twitter knew about security concerns on their platform; (2) Twitter actively worked to hide the security concerns from the board, the investing public, and regulators; (3) contrary to representations in its filings with the U.S. Securities and Exchange Commission, Twitter did not take steps to improve security; (4) Twitter’s active refusal to address security issues increased the risk of loss of public goodwill; and (5) as a result, defendants’ statements about Twitter’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE TWTR CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Twitter you have until November 14, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

MDT Class Action: Learn About the Medtronic plc Lawsuit

Levi & Korsinsky, LLP

September 13, 2022

Levi & Korsinsky, LLP announces that an MDT class action lawsuit has been filed on behalf of investors who purchased Medtronic plc (MDT) securities between June 8, 2019, and May 25, 2022. For more on the MDT Lawsuit please contact us today.

 

 

According to the Medtronic plc lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Medtronic’s product quality control systems were inadequate; (2) Medtronic had failed to comply with numerous regulations regarding risk assessment, corrective and preventive action, complaint handling, device recalls, and reporting of adverse events; (3) these failures increased the risk of regulatory investigation and action; (4) as a result of the Company’s misconduct, the U.S. Food and Drug Administration would delay the approval of additional Medtronic MiniMed devices, including the MiniMed 780G; (5) these delays in product approvals, as well as the Company’s need to improve its quality control systems, would negatively affect the Company’s financial performance and cause Medtronic to fall further behind its competitors; and (6) as a result of the foregoing, defendant’s statements about the Company’s business, operations, and prospects lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE MDT CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Medtronic plc you have until November 7, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SMFR Class Action: Learn About the Sema4 Holdings, Corp. Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an SMFR class action lawsuit has been filed on behalf of investors who purchased Sema4 Holdings, Corp. (SMFR) securities between March 14, 2022, and August 15, 2022. For more on the SMFR Lawsuit please contact us today.

 

 

 

According to the Sema4 Holdings, Corp. lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) there was a significant risk that Sema4 would reverse a material amount of previously recognized revenue that it could not recoup from third-party payors; (2) the Company was experiencing declining selling prices for its reproductive health segment; (3) as a result of the foregoing, Sema4’s financial results would be adversely affected; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE SMFR CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Sema4 Holdings, Corp. you have until November 7, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Dindong (Cayman) Ltd Securities Class Action Lawsuit

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ABT Class Action: Learn About the Abbott Laboratories Lawsuit

Levi & Korsinsky, LLP

September 7, 2022

Levi & Korsinsky, LLP announces that an ABT  class action lawsuit has been filed on behalf of investors who purchased Abbott Laboratories (ABT) This lawsuit is on behalf of all persons or entities who purchased or otherwise acquired shares of Abbott common stock during the period from February 19, 2021, to June 8, 2022, For more on the ABT Lawsuit please contact us today.

 

 

 

According to the Abbott Laboratories lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: the defendants touted the strength of Abbott’s infant formula brands and their contribution to the Company’s sales and revenue growth, despite knowing that the facility that manufactured those products was in flagrant violations of United States Food and Drug Administration (“FDA”) health, safety, and manufacturing regulations. The complaint further alleges that the defendants willfully or recklessly concealed these violations from investors, even though the violations put Abbott’s infant formula business in dire jeopardy and left the Company exposed to a risk of severe regulatory action, including the recall of its products and closure of the Sturgis facility. Indeed, according to the complaint, the defendants received direct warnings, communications, FDA inspection reports, and consumer complaints identifying in detail the safety and regulatory violations that were rampant at the Sturgis

 

TO LEARN MORE ABOUT THE ABT CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Abbott Laboratories you have until October 31, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Dindong (Cayman) Ltd Securities Class Action Lawsuit

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

KSS Class Action: Learn About the Kohl’s Corporation Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a KSS class action lawsuit has been filed on behalf of investors who purchased Kohl’s Corporation (KSS) securities between October 20, 2020, and May 19, 2022 For more on the KSS Lawsuit please contact us today.

 

 

 

According to the Kohl’s Corporation lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Kohl’s new strategic framework to “drive top-line growth,” “expand operating margin,” and become “the most trusted retailer of choice for the active and casual lifestyle” (the “Strategic Plan”) was not well tailored to achieving the Company’s stated goals; (ii) the defendants had likewise overstated the Company’s success in executing its Strategic Plan; (iii) Kohl’s had deficient disclosure controls and procedures, internal control over financial reporting, and corporate governance mechanisms; (iv) as a result, the Company’s board of directors was able to and did withhold material information from shareholders about the state of Kohl’s in the lead-up to the Company’s annual meeting; (v) all the foregoing, once revealed, was likely to have a material adverse impact on Kohl’s financial condition and reputation; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE KSS CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Kohl’s Corporation you have until November 1, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Dindong (Cayman) Ltd Securities Class Action Lawsuit

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

TSP Class Action: Learn About the TuSimple Holdings Lawsuit

Levi & Korsinsky, LLP

September 2, 2022

Levi & Korsinsky, LLP announces that a TSP class action lawsuit has been filed on behalf of investors who purchased TuSimple Holdings Inc. (TSP) This lawsuit is on behalf of all persons who: (a) purchased or otherwise acquired TuSimple common stock pursuant and/or traceable to documents issued in connection with TuSimple’s April 15, 2021, initial public offering; and/or (b) that purchased or otherwise acquired TuSimple securities between April 15, 2021, and August 1, 2022, both dates inclusive. For more on the TSP Lawsuit please contact us today.

 

 

According to the TuSimple Holdings lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) TuSimple’s commitment to safety was significantly overstated and defendants concealed fundamental problems with the Company’s technology; (ii) TuSimple was rushing the testing of its autonomous driving technology in order to deliver driverless trucks to the market ahead of its more safety-conscious competitors; (iii) there was a corporate culture within TuSimple that suppressed or ignored safety concerns in favour of unrealistically ambitious testing and delivery schedules; (iv) the aforementioned conduct made accidents involving the Company’s autonomous driving technology more likely; (v) the aforementioned conduct invited enhanced regulatory scrutiny and investigatory action toward the Company; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE TSP CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in TuSimple Holdings you have until October 31, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Dindong (Cayman) Ltd Securities Class Action Lawsuit

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

AZRE Class Action: Learn About the Azure Power Global Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an AZRE class action lawsuit has been filed on behalf of investors who purchased Azure Power Global Limited (AZRE) securities between June 15, 2021, and August 26, 2022 For more on the AZRE Lawsuit please contact us today.

 

 

According to the Azure Power Global lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) there were procedural irregularities, including deviations from safety and quality standards, at one of Azure’s plants; (2) certain project data was manipulated; (3) as a result of the foregoing, the Company’s internal controls and procedures were not effective; (4) Azure had received a credible whistleblower report alleging such misconduct; and (5) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE AZRE CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Azure Power Global you have until October 31, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

LTCH Class Action: Learn About the Latch Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an LTCH class action lawsuit has been filed on behalf of investors who purchased Latch, Inc. f/k/a TS Innovation Acquisitions Corp. (LTCH) securities between May 13, 2021, and August 25, 2022 For more on the LTCH Lawsuit please contact us today.

 

 

 

According to the Latch lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) there were unreported sales arrangements related to hardware devices; (2) as a result, the Company had improperly recognized revenue throughout fiscal 2021 and first quarter 2022; (3) there were material weaknesses in Latch’s internal control over financial reporting related to revenue recognition; (4) as a result of the preceding, Latch would restate financial statements for fiscal 2021 and first quarter 2022; and (5) as a result of the preceding, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE LTCH CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Latch you have until October 31, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Dindong (Cayman) Ltd Securities Class Action Lawsuit

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

NIO Class Action: Learn About the NIO Lawsuit

Levi & Korsinsky, LLP

September 1, 2022

Levi & Korsinsky, LLP announces that an NIO class action lawsuit has been filed on behalf of investors who purchased NIO Inc. (NIO) securities between March 1, 2021, and July 11, 2022.  For more on the NIO Lawsuit please contact us today.

 

 

 

According to the NIO lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) NIO pulled forward revenue by selling batteries to a related party, which owned the batteries and managed users’ subscriptions; (2) through the related party, NIO also recognized enormous depreciation savings; (3) as a result of the foregoing, the Company’s revenue and net loss were overstated; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis

 

TO LEARN MORE ABOUT THE NIO CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in NIO you have until October 24, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

 


Class Action Reports

DDL Class Action: Learn About the Dingdong Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a DDL class action lawsuit has been filed on behalf of investors who purchased Dingdong (Cayman) Ltd. (DDL) This lawsuit is on behalf of persons who purchased or otherwise acquired, Dingdong American Depository Shares pursuant or traceable to the F-1 registration statements and related prospectus on Form 424B4 issued in connection with Dingdong’s June 2021 initial public stock offering. For more on the DDL Lawsuit please contact us today.

 

 

 

According to the Dingdong lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose: Omitted facts concerning Dingdong’s so-called commitment to ensuring the safety and quality of the food it distributes to the market.  For example, despite claiming that it applies “stringent quality control across [its] entire supply chain to ensure product quality to [its] users,” Dingdong sold food past its sell-by date.  Consequently, Dingdong was, in fact, no better at providing or assuring access to “fresh” groceries than the supermarkets, traditional Chinese wet markets, or traditional e-commerce platforms it repeatedly claimed to be displacing.  Moreover, the foregoing conduct subjected Dingdong to an increased risk of regulatory and/or governmental scrutiny and enforcement, all of which, once revealed, were likely to negatively impact Dingdong’s business, operations, and reputation.

 

TO LEARN MORE ABOUT THE DDL CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Dingdong you have until October 24, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

Dindong (Cayman) Ltd Securities Class Action Lawsuit

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

 


Class Action Reports

SFIX Class Action: Learn About the Stitch Fix Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an SFIX class action lawsuit has been filed on behalf of investors who purchased Stitch Fix, Inc. (SFIX) securities between December 8, 2020, and March 8, 2022, For more on the SFIX Lawsuit please contact us today.

 

 

 

According to the Stitch Fix lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  Stitch Fix made numerous false and misleading statements to investors concerning the synergy between the Company’s Fix and Freestyle programs, and repeatedly denied claims that the Freestyle program could cannibalize the Company’s legacy Fix business. Specifically, Stitch Fix repeatedly assured investors that the Company’s Freestyle business was “an additive experience” and “complementary” to the Fix business, that “the combination of those two things will allow us to address many more types of clients,” and that “we see solid growth in both sides of the business.” In truth, Stitch Fix concealed that these programs were not complementary or additive. Stitch Fix knew that the Freestyle program would be much preferred to the Company’s original Fix model and that the Freestyle program would inevitably cannibalize the Company’s legacy Fix business.

 

TO LEARN MORE ABOUT THE SFIX CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Stitch Fix you have until October 25, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

HGEN Class Action: Learn About the Humanigen Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an HGEN class action lawsuit has been filed on behalf of investors who purchased Humanigen, Inc.(HGEN)securities between May 28, 2021, and July 12, 2022. For more on the HGEN Lawsuit please contact us today.

 

 

According to the Humanigen lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Humanigen’s lead product candidate, lenzilumab, was less effective in treating hospitalized COVID-19 patients than the defendants had represented; (ii) as a result, the U.S. Food and Drug Administration was unlikely to approve the lenzilumab Emergency Use Authorization and the ACTIV-5/BET-B study was unlikely to meet its primary endpoint; (iii) accordingly, lenzilumab’s clinical and commercial prospects were overstated; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE HGEN CLASS ACTION LAWSUIT, CLICK HERE

If you suffered a loss in Humanigen you have until October 25, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

MNSO Class Action: Learn About the MINISO Lawsuit

Levi & Korsinsky, LLP

August 23, 2022

Levi & Korsinsky, LLP announces that an MNSO class action lawsuit has been filed on behalf of investors who purchased MINISO Group Holding Limited (MNSO) This lawsuit is on behalf of persons or entities who purchased or otherwise acquired publicly traded MINISO securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with MINISO’s October 2020 initial public offering. For more on the MNSO Lawsuit please contact us today.

 

 

According to the MINISO lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) defendants and other undisclosed related parties owned and controlled a much larger amount of MINISO stores than previously stated; (2) as a result, MINISO concealed its true costs; (3) the Company did not represent its true business model; (4) defendants, including the Company and its chairman, engaged in planned unusual and unclear transactions; (5) as a result of at least one of these transactions, the Company is at risk of breaching contracts with People’s Republic of China authorities; (6) the Company would imminently and drastically drop its franchise fees; and (7) as a result, defendant’s statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE MNSO CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in MINISO you have until October 17, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CODX Class Action: Learn About the Co-Dx Lawsuit

Levi & Korsinsky, LLP

August 19, 2022

Levi & Korsinsky, LLP announces that a CODX class action lawsuit has been filed on behalf of investors who purchased Co-Diagnostics, Inc.  (CODX) This lawsuit is on behalf of a class of all persons and entities who purchased the publicly traded securities of Co-Dx during the period of May 12, 2022, through the close of the market on August 11, 2022 (4:00 p.m. ET). For more on the CODX Lawsuit please contact us today.

 

 

 

 

According to the Co-Dx lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) demand for the Company’s Logix Smart COVID-19 test had plummeted throughout the quarter ended June 30, 2022, and (ii) as a result, defendants’ positive statements about the demand for its Logix Smart COVID-19 test lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE CODX CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Co-Dx you have until October 17, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

AMPE Class Action: Learn About the Ampio Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an AMPE class action lawsuit has been filed on behalf of investors who purchased  Ampio Pharmaceuticals, Inc. (AMPE) This lawsuit is on behalf of all persons or entities that purchased or otherwise acquired Ampio common stock between December 29, 2020, and August 3, 2022, inclusive.  For more on the AMPE Lawsuit please contact us today.

 

 

 

According to the Ampio lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(i) defendants had inflated the Company’s true ability to successfully file a Biologics License Application (“BLA”) for Ampion; (ii) defendants had inflated the results of the AP-013 study and the timing of unblinding the data from the AP-013 study; and (iii) as a result of the foregoing, defendant’s statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE AMPE CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Ampio you have until October 17, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

TUYA Class Action: Learn About the Tuya Lawsuit

Levi & Korsinsky, LLP

August 18, 2022

Levi & Korsinsky, LLP announces that a TUYA class action lawsuit has been filed on behalf of investors who purchased Tuya Inc. (TUYA)This lawsuit is on behalf of all persons or entities who purchased Tuya American Depositary Shares in or traceable to the Company’s March 2021 initial public offering For more on the TUYA Lawsuit please contact us today.

 

 

 

According to the Tuya lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (a) a material portion of Tuya’s China-based customers were engaged in the widespread and systematic manipulation of reviews and product offerings in violation of Amazon.com’s terms of use; (b) prior to the initial public offering, a consumer investigation and data breach had exposed an illicit fake review scheme being perpetrated by many of Tuya’s clients, among others, which included, inter alia, the exposure of 13 million records of organized fake review scams linked to over 200,000 Amazon account profiles; (c) as a result of (a) and (b) above, there was a substantial risk that a material portion of Tuya’s significant customers would be barred from using Amazon.com’s platform, negatively impacting Tuya’s business, revenue, earnings, and prospects; and (d) as a result of (a)-(c) above, the registration statement’s representations regarding Tuya’s historical financial and operational metrics and purported market opportunities and expected growth did not accurately reflect the actual business, operations, financial results, and trajectory of the Company at the time of the initial public offering, and such statements were materially false and misleading and lacked a reasonable factual basis.

 

TO LEARN MORE ABOUT THE TUYA CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Tuya you have until October 11, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

LFST Class Action: Learn About the LifeStance Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an LFST class action lawsuit has been filed on behalf of investors who purchased LifeStance Health Group, Inc. (LFST) This lawsuit is on behalf of all purchasers of LifeStance common stock pursuant and/or traceable to the documents issued in connection with LifeStance’s June 10, 2021, initial public stock offering. For more on the LFST Lawsuit please contact us today.

 

 

 

According to the LifeStance lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the number of virtual visits clients were undertaking utilizing LifeStance Health was decreasing as the COVID-19 lockdowns were being lifted, thereby flatlining LifeStance Health’s out-patient/virtual revenue growth; (ii) the percentage of in-person visits clients were undertaking utilizing LifeStance Health was increasing as the COVID-19 lockdowns were being lifted, thereby causing LifeStance Health’s operating expenses to increase substantially; (iii) LifeStance Health had lost a large number of physicians due to burn-out and, as a result, its physician retention rate had fallen significantly below the 87% highlighted in the initial public offering’s registration statement, and LifeStance Health had been expending additional costs to onboard new physicians who were less productive than the outgoing physicians they were replacing; and (iv) as a result, LifeStance Health’s business metrics and financial prospects were not as strong as the initial public offering’s registration statement represented.

 

 

TO LEARN MORE ABOUT THE LFST CLASS ACTION LAWSUIT, CLICK HERE

 

 

If you suffered a loss in LifeStance you have until October 11, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

KRBP Class Action: Learn About the Kiromic Lawsuit

Levi & Korsinsky, LLP

August 12, 2022

Levi & Korsinsky, LLP announces that a KRBP class action lawsuit has been filed on behalf of investors who purchased Kiromic BioPharma, Inc. (KRBP) This lawsuit is on behalf of a class consisting of persons and entities that purchased or otherwise acquired: (a) Kiromic common stock issued in connection with the Company’s public offering that closed on July 2, 2021, and/or (b) Kiromic common stock between June 25, 2021, and August 13, 2021, both dates inclusive. For more on the KRBP Lawsuit please contact us today.

 

 

 

According to the Kiromic lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: The complaint alleges that the registration statement and prospectus issued in connection with the Company’s public offering that closed on July 2, 2021 (the “Offering Documents”) failed to disclose that the Food and Drug Administration (“FDA”) had, prior to the filing of these documents, imposed a clinical hold on the Company’s Investigational New Drug (“IND”) applications for its two new drug candidates. Given that the offering closed on July 2, 2021, more than thirty (30) days after the Company submitted the IND applications for its two immunotherapy product candidates, investors were assured that no clinical hold had been issued and clinical trials would commence.

 

 

TO LEARN MORE ABOUT THE KRBP CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Kiromic you have until October 4, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CVNA Class Action: Learn About the Carvana Lawsuit

Levi & Korsinsky, LLP

August 8, 2022

Levi & Korsinsky, LLP announces that a CVNA class action lawsuit has been filed on behalf of investors who purchased Carvana Co.(CVNA) securities between May 6, 2020, and June 24, 2022 For more on the CVNA Lawsuit please contact us today.

 

 

 

According to the Carvana lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Carvana faced severe, ongoing issues with documentation, registration, and title with many of its vehicles; (2) as a result, Carvana was issuing unusually frequent temporary plates; (3) as a result of the foregoing, Carvana was violating laws and regulations in many existing markets; (4) as a result of the foregoing, Carvana risked its ability to continue business and/or expand its business in existing markets; (5) as a result of the foregoing, Carvana was at an increased risk of governmental investigation and action; (6) Carvana was in discussion with state and local authorities regarding the above-stated business tactics and issues; (7) Carvana was facing imminent and ongoing regulatory actions including license suspensions, business cessation, and probation in several states and counties including in Arizona, Illinois, Pennsylvania, Michigan, and North Carolina; and (8) as a result, Defendants’ statements about Carvana’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE CVNA CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Carvana you have until October 3, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ENOB Class Action: Learn About the Enochian Lawsuit

Levi & Korsinsky, LLP

August 3, 2022

Levi & Korsinsky, LLP announces that an ENOB class action lawsuit has been filed on behalf of investors who purchased Enochian BioSciences, Inc.(ENOB) securities between January 17, 2018, and June 27, 2022. For more on the ENOB Lawsuit please contact us today.

 

 

 

According to the Enochian lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s co-founder and inventor Serhat Gumrukcu was engaged in a variety of frauds; (2) Gumrukcu was not a licensed doctor anywhere in the world; (4) as a result of the foregoing, Gumrukcu’s purported contributions to the Company lacked a reasonable basis; (5) as a result of the foregoing, the Company had overstated its commercial prospects; (6) Gumrukcu had improperly diverted approximately $20 million from Enochian to entities he owned; and (7) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE ENOB CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Enochian you have until September 26, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

 


Class Action Reports

WEBR Class Action: Learn About the Weber Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a WEBR class action lawsuit has been filed on behalf of investors who purchased Weber Inc. (WEBR) This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Weber Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s August 2021 initial public offering For more on the WEBR Lawsuit please contact us today.

 

 

 

According to the Weber lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) Weber was reasonably likely to implement price increases; (2) as a result, consumer demand for Weber’s products was reasonably likely to decrease; (3) due to the resulting inventory buildup, Weber was reasonably likely to run promotions to “enhance retail sell through”; (4) the foregoing would adversely impact Weber’s financial results; and (5) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE WEBR CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Weber you have until September 27, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

 


Class Action Reports

YQ Class Action: Learn About the 17 Education & Technology Group Lawsuit

Levi & Korsinsky, LLP

July 27, 2022

Levi & Korsinsky, LLP announces that a YQ class action lawsuit has been filed on behalf of investors who purchased 17 Education & Technology Group Inc.(YQ) This lawsuit is on behalf of persons or entities who purchased or otherwise acquired publicly traded 17EdTech securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with 17EdTech’s December 2020 initial public offering. For more on the YQ Lawsuit please contact us today.

 

 

 

According to the 17 Education & Technology Group lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) 17EdTech’s K-12 Academic AST Services would end less than a year after the Company’s initial public offering; (2) as part of its ongoing regulatory efforts, Chinese authorities would imminently curtail and/or end 17EdTech’s core business; and (3) as a result, defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE YQ CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in 17 Education & Technology Group you have until September 19, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

 


Class Action Reports

TGTX Class Action: Learn About the TG Therapeutics Lawsuit

Levi & Korsinsky, LLP

July 22, 2022

Levi & Korsinsky, LLP announces that a TGTX class action lawsuit has been filed on behalf of investors who purchased  TG Therapeutics, Inc. (TGTX) securities between January 15, 2020, and May 31, 2022. For more on the TGTX Lawsuit please contact us today.

 

 

 

According to the TG Therapeutics lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) clinical trials revealed significant concerns related to the benefit-risk ratio and overall survival data of the Company’s therapeutic product candidates, Ublituximab and Umbralisib; (ii) accordingly, it was unlikely that the Company would be able to obtain approval from the U.S. Food and Drug Administration of the Umbralisib marginal zone lymphoma and follicular lymphoma New Drug Application, the Biologics License Application for Ublituximab in combination with Umbralisib, the supplemental New Drug Application for Ublituximab in combination with Umbralisib, or the Ublituximab relapsing forms of multiple sclerosis Biologics License Application in their current forms; (iii) as a result, the Company had significantly overstated Ublituximab and Umbralisib’s clinical and/or commercial prospects; and (iv) therefore, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE TGTX CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in TG Therapeutics you have until September 16, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

MF Class Action: Learn About the Missfresh Lawsuit

Levi & Korsinsky, LLP

July 18, 2022

Levi & Korsinsky, LLP announces that an MF class action lawsuit has been filed on behalf of investors who purchased Missfresh Limited  (MF) This lawsuit is on behalf of persons who purchased or otherwise acquired Missfresh securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Missfresh’s June 2021 initial public offering For more on the MF Lawsuit please contact us today.

 

 

 

According to the Missfresh lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Missfresh provided false financial figures in its registration statement and related prospectus issued in connection with the Company’s June 2021 initial public offering; (2) Missfresh would need to amend its financial figures; (3) Missfresh, among other things, had lesser net revenues for the quarter ended March 31, 2021; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times and negligently prepared.

 

TO LEARN MORE ABOUT THE MF CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Missfresh you have until September 12, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

MOLN Class Action: Learn About the Molecular Partners Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a MOLN class action lawsuit has been filed on behalf of investors who purchased Molecular Partners AG (MOLN) This lawsuit is on behalf of a class consisting of persons and entities that purchased or otherwise acquired: (a) Molecular Partners American Depositary Shares pursuant and/or traceable to certain documents issued in connection with the Company’s initial public offering conducted on or about June 16, 2021; and/or (b) Molecular Partners securities between June 16, 2021, and April 26, 2022.  For more on the MOLN Lawsuit please contact us today.

 

 

 

 

According to the Molecular Partners lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company’s product, ensovibep, was less effective at treating COVID-19 than defendants had led investors to believe; that (ii) accordingly, the the U.S. Food and Drug Administration (“FDA”) was reasonably likely to require an additional Phase 3 study of ensovibep before granting the drug Emergency Use Authorization (“EUA”); (iii) waning global rates of COVID-19 significantly reduced the Company’s chances of securing EUA for ensovibep; (iv) another of the Company’s product candidates, MP0310, was less attractive to Molecular Partners’ collaborator, Amgen, than defendants had led investors to believe; (v) accordingly, there was a significant likelihood that Amgen would return to global rights of MP0310 to Molecular Partners; (vi) as a result of all the foregoing, the clinical and commercial prospects of ensovibep and MP0310 were overstated; and (vii) as a result, documents issues in connection with the Company’s initial public offer and defendants’ public statements throughout the class period were materially false and/or misleading and failed to state information required to be stated therein.

 

TO LEARN MORE ABOUT THE MOLN CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Molecular Partners you have until September 12, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

AMZN Class Action: Learn About the Amazon Lawsuit

Levi & Korsinsky, LLP

July 12, 2022

Levi & Korsinsky, LLP announces that an AMZN class action lawsuit has been filed on behalf of investors who purchased Amazon.com, Inc.(AMZN) securities between July 30, 2021, and April 28, 2022,  For more on the AMZN Lawsuit please contact us today.

 

 

According to the Amazon lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  1) defendants knew or recklessly disregarded that the Company’s infrastructure and fulfilment network investments substantially outpaced demand; 2) those investments were a massive, self-imposed, undue drain on Amazon’s financial condition; 3) contrary to defendants’ public statements and undisclosed to investors, defendants had already implemented cutbacks to Amazon’s fulfilment capacity by July 2021; and 4) as a result of defendants’ misrepresentations and omissions, Amazon’s common stock traded at artificially inflated prices during the class period.

 

TO LEARN MORE ABOUT THE AMZN CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Amazon you have until September 6, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

U Class Action: Learn About the Unity Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a U class action lawsuit has been filed on behalf of investors who purchased Unity Software Inc. (U) securities between March 5, 2021, and May 10, 2022. For more on the U Lawsuit please contact us today.

 

 

 

According to the Unity lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) deficiencies in Unity’s product platform reduced the accuracy of the Company’s machine learning technology; (ii) the foregoing was likely to have a material negative impact on the Company’s revenues; (iii) accordingly, Unity had overstated the Company’s commercial and/or financial prospects for 2022; (iv) as a result, the Company was likely to have to reduce its fiscal 2022 guidance; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE U CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Unity you have until September 6, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

OM Class Action: Learn About the Outset Medical Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an OM class action lawsuit has been filed on behalf of investors who purchased Outset Medical, Inc. (OM) securities between September 15, 2020, and June 13, 2022. For more on the OM Lawsuit please contact us today.

 

 

 

According to the Outset Medical lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) the Company’s flagship product, Tablo Hemodialysis System (“Tablo”), would require an additional 510(k) application to be filed with The United States Food and Drug Administration (“FDA”), as defendants had “continuously made improvements and updates to Tablo over time since its original clearance”; (2) as a result, the Company could not conduct a human factors study on a cleared device in accordance with FDA protocols; (3) the Company’s inability to perform the human factors study subjected the Company to the likelihood of the FDA imposing a “shipment hold” and marketing suspension, leaving the Company unable to sell Tablo for home use; and (4) as a result, defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and /or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE OM CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Outset Medical you have until September 6, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

WFC Class Action: Learn About the Wells Fargo Lawsuit

Levi & Korsinsky, LLP

July 5, 2022

Levi & Korsinsky, LLP announces that a WFC class action lawsuit has been commenced on behalf of investors who purchased Wells Fargo & Company (WFC) securities between February 24, 2021 and June 9, 2022. For more on the WFC Class Action please contact us today.

 

 

 

 

According to the Wells Fargo lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Wells Fargo had misrepresented its commitment to diversity in the Company’s workplace; (ii) Wells Fargo conducted fake job interviews in order to meet its Diverse Search Requirement; (iii) the foregoing conduct subjected Wells Fargo to an increased risk of regulatory and/or governmental scrutiny and enforcement action, including criminal charges; (iv) all of the foregoing, once revealed, was likely to negatively impact Wells Fargo’s reputation; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

 

TO LEARN MORE ABOUT THE WFC CLASS ACTION, CLICK HERE

 

If you suffered a loss in Wells Fargo you have until August 29, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

NOTV Class Action: Learn About the Inotiv Lawsuit

Levi & Korsinsky, LLP

June 24, 2022

Levi & Korsinsky, LLP announces that a NOTV class action lawsuit has been filed on behalf of investors who purchased Inotiv, Inc. (NOTV) securities between September 21, 2021, and June 13, 2022. For more on the NOTV Lawsuit please contact us today.

 

 

 

According to the Inotiv lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) Inotiv’s acquisition, Envigo RMS, LL (“Envigo”), and Inotiv’s Cumberland, Virginia facility (the “Cumberland Facility”) engaged in widespread and flagrant violations of the Animal Welfare Act (“AWA”); (2) Envigo and Inotiv’s Cumberland Facility continuously violated the AWA; (3) Envigo and Inotiv did not properly remedy issues with regards to animal welfare at the Cumberland facility; (4) as a result, Inotiv was likely to face increased scrutiny and governmental action; (5) Inotiv would imminently shut down two facilities, including the Cumberland Facility; (6) Inotiv did not engage in proper due diligence; and (7) as a result, defendants’ statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE NOTV CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Inotiv you have until August 22, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

 


Class Action Reports

YEXT Class Action: Learn About the Yext Lawsuit

Levi & Korsinsky, LLP

June 23, 2022

Levi & Korsinsky, LLP announces that a YEXT class action lawsuit has been filed on behalf of investors who purchased Yext, Inc.(YEXT) securities between March 4, 2021, and March 8, 2022.  For more on the YEXT Lawsuit please contact us today.

 

 

 

According to the Yext lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Yext’s revenue and earnings were significantly deteriorating because of, among other things, poor sales execution and performance, as well as COVID-19 related disruptions; (ii) accordingly, Yext was unlikely to meet consensus estimates for its full-year fiscal 2022 financial results and fiscal 2023 outlook; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE YEXT CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Yext you have until August 16, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

 


Class Action Reports

XRAY Class Action: Learn About the Dentsply Lawsuit

Levi & Korsinsky, LLP

June 22, 2022

Levi & Korsinsky, LLP announces that an XRAY class action lawsuit has been filed on behalf of investors who purchased Dentsply Sirona Inc. (XRAY) securities between June 9, 2021, and May 9, 2022. For more on the XRAY Lawsuit please contact us today.

 

 

 

According to the Dentsply lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the filed complaint, defendants orchestrated a scheme to inflate Dentsply’s revenue and earnings by manipulating the Company’s accounting for a distributor rebate program so that senior executives would be eligible for significant cash and stock-based incentive compensation. In order to facilitate this scheme, Dentsply and its executives made numerous false and misleading statements to investors during the class period. As a result of the defendants’ misrepresentations, Dentsply’s common stock was traded at artificially inflated prices during the class period.

 

 

TO LEARN MORE ABOUT THE XRAY CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Dentsply you have until August 1, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

 


Class Action Reports

TUP Class Action: Learn About the Tupperware Lawsuit

Levi & Korsinsky, LLP

June 20, 2022

Levi & Korsinsky, LLP announces that a TUP class action lawsuit has been filed on behalf of investors who purchased Tupperware Brands Corporation (TUP) securities between November 3, 2021, and May 3, 2022.  For more on the TUP Lawsuit please contact us today.

 

 

 

According to the Tupperware lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Tupperware was facing significant challenges in maintaining its earnings and sales performance; (ii) accordingly, Tupperware’s full-year 2022 guidance was unrealistic and/or unsustainable; (iii) all the foregoing, once revealed, was likely to have a material negative impact on Tupperware’s financial condition; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE TUP CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Tupperware you have until August 15, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

UL Class Action: Learn About the Unilever Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a UL class action lawsuit has been filed on behalf of investors who purchased Unilever PLC (UL) securities between September 2, 2020, and July 21, 2021 For more on the UL Lawsuit please contact us today.

 

 

 

According to the Unilever lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: a) in July 2020, the board of Ben & Jerry’s, one of Unilever’s marquee brands, passed a resolution to end sales of its ice cream in “Occupied Palestinian Territory”; and b) this boycott decision risked adverse governmental actions for violations of laws, executive orders, or resolutions aimed at discouraging boycotts, divestment, and sanctions of Israel adopted by 35 U.S. states.

 

 

TO LEARN MORE ABOUT THE UL CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Unilever you have until  August 15, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

WM Class Action: Learn About the Waste Management Lawsuit

Levi & Korsinsky, LLP

June 15, 2022

Levi & Korsinsky, LLP announces that a WM class action lawsuit has been filed on behalf of investors who purchased Waste Management, Inc. (WM) securities between February 13, 2020, and June 23, 2020 For more on the WM Lawsuit please contact us today.

 

 

According to the Waste Management lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) the U.S. Department of Justice had indicated to Waste Management that it would require Waste Management to divest significantly more assets than the $200 million indicated in the merger agreement between the Company and Advanced Disposal Services; (ii) as a result, the merger would not be completed by July 14, 2020, the end date under the merger agreement; and (iii) the Waste Management redeemable senior notes would be subject to mandatory redemption at 101% of par.

 

TO LEARN MORE ABOUT THE WM CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Waste Management you have until August 8, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

TDOC Class Action: Learn About the Teladoc Lawsuit

Levi & Korsinsky, LLP

June 8, 2022

Levi & Korsinsky, LLP announces that a TDOC class action lawsuit has been filed on behalf of investors who purchased  Teladoc Health, Inc.  (TDOC) securities between October 28, 2021, and April 27, 2022. For more on the TDOC Lawsuit please contact us today.

 

 

 

According to the Teladoc lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) increased competition, among other factors, was negatively impacting Teladoc’s BetterHelp and chronic care businesses; (ii) accordingly, the growth of those businesses was less sustainable than Defendants had led investors to believe; (iii) as a result, Teladoc’s revenue and adjusted EBITDA projections for FY 2022 were unrealistic; (iv) as a result of all the foregoing, Teladoc would be forced to recognize a significant non-cash goodwill impairment charge; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE TDOC CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Teladoc you have until August 5, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

APPS Class Action: Learn About the Digital Turbine Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an APPS class action lawsuit has been filed on behalf of investors who purchased Digital Turbine, Inc. (APPS) securities between August 9, 2021, and May 17, 2022. For more on the APPS Lawsuit please contact us today.

 

 

 

 

 

According to the Digital Turbine lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s recent acquisitions, AdColony and Fyber, act as agents in certain of their respective product lines; (2) as a result, revenues for those product lines must be reported net of license fees and revenue share, rather than on a gross basis; (3) the Company’s internal control over financial reporting as to revenue recognition was deficient; and (4) as a result of the foregoing, the Company’s net revenues was overstated throughout fiscal 2022; and (5) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE APPS CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Digital Turbineyou have until August 5, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

APYX Class Action: Learn About the Apyx Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an APYX class action lawsuit has been filed on behalf of investors who purchased Apyx Medical Corporation  (APYX) securities between May 12, 2021, and March 11, 2022. For more on the APYX Lawsuit please contact us today.

 

 

 

According to the Apyx lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) a significant number of Apyx’s Advanced Energy products were used for off-label indications; (2) such off-label uses led to an increase in the number of medical device reports filed by Apyx reporting serious adverse events; (3) as a result, the Company was reasonably likely to incur regulatory scrutiny; (4) as a result of the foregoing, the Company’s financial results would be adversely impacted; and (5) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE APYX CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Apyx you have until August 5, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

VRCA Class Action: Learn About the Verrica Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a VRCA class action lawsuit has been filed on behalf of investors who purchased Verrica Pharmaceuticals, Inc. (VRCA) securities between May 28, 2021, and May 24, 2022. For more on the VRCA Lawsuit please contact us today.

 

 

 

According to the Verricalawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) there were manufacturing deficiencies at the facility where Verrica’s contract manufacturer produced a bulk solution for the Company’s lead product candidate, VP-102; (2) these deficiencies were not remediated when Verrica resubmitted its New Drug Application for VP-12 for molluscum; (3) the foregoing presented significant risks to Verrica obtaining regulatory approval of VP-102 for molluscum; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE VRCA CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Verrica you have until August 5, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ET Class Action: Learn About the Energy Transfer Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an ET class action lawsuit has been filed on behalf of investors who purchased Energy Transfer LP (ET) securities between April 13, 2017, and December 20, 2021, For more on the ET Lawsuit please contact us today.

 

 

According to the Energy Transfer lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (a) Energy Transfer had inadequate internal controls and procedures to prevent contractors from engaging in illegal conduct with regards to drilling activities, and/or failed to adequately mitigate known issues related to such controls and procedures; (b) Energy Transfer, through its subsidiary Rover Pipeline, LLC, hired a third-party contractor to conduct Horizontal Directional Drilling Activities for the Rover Pipeline Project, whose conduct of adding illegal additives in the drilling mud caused severe pollution near the Tuscarawas River when a sizeable inadvertent release took place on April 13, 2017; (c) Energy Transfer continually downplayed its potential civil liabilities when the Federal Energy Regulatory Commission (“FERC”) was actively investigating the Energy Transfer’s wrongdoing related to the April 13 release and consistently provided it with updated information about FERC’s findings on this matter.

 

TO LEARN MORE ABOUT THE ET CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Energy Transfer you have until August 2, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

IONQ Class Action: Learn About the IonQ Lawsuit

Levi & Korsinsky, LLP

June 2, 2022

Levi & Korsinsky, LLP announces that an IONQ class action lawsuit has been filed on behalf of investors who purchased IonQ, Inc.(IONQ) securities between March 30, 2021, and May 2, 2022. For more on the IONQ Lawsuit please contact us today.

 

 

According to the IonQ lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) IonQ had not yet developed a 32-qubit quantum computer; (2) the Company’s 11-qubit quantum computer suffered from significant error rates, rendering it useless; (3) IonQ’s quantum the computer is not sufficiently reliable, so it is not accessible despite being available through major cloud providers; (4) a significant portion of IonQ’s revenue was derived from improper roundtripping transactions with related parties; and (5) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were the materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE IONQ CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in IonQ you have until August 1, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SPRO Class Action: Learn About the Spero Therapeutics Lawsuit

Levi & Korsinsky, LLP

June 1, 2022

Levi & Korsinsky, LLP announces that an SPRO class action lawsuit has been filed on behalf of investors who purchased Spero Therapeutics, Inc. (SPRO) securities between October 28, 2021, and May 2, 2022. For more on the SPRO Lawsuit please contact us today.

 

 

According to the Spero Therapeutics lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(i) the data submitted in support of the New Drug Application (“NDA”) for the Company’s product candidate, Tebipenem HBr, were insufficient to obtain approval from the U.S. Food and Drug Administration (“FDA”); (ii) accordingly, it was unlikely that the FDA would approve the Tebipenem HBr NDA in its current form; (iii) the foregoing would necessitate a significant workforce reduction and restructuring of Spero’s operations; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE SPRO CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Spero Therapeutics you have until July 25, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CDNA Class Action: Learn About the CareDx Lawsuit

Levi & Korsinsky, LLP

May 26, 2022

Levi & Korsinsky, LLP announces that a CDNA class action lawsuit has been filed on behalf of investors who purchased CareDx, Inc.  (CDNA) securities between February 24, 2021, and May 5, 2022. For more on the CDNA Lawsuit please contact us today.

 

 

According to the CareDx lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) defendants had engaged in a variety of improper and illegal schemes to inflate testing services revenue and demand, including pushing a surveillance protocol through inaccurate marketing materials, offering extravagant inducements or kickbacks to physicians and other providers, and improperly bundling expensive testing services with other blood tests as part of the Company’s RemoTraC service for remote, home-based, blood-drawing; (2) these practices, and others, subjected CareDx to an undisclosed risk of regulatory scrutiny; (3) these practices rendered the Company’s testing services revenue reported throughout the class period artificially inflated; and (4) as a result, defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE CDNA CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in CareDx you have until July 22, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

OKTA Class Action: Learn About the Okta Lawsuit

Levi & Korsinsky, LLP

May 25, 2022

Levi & Korsinsky, LLP announces that an OKTA class action lawsuit has been filed on behalf of investors who purchased Okta, Inc.(OKTA) securities between March 5, 2021, and March 22, 2022. For more on the OKTA Lawsuit please contact us today.

 

 

According to the Okta lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Okta had inadequate cybersecurity controls; (ii) as a result, Okta’s systems were vulnerable to data breaches; (iii) Okta ultimately did experience a data breach caused by a hacking group, which potentially affected hundreds of Okta customers; (iv) Okta initially did not disclose and subsequently downplayed the severity of the data breach; (v) all the foregoing, once revealed, was likely to have a material negative impact on Okta’s business, financial condition, and reputation; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE OKTA CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Okta you have until July 19, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

PEGA Class Action: Learn About the PEGA Lawsuit

Levi & Korsinsky, LLP

May 23, 2022

Levi & Korsinsky, LLP announces that a PEGA class action lawsuit has been filed on behalf of investors who purchased Pegasystems Inc.  (PEGA) securities between May 29, 2020, and May 9, 2022 For more on the PEGA Lawsuit please contact us today.

 

 

 

According to the PEGA lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) PEGA had engaged in corporate espionage and misappropriation of trade secrets to better compete against Appian, a principal competitor; (2) defendants’ product development and associated success was, in significant part, not the result of its own research and product testing but rather the result of such corporate espionage and trade secret theft; (3) defendants had engaged in a scheme to steal Appian trade secrets, which was not only known to, but carried out through, the personal involvement of the Company’s CEO; (4) the Company’s CEO and other officers and employees did not comply with the Company’s written Code of Conduct, including its express prohibition on “stealing” confidential information from a competitor and “misrepresenting your identity in hopes of obtaining confidential information”; (5) the Company was “unable to reasonably estimate damages” in the lawsuit filed by Appian as a result of the foregoing misconduct (the “Appian Litigation”); and (6) as a result of the foregoing, defendants’ statements about PEGA’s business, operations, prospects, legal compliance, and potential damages exposure in the Appian Litigation were materially false and/or misleading and/or lacked a reasonable basis when made.

 

TO LEARN MORE ABOUT THE PEGA CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in PEGA you have until  July 18, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

AXSM Class Action: Learn About the Axsome Lawsuit

Levi & Korsinsky, LLP

May 17, 2022

Levi & Korsinsky, LLP announces that an AXSM class action lawsuit has been filed on behalf of investors who purchased Axsome Therapeutics, Inc.(AXSM) securities between December 30, 2019, and April 22, 2022. For more on the AXSM Lawsuit please contact us today.

 

 

 

According to the Axsome lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Axsome’s chemistry, manufacturing, and control (“CMC”) practices were deficient with respect to AXS-07, the Company’s medicine for the acute treatment of migraine, and its manufacturing process; (ii) as a result, Axsome was unlikely to submit the AXS-07 New Drug Application (“NDA”) on its initially represented timeline; (iii) the foregoing CMC issues remained unresolved at the time that the U.S. Food and Drug Administration (“FDA”) reviewed the AXS-07 NDA; (iv) accordingly, the FDA was unlikely to approve the AXS-07 NDA; (v) as a result of all the foregoing, Axsome had overstated AXS-07’s regulatory and commercial prospects; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE AXSM CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Axsome you have until July 12, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

UPST Class Action: Learn About the Upstart Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a UPST class action lawsuit has been filed on behalf of investors who purchased Upstart, Inc.  (UPST) securities between November 9, 2021, and May 9, 2022.  For more on the UPST Lawsuit please contact us today.

 

 

According to the Upstart lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) Upstart’s AI model could not adequately account for macroeconomic factors such as interest rates that impact the market-clearing price for loans; (2) as a result, Upstart was experiencing a negative impact on its conversion rate; (3) as a result, the Company was reasonably likely to use its balance sheet to fund loans; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE UPST CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Upstart you have until July 12, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

OSCR Class Action: Learn About the Oscar Lawsuit

Levi & Korsinsky, LLP

May 16, 2022

Levi & Korsinsky, LLP announces that an OSCR class action lawsuit has been filed on behalf of investors who purchased Oscar Health, Inc. (OSCR) This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Oscar Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s March 2021 initial public offering. For more on the OSCR Lawsuit please contact us today.

 

 

 

According to the Oscar lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Oscar was experiencing growing COVID-19 testing and treatment costs; (2) Oscar was experiencing growing net COVID costs; (3) Oscar would be negatively impacted by an unfavourable prior-year Risk Adjustment Data Validation result relating to 2019 and 2020; (4) Oscar was on track to be negatively impacted by significant SEP membership growth; and (5) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE OSCR CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Oscar you have until July 11, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

AMZN Class Action: Learn About the Amazon Lawsuit

Levi & Korsinsky, LLP

May 11, 2022

Levi & Korsinsky, LLP announces that an AMZN class action lawsuit has been filed on behalf of investors who purchased Amazon.com, Inc. (AMZN) securities between February 1, 2019, and April 5, 2022 For more on the AMZN Lawsuit please contact us today.

 

 

 

According to the Amazon lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Amazon engaged in anticompetitive conduct in its private-label business practices, including giving Amazon products preference over those of its competitors and using third-party sellers’ non-public data to compete with them; (ii) the foregoing exposed Amazon to a heightened risk of regulatory scrutiny and/or enforcement actions; (iii) Amazon’s revenues derived from its private-label business were in part the product of impermissible conduct and thus unsustainable; and (iv) as a result, the defendants’ public statements throughout the class period were materially false and/or misleading.

 

TO LEARN MORE ABOUT THE AMZN CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Amazon you have until July 5, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

MULN Class Action: Learn About the Mullen Automotive, Inc. f/k/a Net Element, Inc. or the “Company Lawsuit

Levi & Korsinsky, LLP

May 10, 2022

Levi & Korsinsky, LLP announces that a MULN class action lawsuit has been filed on behalf of investors who purchased Mullen Automotive, Inc. f/k/a Net Element, Inc. (MULN) securities between June 15, 2020, and April 6, 2022. For more on the MULN Lawsuit please contact us today.

 

 

According to the Mullen Automotive, Inc. f/k/a Net Element, Inc. or the “Company lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) Mullen overstates its ability and timeline regarding production; (2) Mullen overstates its deals with business partners, including Qiantu; (3) Mullen overstates its battery technology and capabilities; (4) Mullen overstates its ability to sell its branded products; (5) Net Element did not conduct proper due diligence into Mullen Technologies; (6) the Dragonfly K50, a luxury sports car, was not (solely) delayed due to the COVID-19 pandemic; and (7) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE MULN CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Mullen Automotive, Inc. f/k/a Net Element, Inc. or the “Company you have until July 5, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ARQQ Class Action: Learn About the Arqit Quantum Inc. f/k/a Centricus Acquisition Corp. Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an ARQQ class action lawsuit has been filed on behalf of investors who purchased Arqit Quantum Inc. f/k/a Centricus Acquisition Corp. (ARQQ) This lawsuit is on behalf of: (i) all persons or entities who purchased or otherwise acquired Arqit securities between September 7, 2021, and April 18, 2022, inclusive (the “Class Period”); and/or (ii) all holders of Centricus securities as of the record date for the special meeting of shareholders held on August 31, 2021, to consider approval of the merger between Arqit and Centricus (the “Merger”) and entitled to vote on the Merger. For more on the ARQQ Lawsuit please contact us today.

 

 

 

According to the Arqit Quantum Inc. f/k/a Centricus Acquisition Corp. lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Arqit’s proposed encryption technology would require widespread adoption of new protocols and standards for telecommunications; (2) British cybersecurity officials questioned the viability of Arqit’s proposed encryption technology in a meeting in 2020; (3) the British government was not an Arqit customer but, rather, providing grants to Arqit; (4) Arqit had little more than an early-stage prototype of its encryption system at the time of the Merger; and (5) as a result, Defendants’ statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE ARQQ CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Arqit Quantum Inc. f/k/a Centricus Acquisition Corp. you have until July 5, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

RSKD Class Action: Learn About the Riskified Lawsuit

Levi & Korsinsky, LLP

May 5, 2022

Levi & Korsinsky, LLP announces that an RSKD class action lawsuit has been filed on behalf of investors who purchased Riskified Ltd. (RSKD) The lawsuit seeks to recover losses on behalf of Riskified Ltd. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all persons or entities who purchased Riskified Class A ordinary shares in or traceable to the Company’s July 2021 initial public offering Follow the link below to get more information and be contacted by a member of our team for more on the RSKD Lawsuit please contact us today.

 

 

 

According to the Riskified lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) as Riskified expanded its user base, the quality of Riskified’s machine learning platform had deteriorated (rather than improved as represented in documents issued in connection with the July 2021 initial public offering), because of, among other things, inaccuracies in the algorithms associated with onboarding new merchants and entering new geographies and industries; (ii) Riskified had expanded its customer base into industries with relatively high rates of fraud – including partnerships with cryptocurrency and remittance business – in which Riskified had limited experience and that this expansion has negatively impacted the effectiveness of Riskified’s machine learning platform; (iii) as a result, Riskified was suffering from materially higher chargebacks and cost of revenue and depressed gross profits and gross profit margins during its third fiscal quarter of 2021; and (iv) thus, the representations in documents issued in connection with the July 2021 initial public offering regarding Riskified’s historical financial and operational metrics and purported market opportunities did not accurately reflect the actual business, operations, and financial results and trajectory of Riskified prior to and at the time of the July 2021 initial public offering, and were materially false and misleading, and lacked a factual basis.

 

TO LEARN MORE ABOUT THE RSKD CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Riskified you have until July 1, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

NFLX Class Action: Learn About the Netflix Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an NFLX class action lawsuit has been filed on behalf of investors who purchased Netflix, Inc.(NFLX) securities between October 19, 2021, and April 19, 2022 For more on the NFLX Lawsuit please contact us today.

 

 

 

According to the Netflix lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Netflix was exhibiting slower acquisition growth due to, among other things, account sharing by customers and increased competition from other streaming services; (2) the Company was experiencing difficulties retaining customers; (3) as a result of the foregoing, the Company was losing subscribers on a net basis (4) as a result, the Company’s financial results were being adversely affected; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE NFLX CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Netflix you have until July 5, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

IIPR Class Action: Learn About the Innovative Industrial Properties Lawsuit

Levi & Korsinsky, LLP

April 29, 2022

Levi & Korsinsky, LLP announces that an IIPR class action lawsuit has been filed on behalf of investors who purchased Innovative Industrial Properties, Inc. (IIPR) securities between May 7, 2020, and April 13, 2022.  For more on the IIPR Lawsuit please contact us today.

 

 

 

According to the Innovative Industrial Properties lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Innovative Industrial Properties’ focus is to be a cannabis company lender rather than a REIT; (2) that the true values of the Company’s properties are significantly lower than Innovative Industrial Properties represents; (3) there are existential issues in its top customers; (4) as a result, its top customers may not be able to continue making payments to Innovative Industrial Properties and the Company would face significant issues replacing these customers; and (5) as a result, defendants’ statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE IIPR CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Innovative Industrial Properties you have until June 24, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

NTRA Class Action: Learn About the Natera Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an NTRA class action lawsuit has been filed on behalf of investors who purchased Natera, Inc. (NTRA) securities between February 26, 2020, and April 19, 2022. For more on the NTRA Lawsuit please contact us today.

 

 

According to the Natera lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s non-invasive prenatal test, Panorama, was not reliable and resulted in high rates of false positives; (2) the Company’s screening test for kidney transplant failure, Prospera, did not have superior precision compared to competing tests; (3) as a result of defendants’ false and misleading claims about Natera’s technology, the Company was exposed to substantial legal and regulatory risks; (4) Natera relied upon deceptive sales and billing practices to drive its revenue growth; and (5) as a result of the foregoing, defendants’ statements about the company’s business, operations, and prospects lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE NTRA CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Natera you have until June 27, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

IRNT Class Action: Learn About the Ironnet Lawsuit

Levi & Korsinsky, LLP

April 26, 2022

Levi & Korsinsky, LLP announces that an IRNT class action lawsuit has been filed on behalf of investors who purchased Ironnet, Inc.(IRNT) securities between September 15, 2021, and December 15, 2021. For more on the IRNT Lawsuit please contact us today.

 

 

 

According to the Ironnet lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company had materially overstated its business and financial prospects; (ii) the Company was unable to predict the timing of significant customer opportunities which constituted a substantial portion of its publicly- issued FY 2022 financial guidance; (iii) the Company had not established effective disclosure controls and procedures to reasonably ensure its public disclosures were timely, accurate, complete, and not otherwise misleading; and (iv) as a result, the Company’s public statements were materially false, misleading, and/or lacked any reasonable basis in fact at all relevant times.

 

TO LEARN MORE ABOUT THE IRNT CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Ironnet you have until June 21, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

BKKT Class Action: Learn About the Bakkt Holdings Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a BKKT class action lawsuit has been filed on behalf of investors who purchased Bakkt Holdings, Inc. f/k/a VPC Impact Acquisition Holdings (BKKT) (a) Bakkt securities between March 31, 2021, and November 19, 2021, both dates inclusive; and/or (b) Bakkt Class A common stock pursuant and/or traceable to documents issued in connection with the business combination between the Company and Bakkt Holdings, LLC completed on or about October 15, 2021. For more on the BKKT Lawsuit please contact us today.

 

 

 

According to the Bakkt Holdings lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company had defective financial controls; (ii) as a result, there were errors in the Company’s financial statements related to the misclassification of certain shares issued prior to the business combination between the Company and Bakkt Holdings, LLC; (iii) accordingly, the Company would need to restate certain of its financial statements; (iv) the Company downplayed the true scope and severity of these issues; (v) the Company overstated the remediation of its defective financial controls; and (vi) as a result, the documents issued in connection with the business combination and defendants’ public statements throughout the class period were materially false and/or misleading and failed to state information required to be stated therein.

 

TO LEARN MORE ABOUT THE BKKT CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Bakkt Holdings you have until June 20, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

LICY Class Action: Learn About the Li-Cycle Lawsuit

Levi & Korsinsky, LLP

April 25, 2022

Levi & Korsinsky, LLP announces that a LICY class action lawsuit has been filed on behalf of investors who purchased Li-Cycle Holdings Corp. f/k/a Peridot Acquisition Corp. (LICY) securities between February 16, 2021, and March 23, 2022. For more on the LICY Lawsuit please contact us today.  

 

 

 

According to the Li-Cycle lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Li-Cycle’s largest customer, Traxys, is not actually a customer, but merely a broker providing working capital financial to the Company while Traxys tries to sell Li-Cycle’s product to end customers; (2) the Company engaged in highly questionable related party transactions; (3) the Company’s mark-to-model accounting is vulnerable to abuse and gave a false impression of growth; (4) a significant portion of the Company’s reported revenues were derived from simply marking up receivables on products that had not been sold; (5) the Company’s gross margins have likely been negative since inception; (6) the Company will require an additional $1 billion of funding to support its planned growth (which is a figure greater than the Company raised via the merger); and (7) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE LICY CLASS ACTION LAWSUIT, CLICK HERE 

 

If you suffered a loss in Li-Cycle you have until June 20, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. 

 

CONTACT: 

Levi & Korsinsky, LLP 

Joseph E. Levi, Esq. 

55 Broadway, 10th Floor 

New York, NY 10006 

jlevi@levikorsinsky.com 

Tel: (212) 363-7500 

Fax: (212) 363-7171 

www.zlk.com 

 


Class Action Reports

LILM Class Action: Learn About the Lilium N.V. f/k/a Qell Acquisition Corp Lawsuit

Levi & Korsinsky, LLP

April 20, 2022

Levi & Korsinsky, LLP announces that a LILM class action lawsuit has been filed on behalf of investors who purchased Lilium N.V. f/k/a Qell Acquisition Corp.  (LILM) securities between March 30, 2021, and March 14, 2022. For more on the LILM Lawsuit please contact us today.

 

 

According to the Lilium N.V. f/k/a Qell Acquisition Corp lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Lilium materially overstates the design and capabilities of the Lilium Jet, an electric vertical take-off-and-landing aircraft for use in a new type of high-speed air transport system for people and goods; (2) Lilium materially overstates the likelihood for the Lilium Jet’s timely certification; (3) Lilium misrepresents its ability to obtain or create the necessary batteries for the Lilium Jet; (4) the special purpose acquisition company merger would not and did not generate enough cash to commercially launch the Lilium Jet; (5) Qell Acquisition Corp. did not engage in proper due diligence regarding its merger with Lilium GmbH; and (6) as a result, Defendants’ public statements and statements to journalists were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE LILM CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Lilium N.V. f/k/a Qell Acquisition Corp you have until June 17, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

AUPH Class Action: Learn About the Aurinia Pharmaceuticals Lawsuit

Levi & Korsinsky, LLP

April 19, 2022

Levi & Korsinsky, LLP announces that an AUPH class action lawsuit has been filed on behalf of investors who purchased Aurinia Pharmaceuticals Inc. (AUPH) securities between May 7, 2021, and February 25, 2022. For more on the AUPH Lawsuit please contact us today.  

 

 

According to the Aurinia Pharmaceuticals lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Aurinia was experiencing declining revenues; (ii) Aurinia’s 2022 sales outlook for the Company’s only product which it offers for the treatment of adult patients with active lupus nephritis, LUPKYNIS, would fall well short of expectations; (iii) accordingly, the Company had significantly overstated LUPKYNIS’s commercial prospects; (iv) as a result, the Company had overstated its financial position and/or prospects for 2022; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE AUPH CLASS ACTION LAWSUIT, CLICK HERE 

 

If you suffered a loss in Aurinia Pharmaceuticals you have until June 14, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. 

 

 

CONTACT: 

Levi & Korsinsky, LLP 

Joseph E. Levi, Esq. 

55 Broadway, 10th Floor 

New York, NY 10006 

jlevi@levikorsinsky.com 

Tel: (212) 363-7500 

Fax: (212) 363-7171 

www.zlk.com 


Class Action Reports

SDIG Class Action: Learn About the Stronghold Digital Mining Lawsuit 

Levi & Korsinsky, LLP

April 18, 2022

Levi & Korsinsky, LLP announces that an SDIG class action lawsuit has been filed on behalf of investors who purchased Stronghold Digital Mining, Inc. (SDIG) This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Stronghold Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s October 2021 initial public offering. For more on the SDIG Lawsuit please contact us today.   

 

 

 

According to the Stronghold Digital Mininglawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) contracted suppliers, including Minerva Semiconductor Corp., were reasonably likely to miss anticipated delivery quantities and deadlines; (2) due to strong demand and pre-sold supply of mining equipment in the industry, Stronghold would experience difficulties obtaining miners outside of confirmed purchase orders; (3) as a result of the foregoing, there was a significant risk that Stronghold could not expand its mining capacity as expected; (4) as a result, Stronghold would likely experience significant losses; and (5) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE SDIG CLASS ACTION LAWSUIT, CLICK HERE  

 

If you suffered a loss in Stronghold Digital Mining you have until June 13, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  

 

CONTACT: 


Levi & Korsinsky, LLP  

Joseph E. Levi, Esq.  

55 Broadway, 10th Floor  

New York, NY 10006  

jlevi@levikorsinsky.com  

Tel: (212) 363-7500  

Fax: (212) 363-7171  

www.zlk.com  


Class Action Reports

MYPS Class Action: Learn About the Playstudios Lawsuit

Levi & Korsinsky, LLP

April 10, 2022

Levi & Korsinsky, LLP announces that a MYPS class action lawsuit has been filed on behalf of investors who purchased Playstudios, Inc. (MYPS) (a) purchased, or otherwise acquired securities of Playstudios between June 22, 2021, and March 1, 2022, both dates inclusive, including, but not limited to, those who purchased or acquired Playstudios securities pursuant to the offering of the private investment in public equity (“PIPE” offering); (b) held common stock of Acies as of May 25, 2021, and were eligible to vote at Acies’ June 16, 2021, special meeting who exchanged their shares of Acies stock for shares of Playstudios stock pursuant to the merger of Acies and Old Playstudios (the “Merger”); and/or (c) purchased or otherwise acquired Playstudios common stock pursuant to or traceable to Acies’ documents issued in connection with the June 2021 Merger. For more on the MYPS Lawsuit please contact us today.

 

 

 

According to the Playstudios lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Playstudios was having significant problems with its flagship game, Kingdom Boss; (ii) Playstudios would not be releasing Kingdom Boss as expected; and (iii) Playstudios had not revised its financial projections to account for the problems it had encountered with Kingdom Boss. As a result of the defendants’ wrongful conduct, Class members paid artificially inflated prices for their Playstudios securities and suffered substantial losses and damages.

 

TO LEARN MORE ABOUT THE MYPS CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Playstudios you have until  June 6, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

IBM Class Action: Learn About the IBM Lawsuit

Levi & Korsinsky, LLP

April 8, 2022

Levi & Korsinsky, LLP announces that an IBM class action lawsuit has been filed on behalf of investors who purchased International Business Machines Corporation (IBM) securities between April 4, 2017, and October 20, 2021. For more on the IBM Lawsuit please contact us today.

 

 

 

According to the IBM lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Strategic Imperatives Revenue and growth, CAMSS and CAMSS Components’ revenue and growth, and the Company’s Segments’ revenue and growth were artificially inflated as a result of the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperatives Revenue; (ii) the Company’s present success and positive future growth prospects concerning its Strategic Imperative business strategy were being fueled by the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperative Revenue and, as a result (iii) the Company misled the market by portraying the Company’s Strategic Imperative’s financial performance and future prospects more favorable than they actually were as a result of the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperatives.

 

TO LEARN MORE ABOUT THE IBM CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in IBM you have until June 6, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ABBV Class Action: Learn About the AbbVie Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an ABBV class action lawsuit has been filed on behalf of investors who purchased AbbVie Inc.  (ABBV) securities between April 30, 2021, and August 31 2021. For more on the ABBV Lawsuit please contact us today.

 

 

 

According to the AbbVie lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) safety concerns about Pfizer Inc.’s drug Xeljanz extended to Abbvie’s drug Rinvoq and to other Janus kinase enzyme inhibitor drugs; (2) as a result, it was likely that the U.S. Food and Drug Administration would require additional safety warnings for Rinvoq and would delay the approval of additional treatment indications for Rinvoq; and (3) therefore, defendants’ statements about the Company’s business, operations, and prospects lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE ABBV CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in AbbVie you have until June 6, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

LCID Class Action: Learn About the Lucid Group Lawsuit

Levi & Korsinsky, LLP

April 4, 2022

Levi & Korsinsky, LLP announces that an LCID class action lawsuit has been filed on behalf of investors who purchased Lucid Group, Inc. (LCID) securities between November 15, 2021, and February 28, 2022. For more on the LCID Lawsuit please contact us today. 

 

 

 

 

According to the Lucid Group lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: The filed complaint alleges that defendants made materially false and/or misleading statements and failed to disclose material adverse facts about Lucid’s business and operations. Specifically, the Company overstated its production capabilities while concealing that “extraordinary supply chain and logistics challenges” were hampering Lucid’s operations. As a result of the defendants’ wrongful acts and omissions, and the significant decline in the market value of Lucid’s common stock, Lucid investors have suffered significant damages.

 

TO LEARN MORE ABOUT THE LCID CLASS ACTION LAWSUIT, CLICK HERE 

 

If you suffered a loss in Lucid Group you have until May 31, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. 

 

CONTACT: 

Levi & Korsinsky, LLP 

Joseph E. Levi, Esq. 

55 Broadway, 10th Floor 

New York, NY 10006 

jlevi@levikorsinsky.com 

Tel: (212) 363-7500 

Fax: (212) 363-7171 

www.zlk.com


Class Action Reports

VLTA Class Action: Learn About the Volta Lawsuit

Levi & Korsinsky, LLP

April 1, 2022

Levi & Korsinsky, LLP announces that a VLTA class action lawsuit has been filed on behalf of investors who purchased Volta Inc. (VLTA) securities between August 2, 2021, and March 28, 2022. For more on the VLTA Lawsuit please contact us today.  

 

 

 

 

According to the Volta lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Volta had improperly accounted for restricted stock units issued in connection with the business combination of Volta Industries, Inc. (“Legacy Volta”) and Tortoise Acquisition Corp. II; (2) as a result, the Company had understated its net loss for third-quarter 2021; (3) there were material weaknesses in the Company’s internal control over financial reporting that resulted in a material error; (4) as a result of the foregoing, the Company would restate its financial statements; (5) as a result of the foregoing, Legacy Volta’s founders would imminently exit the Company; (6) as a result, the Company’s financial results would be adversely impacted; and (7) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE VLTA CLASS ACTION LAWSUIT, CLICK HERE 

 

If you suffered a loss in Volta you have until May 31, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. 

CONTACT: 

Levi & Korsinsky, LLP 

Joseph E. Levi, Esq. 

55 Broadway, 10th Floor 

New York, NY 10006 

jlevi@levikorsinsky.com 

Tel: (212) 363-7500 

Fax: (212) 363-7171 

www.zlk.com 

 


Class Action Reports

FIXX Class Action: Learn About the Homology Lawsuit

Levi & Korsinsky, LLP

March 29, 2022

Levi & Korsinsky, LLP announces that a FIXX class action lawsuit has been filed on behalf of investors who purchased Homology Medicines, Inc. (FIXX) securities between June 10, 2019, and February 18, 2022 For more on the FIXX Lawsuit please contact us today.  

 

 

 

 

According to the Homology lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company had overstated the efficacy and risk mitigation of its lead product candidate, HMI-102; (ii) accordingly, it was unlikely that the Company would be able to commercialize HMI102 in its present form; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

 

TO LEARN MORE ABOUT THE FIXX CLASS ACTION LAWSUIT, CLICK HERE 

 

 

If you suffered a loss in Homology you have until May 24, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. 

 

CONTACT: 

Levi & Korsinsky, LLP 

Joseph E. Levi, Esq. 

55 Broadway, 10th Floor 

New York, NY 10006 

jlevi@levikorsinsky.com 

Tel: (212) 363-7500 

Fax: (212) 363-7171 

www.zlk.com


Class Action Reports

VRT Class Action: Learn About the Vertiv Lawsuit

Levi & Korsinsky, LLP

March 28, 2022

Levi & Korsinsky, LLP announces that a VRT class action lawsuit has been filed on behalf of investors who purchased Vertiv Holdings Co (VRT) securities between April 28, 2021, and February 23, 2022 For more on the VRT Lawsuit please contact us today.  

 

 

 

 

According to the Vertiv lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company could not adequately respond to supply chain issues and inflation by increasing its prices; (2) as a result of the increasing costs, Vertiv’s earnings would be adversely impacted; and (3) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE VRT CLASS ACTION LAWSUIT, CLICK HERE 

 

If you suffered a loss in Vertiv you have until May 23, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. 

 

CONTACT: 

Levi & Korsinsky, LLP 

Joseph E. Levi, Esq. 

55 Broadway, 10th Floor 

New York, NY 10006 

jlevi@levikorsinsky.com 

Tel: (212) 363-7500 

Fax: (212) 363-7171 

www.zlk.com 


Class Action Reports

GRAB Class Action: Learn About the Grab Holdings Lawsuit

Levi & Korsinsky, LLP

March 25, 2022

Levi & Korsinsky, LLP announces that a GRAB class action lawsuit has been filed on behalf of investors who purchased Grab Holdings Limited (GRAB) securities between November 12, 2021, and March 2, 2022. For more on the GRAB Lawsuit please contact us today.

 

 

 

 

According to the Grab Holdings lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Grab’s driver supply declined during the third quarter; (2) as a result, Grab continued to invest heavily in driver and consumer incentives to “preemptively recalibrate driver supply”; (3) as a result, the Company’s financial results would be adversely impacted, including, among other things, a significant decline in revenue; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE GRAB CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Grab Holdings you have until May 16, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CELH Class Action: Learn About the Celsius Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CELH class action lawsuit has been filed on behalf of investors who purchased Celsius Holdings, Inc.(CELH) securities between August 12, 2021, and March 1, 2022. For more on the CELH Lawsuit please contact us today. 

 

 

 

 

According to the Celsius lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company had improperly recorded expenses for non-cash share-based compensation for the second and third quarters of 2021; (2) as a result, the Company’s financial statements for those periods would be restated, including to report a net loss for the third quarter of 2021; (3) there was a material weakness in Celsius’s internal controls over financial reporting; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE CELH CLASS ACTION LAWSUIT, CLICK HERE 

 

If you suffered a loss in Celsius you have until May 16, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. 

 

CONTACT: 

Levi & Korsinsky, LLP 

Joseph E. Levi, Esq. 

55 Broadway, 10th Floor 

New York, NY 10006 

jlevi@levikorsinsky.com 

Tel: (212) 363-7500 

Fax: (212) 363-7171 

www.zlk.com 

 


Class Action Reports

FB Class Action: Learn About the Meta Platforms Lawsuit

Levi & Korsinsky, LLP

March 18, 2022

Levi & Korsinsky, LLP announces that a FB class action lawsuit has been filed on behalf of investors who purchased Meta Platforms, Inc. (FB) securities between March 2, 2021, and February 2, 2022. For more on the FB Lawsuit please contact us today.  

 

 

 

According to the Meta Platforms lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Apple’s iOS privacy changes were having a material impact on Meta’s ability to provide the kind of targeted advertising that its customers wanted and, as a result, customer ad spending was dropping precipitously; (2) Meta’s mitigation efforts were either not properly implemented or ineffective; (3) measurement of ads was not accurate as mitigation efforts were failing; and (4) Meta did not have a plan in place to properly address the impact of the iOS privacy changes.

 

TO LEARN MORE ABOUT THE FB CLASS ACTION LAWSUIT, CLICK HERE 

 

If you suffered a loss in Meta Platforms you have until May 9, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. 

 

 

 

CONTACT: 

Levi & Korsinsky, LLP 

Joseph E. Levi, Esq. 

55 Broadway, 10th Floor 

New York, NY 10006 

jlevi@levikorsinsky.com 

Tel: (212) 363-7500 

Fax: (212) 363-7171 

www.zlk.com 


Class Action Reports

AKBA Class Action: Learn About the Akebia Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an AKBA class action lawsuit has been filed on behalf of investors who purchased Akebia Therapeutics, Inc. (AKBA) securities between June 28, 2018, and September 2, 2020 For more on the AKBA Lawsuit please contact us today.  

 

 

 

According to the Akebia lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company’s lead investigational product candidate, vadadustat, was not as safe in treating non-dialysis dependent chronic kidney disease patients with anaemia as defendants had represented; (ii) as a result, defendants overstated the clinical prospects of Phase 3 clinical program for vadadustat; (iii) accordingly, defendants also overstated vadadustat’s overall commercial and regulatory prospects; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE AKBA CLASS ACTION LAWSUIT, CLICK HERE 

 

If you suffered a loss in Akebia you have until May 13, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. 

 

CONTACT: 

Levi & Korsinsky, LLP 

Joseph E. Levi, Esq. 

55 Broadway, 10th Floor 

New York, NY 10006 

jlevi@levikorsinsky.com 

Tel: (212) 363-7500 

Fax: (212) 363-7171 

www.zlk.com 


Class Action Reports

AFRM Class Action: Learn About the Affirm Holdings Lawsuit

Levi & Korsinsky, LLP

March 11, 2022

Levi & Korsinsky, LLP announces that an AFRM class action lawsuit has been filed on behalf of investors who purchased Affirm Holdings, Inc.(AFRM) This lawsuit is on behalf of all investors who purchased or otherwise acquired Affirm Holdings, Inc. securities on February 10, 2022, after the Company sent a Tweet concerning its Second Quarter 2022 financial results at approximately 1:15 p.m. EST. For more on the AFRM Lawsuit please contact us today.

 

 

 

According to the Affirm Holdings lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the filed complaint, on February 10, 2022, at approximately 1:15 p.m., Affirm issued a Tweet from its official account in which the Company disclosed certain metrics from its second-quarter 2022 financial results. The Tweet, which was published prior to the Company’s planned release of its financial results, portrayed a highly successful quarter, which included an increase in revenue of 77%. This caused Affirm’s share price to spike nearly 10% in intra-day trading. The Tweet was materially misleading, in that it omitted to disclose the full details of Affirm’s second-quarter financial results. Affirm deleted the Tweet and released its full second-quarter financial results ahead of schedule. The full financial results were lacklustre – with the Company posting a loss of $0.57 per share, compared with analyst expectations of $0.37 per share.

 

TO LEARN MORE ABOUT THE AFRM CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Affirm Holdings you have until April 29, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ERIC Class Action: Learn About the Telefonaktiebolaget LM Ericsson Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an ERIC class action lawsuit has been filed on behalf of investors who purchased Telefonaktiebolaget LM Ericsson NEWS (ERIC) securities between April 27, 2017, and February 25, 2022 For more on the ERIC Lawsuit please contact us today.

 

 

 

According to the Telefonaktiebolaget LM Ericsson lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Ericsson overstated the extent to which it had reformed its business practices to eliminate the use of bribes to secure business in foreign countries; (ii) Ericsson had paid bribes to the terrorist group the Islamic State in Iraq and Syria to gain access to certain transport routes in Iraq; (iii) accordingly, the Company’s revenues derived from its operations in Iraq were, in at least substantial part, derived from unlawful conduct and thus unsustainable; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE ERIC CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Telefonaktiebolaget LM Ericsson you have until May 2, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

AI Class Action: Learn About the C3.ai Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an AI class action lawsuit has been filed on behalf of investors who purchased C3.ai, Inc. (AI) (a) C3.ai Class A common stock pursuant and/or traceable to the documents issued in connection with the Company’s initial public offering conducted on or about December 9, 2020; and/or (b) C3.ai securities between December 9, 2020, and February 15, 2022, both dates inclusive. For more on the AI Lawsuit please contact us today.

 

 

 

According to the C3.ai lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) C3.ai’s partnership with Baker Hughes was deteriorating; (ii) C3.ai was employing a flawed accounting methodology to conceal the deterioration of its Baker Hughes partnership; (iii) C3.ai faced challenges in product adoption and significant salesforce turnover; (iv) the Company overstated, inter alia, the extent of its investment in technology, description of its customers, its total addressable market, the pace of its market growth, and the scale of alliances with its major business partners; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE AI CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in C3.ai you have until May 3, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

RIVN Class Action: Learn About the Rivian Automotive Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a RIVN class action lawsuit has been filed on behalf of investors who purchased Rivian Automotive, Inc. (RIVN) This lawsuit is on behalf of investors that purchased or otherwise acquired Rivian common stock pursuant and/or traceable to Rivian’s Initial Public Offering on November 10, 2021. For more on the RIVN Lawsuit please contact us today.

 

 

 

According to the Rivian Automotive lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: The Registration Statement (documents issued in connection with the initial public offering) contained representations that were materially inaccurate, misleading, and/or incomplete because they failed to disclose, among other things, that the R1T electric pickup truck and R1S electric SUV were underpriced to such a degree that Rivian would have to raise prices shortly after the IPO and that these price increases would tarnish Rivian’s reputation as a trustworthy and transparent company and would put a significant number of the existing backlog of 55,400 preorders, along with future preorders, in jeopardy of cancellation.

 

TO LEARN MORE ABOUT THE RIVN CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Rivian Automotive you have until May 6, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CABA Class Action: Learn About the Cabaletta Lawsuit

Levi & Korsinsky, LLP

March 3, 2022

Levi & Korsinsky, LLP announces that a CABA class action lawsuit has been filed on behalf of investors who purchased Cabaletta Bio, Inc. (CABA) This lawsuit is on behalf of persons and entities that purchased or otherwise acquired: (a) Cabaletta common stock pursuant and/or traceable to documents issued in connection with the Company’s initial public offering conducted on or about October 24, 2019; and/or (b) Cabaletta securities between October 24, 2019, and December 13, 2021, For more on the CABA Lawsuit please contact us today.

 

 

 

According to the Cabaletta lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) top-line data of the Phase 1 Clinical Trial indicated that Cabaletta’s lead product candidate, DSG3-CAART, had, among other things, worsened certain participants’ disease activity scores and necessitated additional systemic medication to improve disease activity after DSG3-CAART infusion; (ii) accordingly, DSG3-CAART was not as effective as the Company had represented to investors; (iii) therefore, the Company had overstated DSG3-CAART’s clinical and/or commercial prospects; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE CABA CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Cabaletta you have until April 29, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SO Class Action: Learn About the Southern Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a SO class action lawsuit has been filed on behalf of investors who purchased The Southern Company (SO) securities between May 10, 2013, and February 20, 2020 For more on the SO Lawsuit please contact us today.

 

 

 

According to the Southern lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the filed complaint, Deloitte & Touche, LLP allegedly made false and/or materially misleading statements in connection with its audit of The Southern Company’s financial statements and, in particular, its “clean coal” electric power plant in Kemper, Mississippi. Between May 10, 2013 and February 20, 2020 (the “Class Period”), Deloitte intentionally and recklessly violated its professional responsibilities as Southern’s professional auditor and deceived investors about Southern’s accounting for and expected completion of the Kemper Plant. Deloitte’s untrue statements and omissions of material facts concerning the Kemper Plant operated as a fraud and deceit upon plaintiff and others similarly situated in connection with their purchases and value of Southern securities during the Class Period.

 

TO LEARN MORE ABOUT THE SO CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Southern you have until April 25, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CRNC Class Action: Learn About the Cerence Lawsuit

Levi & Korsinsky, LLP

March 2, 2022

Levi & Korsinsky, LLP announces that a CRNC class action lawsuit has been filed on behalf of investors who purchased Cerence Inc. (CRNC) securities between February 8, 2021, and February 4, 2022. For more on the CRNC Lawsuit please contact us today.

 

 

 

According to the Cerence lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the global semiconductor shortage had a materially negative impact on demand for Cerence’s software licenses; (2) defendants masked the impact of the semiconductor shortage on demand for the Company’s software licenses by pulling forward sales; and (3) as a result of the above, defendants’ statements about Cerence’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE CRNC CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Cerence you have until April 26, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

TASK Class Action: Learn About the Taskus Lawsuit

Levi & Korsinsky, LLP

March 1, 2022

Levi & Korsinsky, LLP announces that a TASK class action lawsuit has been filed on behalf of investors who purchased Taskus, Inc.(TASK) securities between June 11, 2021, and January 19, 2022. For more on the TASK Lawsuit please contact us today.

 

 

 

According to the Taskus lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) TaskUs was experiencing severe financial strain and business challenges, particularly with its most important customer, Facebook; (2) the Content Security market was smaller than defendants represented and defendants’ representations were based on outdated market data; (3) TaskUs improperly recognized revenue from certain key contracts; (4) defendants overstated the size of TaskUs’ workforce as well as employee retention rates, and understated attrition rates; and (5) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE TASK CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Taskus you have until April 25, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

GATO Class Action: Learn About the Gatos Lawsuit

Levi & Korsinsky, LLP

February 28, 2022

Levi & Korsinsky, LLP announces that a GATO class action lawsuit has been filed on behalf of investors who purchased Gatos Silver, Inc. (GATO) This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Gatos: (a) common stock pursuant and/or traceable to documents issued in connection with the Company’s initial public offering conducted on or about October 28, 2020; and/or (b) securities between October 28, 2020, and January 25, 2022, For more on the GATO Lawsuit please contact us today.

 

 

 

According to the Gatos lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the technical report for Gatos’s primary mine, the Cerro Los Gatos deposit, contained certain errors; (2) among other things, the mineral reserves had been overestimated by as much as 50%; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE GATO CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Gatos you have until April 25, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

MP Class Action: Learn About the MP Materials Corp Lawsuit

Levi & Korsinsky, LLP

February 24, 2022

Levi & Korsinsky, LLP announces that an MP class action lawsuit has been filed on behalf of investors who purchased MP Materials Corp. f/k/a Fortress Value Acquisition Corp. (MP) securities between May 1, 2020, and February 2, 2022 For more on the MP Lawsuit please contact us today.

 

 

 

According to the MP Materials Corp lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Fortress Value Acquisition Corp. (“FVAC”) had overstated its due diligence efforts and expertise with respect to identifying target companies to acquire; (ii) FVAC performed inadequate due diligence into Legacy MP Materials prior to the business combination, or else ignored significant red flags regarding, inter alia, Legacy MP Materials’ management, compliance policies, and Mountain Pass’s profitability; (iii) as a result, the Company’s future business and financial prospects post-business combination were overstated; (iv) MP Materials engaged in an abusive transfer price manipulation scheme with a related party in the People’s Republic of China to artificially inflate the Company’s profits; (v) MP Materials’ ore at the Mountain Pass Rare Earth Mine and Processing Facility was not economically viable to harvest for rare earth metals; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE MP CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in MP Materials Corp you have until April 25, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SPWR Class Action: Learn About the SunPower Corporation Lawsuit

Levi & Korsinsky, LLP

February 23, 2022

Levi & Korsinsky, LLP announces that an SPWR class action lawsuit has been filed on behalf of investors who purchased SunPower Corporation (SPWR) securities between August 3, 2021, and January 20, 2022. For more on the SPWR Lawsuit please contact us today.

 

 

 

According to the SunPower Corporation lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) certain connectors used by SunPower suffered from cracking issues; (2) as a result, the Company was reasonably likely to incur costs to remediate the faulty connectors; (3) as a result of the foregoing, SunPower’s financial results would be adversely impacted; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE SPWR CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in SunPower Corporation you have until April 18, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

BFLY Class Action: Learn About the Butterfly Network Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a BFLY class action lawsuit has been filed on behalf of investors who purchased Butterfly Network, Inc. f/k/a Longview Acquisition Corp.  (BFLY) (a) all persons or entities that purchased or otherwise acquired Butterfly securities between February 16, 2021, and November 15, 2021, both dates inclusive and/or (b) all holders of Butterfly common stock as of the record date for the special meeting of shareholders held on February 12, 2021, to consider approval of the merger between Longview Acquisition Corp. and Butterfly. securities between February 16, 2021, and November 15, 2021.  For more on the BFLY Lawsuit please contact us today.

 

 

 

According to the Butterfly Network lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Butterfly had overstated its post-merger business and financial prospects; (ii) notwithstanding the ongoing COVID-19 pandemic, Butterfly’s financial projections failed to take into account the pandemic’s broad consequences, which included healthcare logistical challenges, and medical personnel fatigue; (iii) accordingly, Butterfly’s gross margin levels and revenue projections were less sustainable than the Company had represented; (iv) all the foregoing was reasonably likely to have a material negative impact on Butterfly’s business and financial condition; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE BFLY CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Butterfly Network you have until April 18, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

AFIB Class Action: Learn About the AcQMap Lawsuit

Levi & Korsinsky, LLP

February 17, 2022

Levi & Korsinsky, LLP announces that an AFIB class action lawsuit has been filed on behalf of investors who purchased Acutus Medical, Inc. (AFIB) securities between May 13, 2021, and November 11, 2021,  For more on the AFIB Lawsuit please contact us today.

 

 

 

According to the AcQMap lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (a) a material percentage of the Company’s AcQMap imaging and mapping systems under evaluation had been randomly installed at sites with little, if any, consideration given to whether the healthcare providers at the selected locations were likely to adopt, or desire, the Company’s products; (b) a material percentage of the AcQMap systems under evaluation had been installed in locations where the Company did not possess the infrastructure necessary to appropriately educate, train, and support medical service providers on the system’s operations; (c) as a result of (a) and (b) above, defendants were in the process of designing a strategic plan to terminate and relocate approximately 20% of then-existing AcQMap systems evaluation arrangements; (d) the Company’s management discussion and analysis was materially false and misleading and failed to disclose that the termination and relocation of approximately 20% of existing AcQMap systems evaluation arrangements was reasonably likely to have a material adverse effect on the Company’s 2021 financial results; and (e) the Company’s risk factor discussions were materially false and misleading and made reference to potential risks without disclosing that such risks were then-existing or adequately describing the specific nature of the risks then facing the Company.

 

TO LEARN MORE ABOUT THE AFIB CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in AcQMap you have until April 18, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ASTR Class Action: Learn About the Astra Space Inc. f/k/a Holicity Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an ASTR class action lawsuit has been filed on behalf of investors who purchased Astra Space Inc. f/k/a Holicity Inc. (ASTR) securities between February 2, 2021, and December 29, 2021. For more on the ASTR Lawsuit please contact us today.

 

 

 

According to the Astra Space Inc. f/k/a Holicity lawsuit, throughout the Class Period defendants, made false and/or misleading statements and/or failed to disclose that: (1) Astra cannot launch “anywhere”; (2) Astra significantly overstated its addressable market; (3) Astra overstated the effectiveness of its designs and reliability; (4) Astra significantly overstated its plans for diversification and its broadband constellation plan; and (5) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE ASTR CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Astra Space Inc. f/k/a Holicity you have until April 11, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

FENC Class Action: Learn About the Fennec Pharmaceuticals Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a FENC class action lawsuit has been filed on behalf of investors who purchased Fennec Pharmaceuticals Inc. (FENC) securities between May 28, 2021, and November 26, 2021. For more on the FENC Lawsuit please contact us today.

 

 

 

According to the Fennec Pharmaceuticals lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Fennec had not successfully remediated and overstated its efforts to remediate, issues with the manufacturing facility of its drug product manufacturer for PEDMARK, a new compound developed to reduce the incidence of hearing loss in children undergoing chemotherapy; (ii) as a result, the Food and Drug Administration likely to approve the Resubmitted Pedmark New Drug Application (“NDA”); (iii) accordingly, the regulatory and commercial prospects of the Resubmitted Pedmark NDA were overstated; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE FENC CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Fennec Pharmaceuticals you have until April 11, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

BIIB Class Action: Learn About the Biogen Lawsuit

Levi & Korsinsky, LLP

February 11, 2022

Levi & Korsinsky, LLP announces that a BIIB class action lawsuit has been filed on behalf of investors who purchased Biogen Inc. (BIIB) securities between June 7, 2021, and January 11, 2022.  For more on the BIIB Lawsuit please contact us today.

 

 

 

According to the Biogen lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: 1) there was a significant, undisclosed lobbying campaign between Biogen and the Food and Drug Administration (“FDA”) that was instrumental in the decision to file and approve Aduhelm, a drug being developed to treat Alzheimer’s disease; 2) the Phase III ENGAGE study demonstrated that Aduhelm failed to achieve a clinical benefit to Alzheimer’s patients; 3) ENGAGE was a failed study from which Biogen concluded not to seek FDA approval for Aduhelm in 2019, and 4) defendants misled investors as to the way in which approval was achieved, that the clinical data did not support a clinical benefit by taking Aduhelm and those side-effects were dangerous and serious.

 

TO LEARN MORE ABOUT THE BIIB CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Biogen you have until April 8, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

TLS Class Action: Learn About the Telos Corporation Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a TLS class action lawsuit has been filed on behalf of investors who purchased Telos Corporation (TLS) securities between November 19, 2020, and November 12, 2021 For more on the TLS Lawsuit please contact us today.

 

 

 

According to the Telos Corporation lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Transportation Security Administration (“TSA”) and Centers for Medicare and Medicaid Services (“CMS”) contracts, which constituted a majority of the Company’s future revenues, were not on track to commence as represented at the end of 2021 and in 2022; (2) Defendants lacked a reasonable basis and sufficient visibility to provide and affirm the Company’s 2021 guidance in the face of the uncertainty surrounding the TSA and CMS contracts; (3) COVID-19- and hacking scandal-related headwinds were throwing off the timing for performance of the TSA and CMS contracts and their associated revenues; (4) as a result, the guidance provided by Defendants was not in fact “conservative”; (5) as a result of the delays, Telos would be forced to dramatically reduce its revenue estimates; and (6) as a result of the foregoing, Defendants’ statements about Telos’ business, operations, and prospects, were materially false and/or misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE TLS CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Telos Corporation you have until April 8, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

TAL Class Action: Learn About the TAL Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a TAL class action lawsuit has been filed on behalf of investors who purchased Tal Education Group (TAL) securities between April 26, 2018, and July 22, 2021. For more on the TAL Lawsuit please contact us today.

 

 

 

According to the TAL lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (a) TAL’s revenue and operational growth was the result of deceptive marketing tactics and illicit business practices that flouted Chinese laws,  regulations and policies,  and exposed the Company to an extreme risk that more draconian measures would be imposed on the Company; (b) TAL had engaged in misleading and fraudulent advertising practices, including the provision of false and misleading discount information designed to obfuscate the true cost of the Company’s programs to its customers, the creation of fake customer reviews designed to fraudulently lure new customers to TAL programs, the misrepresentation of teacher qualifications and course qualities, and the marketing of rigged promotional events; (c) TAL had defied Chinese policies designed to alleviate the burden imposed by tutoring services on students and their families, including by imposing hefty advances and recurring debt payments on course enrollees, by offering courses designed to give affluent students unfair advantages, by holding courses outside of allowable tutoring hours, and by linking for-profit courses to government-mandated schooling; (d) as a result of the foregoing, TAL was subject to an extreme undisclosed risk of adverse enforcement actions, regulatory fines and penalties, and the imposition of new rules and regulations adverse to the Company’s business and financial interests; and (e) as a result of the foregoing, TAL’s historical growth was not sustainable or the result of legitimate business tactics as represented, and defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and lacked a reasonable factual basis.

 

TO LEARN MORE ABOUT THE TAL CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in TAL you have until April 5, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

EDU Class Action: Learn About the New Oriental Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an EDU class action lawsuit has been filed on behalf of investors who purchased New Oriental Education & Technology Group Inc. (EDU) securities between April 24, 2018, and July 22, 2021. For more on the EDU Lawsuit please contact us today.

 

 

According to the New Oriental lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (a) New Oriental’s revenue and operational growth was the result of deceptive marketing tactics and abusive business practices that flouted Chinese regulations and policies and exposed the Company to an extreme risk that more draconian measures would be imposed on the Company; (b) New Oriental had engaged in misleading and fraudulent advertising practices, including the provision of false and misleading discount Information designed to obfuscate the true cost of the Company’s programs to its customers; (c) New Oriental had falsified teacher qualifications and experience in order to attract customers and increase student enrollments; (d) New Oriental had defied prior government warnings against linking school enrollments with the provision of private tutoring services; (e) as a result of the foregoing, New Oriental was subject to an extreme undisclosed risk of adverse enforcement actions, regulatory fines and penalties, and the imposition of new rules and regulations adverse to the Company’s business and interests; and (f) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and lacked a reasonable, factual basis.

 

TO LEARN MORE ABOUT THE EDU CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in New Oriental you have until April 5, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ELMS Class Action: Learn About the ELMS Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an ELMS class action lawsuit has been filed on behalf of investors who purchased Electric Last Mile Solutions, Inc. f/k/a Forum Merger III Corp. (ELMS) securities between March 31, 2021, and February 1, 2022. For more on the ELMS Lawsuit please contact us today.

 

 

 

According to the ELMS lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) ELMS’ previously issued financial statements were false and unreliable; (2) ELMS’s earlier reported financial statements would need restatement; (3) certain ELMS executives and/or directors purchased equity in the Company at substantial discounts to market value without obtaining an independent valuation; (4) on November 25, 2021 (Thanksgiving), the Company’s Board formed an independent Special Committee to conduct an inquiry into certain sales of equity securities made by and to individuals associated with the Company; and (5) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE ELMS  CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in ELMS you have until April 4, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

STTK Class Action: Learn About the Shattuck Lawsuit

Levi & Korsinsky, LLP

February 4, 2022

Levi & Korsinsky, LLP announces that an STTK class action lawsuit has been filed on behalf of investors who purchased Shattuck Labs, Inc. (STTK) This lawsuit is on behalf of persons or entities who purchased or otherwise acquired publicly traded Shattuck securities: (1) pursuant and/or traceable to the registration statement and related prospectus issued in connection with Shattuck’s October 2020 initial public offering; and/or (2) between October 9, 2020, and November 9, 2021, For more on the STTK Lawsuit please contact us today.

 

 

According to the Shattuck lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the collaboration agreement with Takeda was not solid; (2) Takeda and Shattuck would “mutually agree” to terminate the collaboration agreement in essentially one year; (3) as a result, Shattuck would cease to receive any future milestone, royalty, or other payments from Takeda; and (4) as a result, defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE STTK CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Shattuck you have until April 1, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

TALK Class Action: Learn About the Talkspace Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a TALK class action lawsuit has been filed on behalf of investors who purchased Talkspace, Inc. f/k/a Hudson Executive Investment Corporation (TALK) The lawsuit seeks to recover losses on behalf of Talkspace investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of: (a) all persons or entities that purchased or otherwise acquired Talkspace securities between June 11, 2020 and November 15, 2021, both dates inclusive, and/or (b) all holders of Talkspace common stock as of the record date for the special meeting of shareholders held on June 17, 2021. For more on the TALK Lawsuit please contact us today.

 

 

 

According to the Talkspace lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: The filed complaint alleges that defendants made false statements and/or concealed that: (i) Hudson Executive Investment Corporation (“HEIC”) had overstated its competitive advantage and due diligence capabilities with respect to identifying and effectuating a merger with target companies; (ii) HEIC had conducted inadequate due diligence into then-private, pre-Merger Talkspace, or else ignored and/or failed to disclose multiple red flags concerning then-private, pre-Merger Talkspace’s business and operations; (iii) Talkspace was experiencing significantly increased online advertising costs in its B2C business since the beginning of 2021; (iv) Talkspace was experiencing lower conversion rates in its online advertising in its business-to-consumer (“B2C”) business; (v) as a result of (iii) and (iv) above, Talkspace was experiencing increased customer acquisition costs and more tepid B2C demand than represented to investors; (vi) as a result of (iii)-(v) above, Talkspace was suffering from ballooning customer acquisition costs and worsening growth and gross margin trends; (vii) Talkspace had overvalued its accounts receivables from certain of its health plan clients in its B2B business, which amounts required adjustment downward; and (viii) as a result of (iii)-(vii) above, Talkspace’s 2021 financial guidance was not achievable and lacked any reasonable basis in fact.

 

TO LEARN MORE ABOUT THE TALK CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Talkspace you have until March 8, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SLI Class Action: Learn About the Standard Lithium Lawsuit

Levi & Korsinsky, LLP

February 2, 2022

Levi & Korsinsky, LLP announces that an SLI class action lawsuit has been filed on behalf of investors who purchased Standard Lithium Ltd. (SLI) securities between May 19, 2020, and November 17, 2021 For more on the SLI Lawsuit please contact us today.

 

 

 

According to the Standard Lithium lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the LiSTR Direct Lithium Extraction technology’s extraction recovery efficiencies were overstated; (ii) accordingly, the Company’s final product lithium recovery percentage at the Demonstration Plant would not be as high as the Company had represented to investors; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE SLI CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Standard Lithium you have until March 28, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

BMBL Class Action: Learn About the Bumble Lawsuit 

Levi & Korsinsky, LLP

January 28, 2022

Levi & Korsinsky, LLP announces that a BMBL class action lawsuit has been filed on behalf of investors who purchased Bumble Inc.  (BMBL) This lawsuit is on behalf of all purchasers of the Class A common stock of Bumble directly in Bumble’s secondary public stock offering which took place on or about September 10, 2021. For more on the BMBL Lawsuit please contact us today.   

 

 

 

According to the Bumble lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (a) Bumble’s paying user growth trends had abruptly reversed in 3Q21 and the Company had actually lost tens of thousands of paying users during the quarter; (b) paying users had been more reluctant to sign up for the Bumble app during 3Q21 because of the recent price hike for paid services on the app; (c) a material number of paying users were leaving the Badoo app, a dating-focused social network, and/or could not make payments through the Badoo app due, in substantial part, to problems arising from the Company’s transition of its payment platform; and (d) as a result of the foregoing, Bumble’s business metrics and financial prospects were not as strong as the Registration Statement had represented.

 

TO LEARN MORE ABOUT THE BMBL CLASS ACTION LAWSUIT, CLICK HERE  

 

If you suffered a loss in Bumble  you have until March 25, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  

 

CONTACT: 


Levi & Korsinsky, LLP  

Joseph E. Levi, Esq.  

55 Broadway, 10th Floor  

New York, NY 10006  

jlevi@levikorsinsky.com  

Tel: (212) 363-7500  

Fax: (212) 363-7171  

www.zlk.com  


Class Action Reports

CLVT Class Action: Learn About the Clarivate Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CLVT class action lawsuit has been filed on behalf of investors who purchased Clarivate Plc (CLVT) securities between February 26, 2021, and December 27, 2021.  For more on the CLVT Lawsuit please contact us today.

 

 

 

According to the Clarivate lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Clarivate maintained defective disclosure controls and procedures as a result of a material weakness in its internal control over financial reporting; (ii) the foregoing material weakness was not limited to how the Company accounted for warrants; (iii) as a result, Clarivate failed to properly account for an equity plan included in its acquisition of CPA Global, a global leader in Intellectual Property software and tech-enabled services; (iv) accordingly, the Company was reasonably likely to restate one or more of its previously issued financial statements following its acquisition of CPA Global; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE CLVT CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Clarivate you have until March 25, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

OSH Class Action: Learn About the Oak Street Lawsuit

Levi & Korsinsky, LLP

January 17, 2022

Levi & Korsinsky, LLP announces that an OSH class action lawsuit has been filed on behalf of investors who purchased Oak Street Health, Inc. (OSH) securities between August 6, 2020, and November 8, 2021. For more on the OSH Lawsuit please contact us today.

 

 

 

According to the Oak Street lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) that Oak Street maintained relationships with third-party marketing agents likely to provoke law enforcement scrutiny; (2) that Oak Street was providing free transportation to federal health care beneficiaries in a manner that would provoke law enforcement scrutiny; (3) that these activities may be violations of the False Claims Act; (4) that, as such, Oak Street was at heightened risk of investigation by the U.S. Department of Justice and/or other federal law enforcement agencies; (5) that, as a result, Oak Street was subject to adverse impacts related to defence and settlement costs and diversion of management resources; and (6) that, as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE OSH CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Oak Street you have until March 14, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

TLIS Class Action: Learn About the Talis Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a TLIS class action lawsuit has been filed on behalf of investors who purchased Talis Biomedical Corporation (TLIS) common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s February 2021 initial public offering (“IPO”). You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of California.  For more on the TLIS Lawsuit please contact us today.

 

 

 

According to the Talis lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) that the comparator assay in the primary study lacked sufficient sensitivity to support Talis’s Emergency Use Authorization application for Talis One COVID-19 test; (2) that, as a result, Talis was reasonably likely to experience delays in obtaining regulatory approval for the Talis One COVID-19 test; (3) that, as a result, the Company’s commercialization timeline would be significantly delayed; and (4) that, as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE TLIS CLASS ACTION LAWSUIT, CLICK HERE  

 

If you suffered a loss in Talis you have until March 8, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  

 

 

CONTACT: 


Levi & Korsinsky, LLP  

Joseph E. Levi, Esq.  

55 Broadway, 10th Floor  

New York, NY 10006  

jlevi@levikorsinsky.com  

Tel: (212) 363-7500  

Fax: (212) 363-7171  

www.zlk.com  


Class Action Reports

FSLR Class Action: Learn About the First Solar Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an FSLR class action lawsuit has been filed on behalf of investors who purchased First Solar, Inc. (FSLR) securities between February 22, 2019, and February 20, 2020. For more on the FSLR Lawsuit please contact us today.

 

 

 

According to the First Solar lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the filed complaint, defendants made repeated misrepresentations to investors regarding the development of First Solar’s newest “Series 6” solar module, the cost per unit it could achieve with that module, and the impact the changeover to this new product would have on the viability of its other business segments. As a result of the defendants’ misrepresentations, First Solar common stock was traded at artificially inflated prices during the class period.

 

TO LEARN MORE ABOUT THE FSLR CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in First Solar you have until March 8, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

DISCA Class Action: Learn About the Discovery Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a DISCA class action lawsuit has been filed on behalf of investors who purchased Discovery Inc. (DISCA) securities between March 22, 2021, and March 29, 2021 For more on the DISCA Lawsuit please contact us today.

 

 

 

According to the Discovery lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the filed complaint: Goldman Sachs and Morgan Stanley sold a large amount of Discovery shares during the class period while in possession of material, non-public information about Archegos and its need to fully liquidate its position in the Company because of margin call pressure. As a result of these sales, Defendants Goldman Sachs and Morgan Stanley avoided billions in losses combined.

 

TO LEARN MORE ABOUT THE DISCA CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Discovery you have until March 8, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

 


Class Action Reports

MMAT Class Action: Learn About the Meta Materials Lawsuit

Levi & Korsinsky, LLP

January 11, 2022

Levi & Korsinsky, LLP announces that an MMAT class action lawsuit has been filed on behalf of investors who purchased Meta Materials Inc. f/k/a Torchlight Energy Resources, Inc. (MMAT) securities between September 21, 2020, and December 14, 2021. For more on the MMAT Lawsuit please contact us today.

 

Levi & Kowsinsky Securities Class Action Lawyers

 

According to the Meta Materials lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) the business combination would result in a U.S. Securities and Exchange Commission investigation and subpoena in the matter captioned In the matter of Torchlight Energy Resources, Inc.; (2) the Company has materially overstated its business connections and dealings; (3) the Company has materially overstated its ability to produce and commercialize its products; (4) the Company has materially overstated its products’ novelty and capabilities; (5) the Company’s products did not have the potential to be disruptive because, among other things, the Company priced its products too high; and (6) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE MMAT CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Meta Materials you have until March 4, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

INSD Class Action: Learn About the Instadose Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an INSD class action lawsuit has been filed on behalf of investors who purchased Instadose Pharma Corp. f/k/a Mikrocoze, Inc.(INSD) securities between December 8, 2020, and November 24, 2021. For more on the INSD Lawsuit please contact us today.

 

 

 

According to the Instadose lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Instadose had performed inadequate due diligence into the business combination and/or ignored significant red flags associated with Instadose Canada; (ii) Instadose’s internal controls and policies were inadequate to detect and/or prevent impermissible trading activity by control persons of the Company; (iii) the foregoing subjected Instadose to a heightened risk of regulatory scrutiny and enforcement action; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE INSD CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Instadose you have until February 28, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

BHG Class Action: Learn About the Bright Health Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a BHG class action lawsuit has been filed on behalf of investors who purchased Bright Health Group, Inc. (BHG) (a) common stock pursuant and/or traceable to the documents issued in connection with the Company’s initial public offering conducted on or about June 24, 2021; and/or (b) securities between June 24, 2021, and November 10, 2021.  For more on the BHG Lawsuit please contact us today.

 

Levi & Kowsinsky Securities Class Action Lawyers

 

According to the Bright Health lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Bright Health had overstated its post-IPO business and financial prospects; (ii) the Company was ill-equipped to handle the impact of COVID-19-related costs; (iii) the Company was experiencing a decline in premium revenue because of a failure to capture risk adjustment on newly added lives; (iv) all the foregoing was reasonably likely to have a material negative impact on Bright Health’s business and financial condition; and (v) as a result, the documents issued in connection with the IPO and Defendants’ public statements throughout the class period were materially false and/or misleading and failed to state information required to be stated therein.

 

TO LEARN MORE ABOUT THE BHG CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Bright Health you have until March 7, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

DOCU Class Action: Learn About the Docusign Lawsuit

Levi & Korsinsky, LLP

January 3, 2022

Levi & Korsinsky, LLP announces that a DOCU class action lawsuit has been filed on behalf of investors who purchased Docusign, Inc. (DOCU) securities between March 27, 2020, and December 2, 2021. For more on the DOCU Lawsuit please contact us today.

 

According to the Docusign lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the impact of the Covid-19 pandemic on DocuSign’s business was positive, not negative; (2) DocuSign misrepresented the role that the Covid-19 pandemic had on its growth; (3) DocuSign downplayed the impact that a ‘return to normal’ would have on the Company’s growth and business; and (4) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE DOCU CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Docusign you have until February 22, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CHGG Class Action: Learn About the Chegg Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CHGG class action lawsuit has been filed on behalf of investors who purchased Chegg, Inc.  (CHGG) securities between May 5, 2020, and November 1, 2021. For more on the CHGG Lawsuit please contact us today.

 

Levi & Kowsinsky Securities Class Action Lawyers

 

According to the Chegg lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Chegg’s increase in subscribers, growth, and revenue had been a temporary effect of the COVID-19 pandemic that resulted in remote education for the vast majority of United States students and once the pandemic-related restrictions eased and students returned to campuses nationwide, Chegg’s extraordinary growth trends would end; (ii) Chegg’s subscriber and revenue growth were largely due to the facilitation of remote education cheating – an unstable business proposition – rather than the strength of its business model or the acumen of its senior executives and directors; and (iii) as a result, the Company’s current business metrics and financial prospects were not as strong as it had led the market to believe during the Class Period.

 

TO LEARN MORE ABOUT THE CHGG CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Chegg you have until February 22, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

FFIE Class Action: Learn About the Faraday Future Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an FFIE class action lawsuit has been filed on behalf of investors who purchased Faraday Future Intelligent Electric Inc. F/K/A Property Solutions Acquisition Corp.(FFIE) securities between January 28, 2021, and November 15, 2021.  For more on the FFIE Lawsuit please contact us today.

 

 

 

 

According to the Faraday Future lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company had assets in China frozen by courts, (2) a significant percentage of its deposits for future deliveries were attributable to a single undisclosed affiliate; (3) the Company’s cars were not as close to production as the Company claimed; (4) as a result of previously issued statements that were misleading and/or inaccurate, Faraday Future could not timely file its quarterly report; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE FFIE CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Faraday Future you have until February 22, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

DM Class Action: Learn About the Desktop Metal Lawsuit

Levi & Korsinsky, LLP

December 28, 2021

Levi & Korsinsky, LLP announces that a DM class action lawsuit has been filed on behalf of investors who purchased Desktop Metal, Inc. (DM) securities between March 15, 2021, and November 15, 2021. For more on the DM Lawsuit please contact us today.

 

Levi & Kowsinsky Securities Class Action Lawyers

 

 

According to the Desktop Metal lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the filed complaint: (1) there were deficiencies in EnvisionTEC’s manufacturing and product compliance practices and procedures; (2) the foregoing deficiencies presented a material risk to the commercialization of EnvisionTEC’s products; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE DM CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Desktop Metal you have until February 22, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ARVL Class Action: Learn About the Arrival Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an ARVL class action lawsuit has been filed on behalf of investors who purchased Arrival SA. (ARVL) securities between November 18, 2020, and November 19, 2021. For more on the ARVL Lawsuit please contact us today.

 

 

 

According to the Arrival lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company would record a substantially greater net loss and adjusted earnings before interest, taxes, depreciation, and amortization (“EBITDA”) loss in the third quarter of 2021 compared to the third quarter of 2020; (ii) the Company would experience far greater capital and operational expense to operate and deploy its micro-factories and manufacture EV vehicles than it had disclosed; (iii) the Company would not capitalize on or achieve profitability or provide meaningful revenue in the time periods disclosed; (iv) the Company would not achieve its disclosed production and sales volumes; (v) the Company would not meet the disclosed production rollout deadlines. Accordingly, the Company materially overstated its financial and operational position and/or prospects, and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE ARVL CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Arrival you have until February 22, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

MARA Class Action: Learn About the Marathon Lawsuit

Levi & Korsinsky, LLP

December 23, 2021

Levi & Korsinsky, LLP announces that a MARA class action lawsuit has been filed on behalf of investors who purchased Marathon Digital Holdings, Inc. f/k/a Marathon Patent Group, Inc. (MARA) securities between October 13, 2020, and November 15, 2021. For more on the MARA Lawsuit please contact us today.

 

 

 

According to the Marathon lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the filed complaint: (i) the Beowulf Joint Venture, as it related to the Hardin Facility, implicated potential regulatory violations, including U.S. securities law violations; (ii) as a result, the Beowulf Joint Venture subjected Marathon to a heightened risk of regulatory scrutiny; (iii) the foregoing was reasonably likely to have a material negative impact on the Company’s business and commercial prospects; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE MARA CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Marathon you have until February 15, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

 


Class Action Reports

RETA Class Action: Learn About the Reata Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a RETA class action lawsuit has been filed on behalf of investors who purchased Reata Pharmaceuticals, Inc. (RETA) securities between November 9, 2020, and December 8, 2021. For more on the RETA Lawsuit please contact us today.

 

Levi & Kowsinsky Securities Class Action Lawyers

 

According to the Reata lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Food and Drug Administration had raised concerns regarding the validity of the clinical study designed to measure the efficacy and safety of bardoxolone for the treatment of chronic kidney disease caused by Alport syndrome; (2) as a result, there was a material risk that Reata’s New Drug Application would not be approved; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE RETA CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Reata you have until February 18, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

 


Class Action Reports

RDW Class Action: Learn About the Redwire Lawsuit

Levi & Korsinsky, LLP

December 22, 2021

Levi & Korsinsky, LLP announces that an RDW class action lawsuit has been filed on behalf of investors who purchased Redwire Corporation f/k/a/ Genesis Park Acquisition Corp (RDW) securities between August 11, 2021, and November 14, 2021. For more on the RDW Lawsuit please contact us today.

 

 

 

According to the Redwire lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) there were accounting issues at one of Redwire’s subunits; (2) as a result, there were additional material weaknesses in Redwire’s internal control over financial reporting; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE RDW CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Redwire you have until February 15, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

BIDU Class Action: Learn About the Baidu Lawsuit

Levi & Korsinsky, LLP

December 21, 2021

Levi & Korsinsky, LLP announces that a BIDU class action lawsuit has been filed on behalf of investors who purchased Baidu, Inc(BIDU) securities between March 22, 2021, and March 29, 2021. For more on the BIDU Lawsuit please contact us today.

 

Levi & Kowsinsky Securities Class Action Lawyers

 

According to the Baidu lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the filed complaint: Goldman Sachs Group Inc. and Morgan Stanley sold a large number of Baidu shares while in possession of material non-public information. The defendants knew that Archegos Capital Management would need to fully liquidate its position in Baidu based on margin call pressures. The defendants avoided billions in losses by selling the Company’s shares while in possession of this information. When the market learned the truth about Baidu, investors suffered damages.

 

TO LEARN MORE ABOUT THE BIDU CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Baidu you have until February 14, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

HOOD Class Action: Learn About the Robinhood Lawsuit 

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a HOOD class action lawsuit has been filed on behalf of investors who purchased Robinhood Markets, Inc.(HOOD) shares pursuant and/or traceable to the Company’s initial public offering (“IPO”) conducted in July 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of California. For more on the HOOD Lawsuit please contact us today.

 

Levi & Kowsinsky Securities Class Action Lawyers

 

According to the Robinhoodlawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the lawsuit, documents that the Company issued in connection with its IPO contained representations that were materially inaccurate, misleading, and/or incomplete because they failed to disclose that, at the time of the IPO, Robinhood’s revenue growth was experiencing a major reversal, with transaction-based revenues from cryptocurrency trading serving only as a short-term, transitory injection masking what was actually stagnating growth. In addition, the Company’s “significant investments” in enhancing the reliability and scalability of its platform were patently inadequate and/or defective, exposing Robinhood to worsening service-level disruptions and security breaches, particularly as the Company scaled its services to a larger user base.

 

TO LEARN MORE ABOUT THE HOOD CLASS ACTION LAWSUIT, CLICK HERE  

 

If you suffered a loss in Robinhood you have until February 15, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  

 

 

CONTACT: 


Levi & Korsinsky, LLP  

Joseph E. Levi, Esq.  

55 Broadway, 10th Floor  

New York, NY 10006  

jlevi@levikorsinsky.com  

Tel: (212) 363-7500  

Fax: (212) 363-7171  

www.zlk.com  


Class Action Reports

PSFE Class Action: Learn About the Paysafe Lawsuit

Levi & Korsinsky, LLP

December 17, 2021

Levi & Korsinsky, LLP announces that a PSFE class action lawsuit has been filed on behalf of investors who purchased Paysafe Limited (PSFE) securities between December 7, 2020, and November 10, 2021. For more on the PSFE Lawsuit please contact us today.

 

Levi & Kowsinsky Securities Class Action Lawyers

 

 

According to the Paysafe lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Paysafe was being negatively impacted by gambling regulations in key European markets; (2) Paysafe was encountering performance challenges in its Digital Wallet segment; (3) new eCommerce customer agreements were being pushed back; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE PSFE CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Paysafe you have until February 8, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SNBR Class Action: Learn About the Sleep Number Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an SNBR class action lawsuit has been filed on behalf of investors who purchased Sleep Number Corporation (SNBR) securities between February 18, 2021, and July 20, 2021. For more on the SNBR Lawsuit please contact us today.

 

Levi & Kowsinsky Securities Class Action Lawyers

 

According to the Sleep Number lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (a) Sleep Number had suffered a severe disruption in its supply chain for foam as a result of Winter Storm Uri; (b) Sleep Number did not have in place the supply chain flexibility, redundancies and fail-safes, as had been represented to investors, sufficient to offset the foam supply disruption caused by Winter Storm Uri; (c) because foam was a necessary component for Sleep Number’s production of its primary mattress products, Sleep Number’s ability to timely fulfill customer orders had been materially impaired; (d) as a result of (a)-(c) above, Sleep Number was unable to meet surging customer demand for the Company’s products; and (e) as a result of (a)-(d) above, Sleep Number had been forced to delay mattress shipments to end consumers, pushing millions of dollars’ worth of sales into subsequent quarters and negatively impacting the Company’s financial results.

 

TO LEARN MORE ABOUT THE SNBR CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Sleep Number you have until February 14, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

RAAS Class Action: Learn About the Cloopen Lawsuit

Levi & Korsinsky, LLP

December 15, 2021

Levi & Korsinsky, LLP announces that a RAAS class action lawsuit has been filed on behalf of investors who purchased Cloopen Group Holding Limited  (RAAS) (a)pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s February 2021 initial public offering; and/or (b)between February 9, 2021, and May 10, 2021, inclusive. For more on the RAAS Lawsuit please contact us today.   

 

Levi & Kowsinsky Securities Class Action Lawyers

 

 

According to the Cloopen lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: an increasing number of its customers were refusing to pay, forcing the Company to record massive increases in its accounts receivables and allowance for doubtful accounts. The Registration Statement also failed to disclose that Cloopen was weighed down by massive liabilities related to the fair value of certain recently-granted warrants.

 

TO LEARN MORE ABOUT THE RAAS CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Cloopen you have until February 8, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

 


Class Action Reports

RVNC Class Action: Learn About the Revance Lawsuit

Levi & Korsinsky, LLP

December 14, 2021

Levi & Korsinsky, LLP announces that an RVNC class action lawsuit has been filed on behalf of investors who purchased Revance Therapeutics, Inc. (RVNC) securities between November 25, 2019, and October 11, 2021 For more on the RVNC Lawsuit please contact us today.

 

 

 

According to the Revance lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) quality control deficiencies existed at the Company’s manufacturing facility for DaxibotulinumtoxinA for Injection (“DXAI”); (ii) the foregoing deficiencies decreased the likelihood that the Food and Drug Administration (“FDA”) would approve the DAXI Biologics License Application (“BLA”) in its current form; (iii) accordingly, it was unlikely that the DAXI BLA would obtain FDA approval within the timeframe the Company had represented to investors; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE RVNC CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Revance you have until February 8, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ORGO Class Action: Learn About the Organogenesis Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an ORGO class action lawsuit has been filed on behalf of investors who purchased Organogenesis Holdings Inc. (ORGO) securities between March 17, 2021, and October 11, 2021. For more on the ORGO Lawsuit please contact us today.

 

 

 

According to the Organogenesis lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Organogenesis improperly billed the federal government for its Affinity and PuraPly XT products by, among other things, setting the price for those products multiple times higher than similar products; (ii) the Company improperly induced doctors to use its Affinity and PuraPly XT products through lucrative reimbursements; (iii) as a result of all the foregoing, the Company’s revenue and profits derived from its Affinity and PuraPly XT products were at least in substantial part unsustainable; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE ORGO CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Organogenesis you have until February 8, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

BLI Class Action: Learn About the Berkeley Lights Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a BLI class action lawsuit has been filed on behalf of investors who purchased Berkeley Lights, Inc. (BLI) securities between July 17, 2020, and September 14, 2021. For more on the BLI Lawsuit please contact us today.

 

Levi & Kowsinsky Securities Class Action Lawyers

 

According to the Berkeley Lights lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (a) Berkeley Lights’ flagship instrument, the Beacon, suffered from numerous design and manufacturing defects including breakdowns, high error rates, data integrity issues and other problems, limiting the ability of biotechnology companies and research institutions to consistently use the machines at scale; (b) Berkeley Lights had received numerous customer complaints regarding the durability and effectiveness of the Company’s automation systems; (c) the actual market for Berkeley Lights’ products and services was a fraction of the $23 billion represented to investors because of, inter alia, the relatively high cost of the Company’s instruments and consumables and inability to provide the sustained performance necessary to justify these high costs; and (d) as a result of (a)-(c), above, defendants’ statements to investors during the Class Period regarding Berkeley Lights’ business, operations and financial results were materially false and misleading.

 

TO LEARN MORE ABOUT THE BLI CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Berkeley Lights you have until February 7, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

STNE Class Action: Learn About the StoneCo Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an STNE class action lawsuit has been filed on behalf of investors who purchased StoneCo Ltd. (STNE) securities between March 11, 2021, and November 16, 2021. For more on the STNE Lawsuit please contact us today.

 

 

According to the StoneCo lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) StoneCo was experiencing difficulties in implementing its credit product; (2) StoneCo faced significant risks via its point-of-sale vendor, PAX Global Technology Ltd.; (3) as a result of the foregoing, the Company’s financial results would be adversely impacted; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE STNE CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in StoneCo you have until January 18, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

PLTK Class Action: Learn About the Playtika Holding Lawsuit 

Levi & Korsinsky, LLP

December 8, 2021

Levi & Korsinsky, LLP announces that a PLTK class action lawsuit has been filed on behalf of investors who purchased Playtika Holding Corp. (PLTK) (a) Playtika securities pursuant and/or traceable to the Company’s initial public offering conducted on or about January 15, 2021, or (b) Playtika securities between January 15, 2021, and November 2, 2021. . For more on the PLTK Lawsuit please contact us today.

 

 

 

According to the Playtika Holdinglawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company’s year-over-year total costs and costs related to sales & marketing and research & development were on track to rise significantly by the third quarter of 2021; (ii) the success of the Company’s game portfolio was less sustainable than the Company had represented; (iii) the foregoing issues were likely to negatively impact the Company’s revenue and earnings; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE PLTK CLASS ACTION LAWSUIT, CLICK HERE  

 

If you suffered a loss in Playtika Holding you have until January 24, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  

Levi and Korsinsky

CONTACT: 


Levi & Korsinsky, LLP  

Joseph E. Levi, Esq.  

55 Broadway, 10th Floor  

New York, NY 10006  

jlevi@levikorsinsky.com  

Tel: (212) 363-7500  

Fax: (212) 363-7171  

www.zlk.com  

 


Class Action Reports

IQ Class Action: Learn About the iQIYI Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an IQ class action lawsuit has been filed on behalf of investors who purchased iQIYI, Inc. (IQ) securities between March 22, 2021, and March 29, 2021. For more on the IQ Lawsuit please contact us today.

 

Levi & Kowsinsky Securities Class Action Lawyers

 

According to the iQIYI lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: Goldman Sachs Group Inc. and Morgan Stanley sold a large number of iQIYI shares while in possession of material non-public information. The defendants knew that Archegos Capital Management would need to fully liquidate its position in iQIYI based on margin call pressures. The defendants avoided billions in losses by selling the Company’s shares while in possession of this information. When the market learned the truth about iQIYI investors suffered damages.

 

TO LEARN MORE ABOUT THE IQ CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in iQIYI you have until January 31, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

TWVLX Class Action: Learn About the American Century Lawsuit 

Levi & Korsinsky, LLP

December 2, 2021

Levi & Korsinsky, LLP announces that a TWVLX class action lawsuit has been filed on behalf of investors who purchased American Century Capital Portfolios, Inc. (TWVLX) pursuant and or traceable to registration statements and prospectuses filed between November 5, 2018, and the present. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of California For more on the TWVLX Lawsuit please contact us today.

 

Levi & Kowsinsky Securities Class Action Lawyers

 

According to the American Centurylawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Fund’s investment strategy was neither to identify companies whose stock price may not reflect the company’s value, nor to purchase the stocks of these undervalued companies and hold each stock until the price has increased to, or is higher than, a level the managers believe more accurately reflects the fair value of the company; (ii) Defendants were not actively managing the Fund (which allegedly included researching and selecting investments for the Fund); (iii) Defendants employed an investment strategy designed to closely track the performance of the Fund’s stated benchmark index, the Russell 1000 Value index, known as “closet indexing”; (iv) Defendants had no reason to charge substantial fees to the Fund for this purportedly active management while engaging in closet indexing; (v) the excessive fees virtually ensured that the Fund could not match its benchmark over time, let alone outperform it; and (vi) as a result, the Fund would consistently fail to meet or outperform its benchmark index.

 

TO LEARN MORE ABOUT THE TWVLX CLASS ACTION LAWSUIT, CLICK HERE  

 

If you suffered a loss in American Century you have until January 10, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  

 

CONTACT: 


Levi & Korsinsky, LLP  

Joseph E. Levi, Esq.  

55 Broadway, 10th Floor  

New York, NY 10006  

jlevi@levikorsinsky.com  

Tel: (212) 363-7500  

Fax: (212) 363-7171  

www.zlk.com  


Class Action Reports

PKKFF Class Action: Learn About the Tenet Lawsuit

Levi & Korsinsky, LLP

November 29, 2021

Levi & Korsinsky, LLP announces that a PKKFF class action lawsuit has been filed on behalf of investors who purchased Tenet Fintech Group Inc. (PKKFF) securities between September 2, 2021, and October 13, 2021. For more on the PKKFF Lawsuit please contact us today.

 

 

 

 

According to the Tenet lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company did not own 51% of Asia Synergy Financial Capital Ltd. (“ASFC”) through Wuxi Aorong; (2) the Company did not disclose its actual ownership structure of ASFC, an undisclosed and potentially problematic nominee shareholder agreement; (3) Huayan did not own the Heartbeat platform; (4) the Heartbeat platform did not exist prior to the alleged acquisition; (5) the Company faced imminent delisting from NASDAQ due to non-compliance with known regulations; and (6) as a result of the foregoing, defendants’ public statements were materially false and/or misleading at all relevant times.

 

 

TO LEARN MORE ABOUT THE PKKFF CLASS ACTION LAWSUIT, CLICK HERE

 

 

If you suffered a loss in Tenet you have until January 18, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

OWLT Class Action: Learn About the Owlet, Inc. Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an OWLT class action lawsuit has been filed on behalf of investors who purchased Owlet, Inc. f/k/a Sandbridge Acquisition Corporation (OWLT) securities between March 31, 2021, and October 4, 2021. For more on the OWLT Lawsuit please contact us today.

 

Levi & Kowsinsky Securities Class Action Lawyers

 

According to the Owlet, Inc. lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Owlet was reasonably likely to be required to obtain marketing authorization for the Smart Sock because the Food and Drug Administration concluded it was a medical device; (2) as a result, Owlet was reasonably likely to cease commercial distribution of the Smart Sock in the U.S. until it obtained the requisite approval; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE OWLT CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Owlet, Inc. you have until January 18, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

DNA Class Action: Learn About the Ginkgo Bioworks Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a DNA class action lawsuit has been filed on behalf of investors who purchased Ginkgo Bioworks Holdings, Inc. (DNA) securities between May 11, 2021, and October 5, 2021. For more on the DNA Lawsuit please contact us today.

 

Levi & Kowsinsky Securities Class Action Lawyers

 

According to the Ginkgo Bioworks lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company’s failure to derive real revenue from third-party customers left it almost completely dependent on related parties; (2) as a result, most, if not all, of the Company’s revenue came from related parties the Company created, funded, or controlled through its ownership and board seats; (3) the Company was misclassifying and underreporting related party revenue in order to conceal the Company’s near total-dependence on related parties; (4) many of the Company’s new R&D partners are undisclosed related parties and/or facades; (5) as a result, the Company’s valuation was significantly less than Defendants disclosed to investors; and (6) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE DNA CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Ginkgo Bioworks you have until January 18, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

 


Class Action Reports

CTXS Class Action: Learn About the Citrix Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CTXS class action lawsuit has been filed on behalf of investors who purchased Citrix Systems, Inc. (CTXS) securities between January 22, 2020, and October 6, 2021. For more on the CTXS Lawsuit please contact us today.

 

Levi & Kowsinsky Securities Class Action Lawyers

 

According to the Citrix lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: the transition from on-premise to the cloud product was going smoothly. In addition, in response to the COVID-19 pandemic and the shift to remote work, Citrix created a shorter duration, on-premise subscription license (the “Business Continuity Licenses”) that the Company offered at a discounted rate, and which Defendants claimed would transition to cloud accounts after the one-year license expired. As a result of Defendants’ misrepresentations, Citrix common stock traded at artificially inflated prices during the Class Period.

 

 

TO LEARN MORE ABOUT THE CTXS CLASS ACTION LAWSUIT, CLICK HERE

 

 

If you suffered a loss in Citrix you have until January 18, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

 


Class Action Reports

ZME Class Action: Learn About the Zhangmen Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a ZME class action lawsuit has been filed on behalf of investors who purchased Zhangmen Education Inc.(ZME) Company’s initial public offering, conducted on or about June 8, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Southern District of New York For more on the ZME Lawsuit please contact us today.  

 

Levi & Kowsinsky Securities Class Action Lawyers

 

 

According to the Zhangmen lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (a) People’s Republic of China authorities were in the process of implementing sweeping new regulatory reforms on the private education industry in China including, among others, prohibitions on (i) profit-making by private education companies, (ii) engaging in core-curriculum tutoring on weekends and vacations, and (iii) capital-raising by companies like Zhangmen; (b) the known risks, events and uncertainties noted in (a) above were reasonably likely to have a material adverse effect on the Company’s business; and (c) based on the foregoing, the statements in the Registration Statement concerning the Company’s historical financial performance, market demand, and industry trends were materially incomplete, inaccurate and misleading.

 

TO LEARN MORE ABOUT THE ZME CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Zhangmen you have until January 18, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

PTON Class Action: Learn About the Peloton Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a PTON class action lawsuit has been filed on behalf of investors who purchased Peloton Interactive, Inc. (PTON) securities between December 9, 2020, and November 4, 2021. For more on the PTON Lawsuit please contact us today.

 

 

 

According to the Peloton lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: Defendants repeatedly, falsely assured investors that the Company’s positive results and growth would continue after the pandemic. In addition, during the Class Period, Defendants made false and misleading statements about the amount of inventory that Peloton held, and touted the Company’s ability to keep its inventory levels in line with substantial, sustained demand. As a result of Defendants’ misrepresentations, Peloton common stock traded at artificially inflated prices during the Class Period.

 

TO LEARN MORE ABOUT THE PTON CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Peloton you have until January 18, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

LSPD Class Action: Learn About the Lightspeed Commerce Lawsuit

Levi & Korsinsky, LLP

November 18, 2021

Levi & Korsinsky, LLP announces that an LSPD class action lawsuit has been filed on behalf of investors who purchased Lightspeed Commerce Inc. (LSPD) securities between September 11, 2020, and September 28, 2021. For more on the LSPD Lawsuit please contact us today.

 

Levi & Kowsinsky Securities Class Action Lawyers

 

 

According to the Lightspeed Commerce lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Lightspeed had misrepresented the strength of its business by, inter alia, overstating its customer count, gross transaction volume, and increase in Average Revenue Per User, while concealing the Company’s declining organic growth and business deterioration; (ii) Lightspeed had overstated the benefits and value of the Company’s various acquisitions; (iii) accordingly, the Company had overstated its financial position and prospects; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE LSPD CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Lightspeed Commerce you have until January 18, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

Z Class Action: Learn About the Zillow Group Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a Z class action lawsuit has been filed on behalf of investors who purchased Zillow Group, Inc. (Z) securities between February 10, 2021, and November 2, 2021. For more on the Z Lawsuit please contact us today.

 

 

 

According to the Zillow Group lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) despite operational improvements, the Company experienced significant unpredictability in forecasting home prices for its Zillow Offers business; (2) such unpredictability, as well as labour and supply shortages, led to a backlog of inventory; (3) as a result of the foregoing, the Company was reasonably likely to wind-down its Zillow Offers business, which would have a material adverse impact on its financial results; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE Z CLASS ACTION LAWSUIT, CLICK HERE

If you suffered a loss in Zillow Group you have until January 18, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SNAP Class Action: Learn About the SnapLawsuit

Levi & Korsinsky, LLP

November 17, 2021

Levi & Korsinsky, LLP announces that a SNAP class action lawsuit has been filed on behalf of investors who purchased Snap Inc.  (SNAP) securities between July 22, 2020, and October 21, 2021. For more on the SNAP Lawsuit please contact us today.

 

 

 

According to the Snap lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Apple’s privacy changes would have, and we’re having, a material impact on the Company’s advertising business; (2) Snap overstated its ability to transition its advertising with Apple’s privacy changes; (3) Snap knew of, but downplayed, the risks of the impact that Apple’s privacy changes had on the Company’s advertising business; (4) Snap overstated its commitment to privacy; and (5) as a result of the foregoing, Defendants’ public statements and statements to journalists were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE SNAP CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Snap you have until January 10, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

TMC Class Action: Learn About the TMC Lawsuit

Levi & Korsinsky, LLP

November 10, 2021

Levi & Korsinsky, LLP announces that a TMC class action lawsuit has been filed on behalf of investors who purchased TMC the metals company Inc. f/k/a Sustainable Opportunities Acquisition Corp. (TMC) securities between March 4, 2021, and October 5, 2021. For more on the TMC Lawsuit please contact us today.

 

 

 

According to the TMC lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company had significantly overpaid for the Tongo Offshore Mining Limited acquisition to undisclosed insiders; (2) the Company had artificially inflated its Nauru Ocean Resources Inc. (“NORI”) exploration expenditures to give investors a false scale of its operations; (3) the Company’s purported 100% interest in NORI was questionable given prior disclosures to the International Seabed Authority that NORI was wholly owned by two Nauruan foundations and that all future income from NORI would be used in Nauru; (4) Defendants had significantly downplayed the environmental risks of deep-sea mining polymetallic nodules and failed to adequately warn investors of the regulatory risks faced by the Company’s environmentally risky exploitation plans; (5) the Company’s PIPE financing was not fully committed and, therefore, the Company would not have the cash necessary for large sale commercial production; (6) as a result of the foregoing, the Company’s valuation was significantly less than Defendants disclosed to investors; and (7) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE TMC CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in TMC you have until December 27, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SBTX Class Action: Learn About the Silverback Therapeutics Lawsuit 

Levi & Korsinsky, LLP

November 9, 2021

Levi & Korsinsky, LLP announces that an SBTX class action lawsuit has been filed on behalf of investors who purchased Silverback Therapeutics, Inc.(SBTX) This lawsuit is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired: (a) Silverback common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company’s initial public offering conducted on or about December 3, 2020, and/or (b) Silverback securities between December 3, 2020, and September 10, 2021, both dates inclusive. For more on the SBTX Lawsuit please contact us today.   

 

 

 

 

According to the Silverback Therapeuticslawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(i) Silverback’s lead product candidate SBT6050, which is in a Phase I/Ib clinical trial, a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody that targets tumours, such as breast, gastric, and non-small cell lung cancers, was less effective than the Company had represented to investors; (ii) accordingly, the Company had overstated SBT6050’s commercial and/or clinical prospects; and (iii) as a result, the Offering Documents and Defendants’ public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein.

 

TO LEARN MORE ABOUT THE SBTX CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Silverback Therapeutics you have until January 4, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  

 

Levi and Korsinsky

CONTACT: 


Levi & Korsinsky, LLP  

Joseph E. Levi, Esq.  

55 Broadway, 10th Floor  

New York, NY 10006  

jlevi@levikorsinsky.com  

Tel: (212) 363-7500  

Fax: (212) 363-7171  

www.zlk.com  


Class Action Reports

ONTF Class Action: Learn About the On24 Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an ONTF class action lawsuit has been filed on behalf of investors who purchased On24, Inc. (ONTF) This lawsuit is on behalf of persons and entities who also acquired ON24’s shares pursuant and traceable to the Offering issued in connection with the Company’s February 2, 2021, initial public offering. For more on the ONTF  Lawsuit please contact us today.   

 

 

According to the On24 lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the filed complaint, the surge in COVID-19 customers observed in the lead up to the IPO consisted of a significant number that did not fit ON24’s traditional customer profile, and, as a result, were significantly less likely to renew their contracts.

 

TO LEARN MORE ABOUT THE ONTF CLASS ACTION LAWSUIT, CLICK HERE  

 

If you suffered a loss in On24  you have until January 3, 2022,to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  

 

Levi and Korsinsky

CONTACT: 


Levi & Korsinsky, LLP  

Joseph E. Levi, Esq.  

55 Broadway, 10th Floor  

New York, NY 10006  

jlevi@levikorsinsky.com  

Tel: (212) 363-7500  

Fax: (212) 363-7171  

www.zlk.com  


Class Action Reports

HMLP Class Action: Learn About the Hoegh LNG Partners Lawsuit

Levi & Korsinsky, LLP

November 3, 2021

Levi & Korsinsky, LLP announces that an HMLP class action lawsuit has been filed on behalf of investors who purchased Hoegh LNG Partners Lp (HMLP) securities between August 22, 2019, and July 27, 2021. For more on the HMLP Lawsuit please contact us today.

 

 

 

According to the Hoegh LNG Partners lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Partnership was facing issues with the PT Perusahaan Gas Negara (“PGN”) Floating Storage Regasification Unit (“FSRU”) Lampung charter; (2) as a result, the PGN FSRU Lampung charterer would state that it would commence arbitration to declare the charter null and void, and/or to terminate the charter, and/or seek damages; (3) the Partnership would need to find alternative refinancing for its PGN FSRU Lampung credit facility; (4) the PGN FSRU Lampung credit facility matured in September 2021, not October 2021 as previously stated; (5) the Partnership would be forced to accept less favorable refinancing terms with regards to the PGN FSRU Lampung credit facility; (6) Höegh LNG would not extend the revolving credit line to the Partnership past its maturation date; (7) Höegh LNG would reveal that it “will have very limited capacity to extend any additional advances to the Partnership beyond what is currently drawn under the facility”; (8) as a result of the foregoing, the Partnership would essentially end distributions to common units holders; (9) the COVID-19 pandemic was not the sole or root cause of the Partnership’s issues in Indonesia, in 2019, before the pandemic, there were already a very low amount of demand in Indonesia for the Partnership’s gas; (10) the auditing, tax, nor maintenance of PGN FSRU Lampung were not the sole or root cause(s) of the Partnership’s issues in Indonesia; and (11) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE HMLP CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Hoegh LNG Partners you have until December 27, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CEI Class Action: Learn About the Camber Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CEI class action lawsuit has been filed on behalf of investors who purchased Camber Energy, Inc. (CEI) securities between February 18, 2021, and October 4, 2021. For more on the CEI Lawsuit please contact us today.

 

 

 

According to the Camber lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Camber overstated the financial and business prospects of Viking as well as the combined company post-merger; (ii) Camber failed to apprise investors of, and/or downplayed, the fact that its acquisition of a controlling interest in Viking would exacerbate the Company’s delinquent financial statements and listing obligations with the NYSE; (iii) an institutional investor was diluting Camber’s shares at a significant rate following the Company’s July 12, 2021 update regarding the number of its shares of common stock issued and outstanding; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE CEI CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Camber you have until December 28, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

FB Class Action: Learn About the Facebook Lawsuit

Levi & Korsinsky, LLP

November 2, 2021

Levi & Korsinsky, LLP announces that a FB class action lawsuit has been filed on behalf of investors who purchased Facebook, Inc. (FB) securities between November 3, 2016, and October 4, 2021. For more on the FB Lawsuit please contact us today.

 

 

 

According to the Facebook lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Facebook misrepresented its user growth; (2) Facebook knew or should have known, that duplicate accounts represented a greater portion of its growth than stated, and it should have provided more detailed disclosures as to the implication of duplicate accounts to Facebook’s user base and growth; (3) Facebook did not provide a fair platform for speech, and regularly protected high profile users via its Cross Check/XCheck system; (4) despite being aware of their use of Facebook’s platforms, the Company failed to respond meaningfully to drug cartels, human traffickers, and violent organizations; (5) Facebook has been working to attract preteens to its platform and services; and (6) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE FB CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Facebook you have until December 27, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

TME Class Action: Learn About the Tencent Music Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a TME class action lawsuit has been filed on behalf of investors who purchased Tencent Music Entertainment Group(TME) securities between March 22, 2021, and March 29, 2021.  For more on the TME Lawsuit please contact us today.

 

 

 

According to the Tencent Music lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the filed complaint: Goldman Sachs Group Inc. and Morgan Stanley sold a large number of Tencent Music shares while in possession of material non-public information. The defendants knew that Archegos Capital Management would need to fully liquidate its position in Tencent Music based on margin call pressures. The defendants avoided billions in losses by selling the Company’s shares while in possession of this information. When the market learned the truth about Tencent Music, investors suffered damages.

 

TO LEARN MORE ABOUT THE TME CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Tencent Music you have until December 27, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

GOTU Class Action: Learn About the Gaotu Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a GOTU class action lawsuit has been filed on behalf of investors who purchased Gaotu Techedu Inc. (GOTU) securities between March 22, 2021, and March 29, 2021. For more on the GOTU Lawsuit please contact us today.

 

 

 

According to the Gaotu lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the filed complaint: Goldman Sachs and Morgan Stanley sold a large amount of Gaotu shares during the Class Period while in possession of material, non-public information about Archegos and its need to fully liquidate its position in the Company because of margin call pressure. As a result of these sales, Defendants Goldman Sachs and Morgan Stanley avoided billions in losses combined.

 

TO LEARN MORE ABOUT THE GOTU CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Gaotu you have until December 20, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

RECAF Class Action: Learn About the ReconAfrica Lawsuit

Levi & Korsinsky, LLP

October 28, 2021

Levi & Korsinsky, LLP announces that a RECAF class action lawsuit has been filed on behalf of investors who purchased Reconnaissance Energy Africa Ltd. f/k/a Lund Enterprises Corp.  (RECAF) securities between February 28, 2019, and September 7, 2021. For more on the RECAF Lawsuit please contact us today.

 

 

 

According to the ReconAfrica lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) ReconAfrica’s plan for using unconventional means for energy extraction (including fracking) in the fragile Kavango area; (2) ReconAfrica would begin unlicensed drilling tests; (3) ReconAfrica would illegally use water for well testing; (4) ReconAfrica would illegally store used water in unlined pools; (5) ReconAfrica would skirt Namibian law and hire an inadequate and inappropriate consultant; (6) as a result, ReconAfrica risked future well, drilling, and water-related licenses in Namibia and Botswana; (7) as opposed to its representations, ReconAfrica did not reach out nor provide adequate information (including in relevant local languages) through accessible means to those to be impacted by its testing and potential energy extraction; (8) ReconAfrica’s interests are in the Owambo Basin, not the so-called Kavango Basin; (9) ReconAfrica has continuously engaged in stock pumping; and (10) as a result of the foregoing, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE RECAF CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in ReconAfrica you have until December 27, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

HEPS Class Action: Learn About the Hepsiburada  Lawsuit 

Levi & Korsinsky, LLP

October 26, 2021

Levi & Korsinsky, LLP announces that a HEPS class action lawsuit has been filed on behalf of investors who purchased D-MARKET Elektronik Hizmetler ve Ticaret Anonim irketi a/k/a D-MARKET Electronic Services & Trading d/b/a/ Hepsiburada (HEPS) This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Hepsiburada American Depositary Receipts (“ADRs”) pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s July 2021 initial public offering. For more on the HEPS Lawsuit please contact us today.   

 

 

 

According to the Hepsiburada lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Hepsiburada suffered a sharp deceleration in operational and sales growth during second quarter 2021; (2) as a result, the Company initiated certain actions to fortify its competitive position, including investing in electronics and high-frequency categories and discounting certain categories; (3) as a result of the foregoing, Hepsiburada’s revenue and Gross Merchandise Value had declined during second quarter 2021; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE HEPS CLASS ACTION LAWSUIT, CLICK HERE  

 

If you suffered a loss in Hepsiburada  you have until December 20, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  

Levi and Korsinsky

CONTACT: 


Levi & Korsinsky, LLP  

Joseph E. Levi, Esq.  

55 Broadway, 10th Floor  

New York, NY 10006  

jlevi@levikorsinsky.com  

Tel: (212) 363-7500  

Fax: (212) 363-7171  

www.zlk.com  


Class Action Reports

BMRN Class Action: Learn About the BioMarin Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a BMRN class action lawsuit has been filed on behalf of investors who purchased BioMarin Pharmaceutical Inc. (BMRN) securities between January 13, 2020, and September 3, 2021 For more on the BMRN Lawsuit please contact us today.

 

 

Levi & Kowsinsky Securities Class Action Lawyers

 

 

According to the BioMarin lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) BMN 307 was less safe than BioMarin had led investors to believe; (ii) BMN 307’s safety profile made it likely that the FDA would place a clinical hold on the Phearless Phase 1/2 study; (iii) accordingly, the Company had overstated BMN 307’s clinical and commercial prospects; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE BMRN CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in BioMarin you have until December 22, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

AMRN Class Action: Learn About the Amarin Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an AMRN class action lawsuit has been filed on behalf of investors who purchased Amarin Corporation Plc (AMRN) securities between December 5, 2018, and June 21, 2021. For more on the AMRN Lawsuit please contact us today.

 

 

 

According to the Amarin lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) there was an increasingly high risk that certain of Amarin’s patents would be invalidated; (ii) once the District Court invalidated certain of Amarin’s patents, there was little to no chance of reversing that ruling; (iii) the Company’s litigation was preventing it from effectuating a successful takeover; (iv) Defendants were downplaying the true threat the ongoing abbreviated new drug application litigation posed to the Company’s business and future prospects; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE AMRN CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Amarin you have until December 23, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

INNV Class Action: Learn About the InnovAge Lawsuit 

Levi & Korsinsky, LLP

October 20, 2021

Levi & Korsinsky, LLP announces that an INNV class action lawsuit has been filed on behalf of investors who purchased InnovAge Holding Inc.  (INNV) This lawsuit is on behalf of persons and entities that purchased or otherwise acquired InnovAge common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s March 2021 initial public offering. For more on the INNV Lawsuit please contact us today.

 

 

 

According to the InnovAgelawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) certain of InnovAge’s facilities failed to provide covered services, provide accessible and adequate services, manage participants’ medical situations, and oversee the use of specialists; (2) as a result, the Company was reasonably likely to be subject to regulatory scrutiny, including by the Centers for Medicare and Medicaid Services; (3) as a result, there as a significant risk that CMS would suspend new enrollments pending an audit of the Company’s services; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE INNV CLASS ACTION LAWSUIT, CLICK HERE  

 

If you suffered a loss in InnovAge you have until December 13, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  

 

Levi and Korsinsky

CONTACT: 


Levi & Korsinsky, LLP  

Joseph E. Levi, Esq.  

55 Broadway, 10th Floor  

New York, NY 10006  

jlevi@levikorsinsky.com  

Tel: (212) 363-7500  

Fax: (212) 363-7171  

www.zlk.com 


Class Action Reports

ZEV Class Action: Learn About the Lightning Emotors Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a ZEV class action lawsuit has been filed on behalf of investors who purchased Lightning Emotors, Inc (ZEV) securities between May 7, 2021, and August 16, 2021. For more on the ZEV Lawsuit please contact us today.

 

 

 

According to the Lightning Emotors lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company would record a substantially greater net loss per share in the second quarter of 2021 compared to the second quarter of 2020 and would pull its full-year guidance for the remainder of 2021; (ii) accordingly, the Company materially overstated its financial position and/or prospects; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE ZEV CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Lightning Emotors you have until December 15, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

 


Class Action Reports

VIPS Class Action: Learn About the Vipshop Lawsuit

Levi & Korsinsky, LLP

October 14, 2021

Levi & Korsinsky, LLP announces that a VIPS class action lawsuit has been filed on behalf of investors who purchased Vipshop Holdings Ltd. (VIPS) securities between March 22, 2021, and March 29, 2021 For more on the VIPS Lawsuit please contact us today.

 

 

 

According to the Vipshop lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: Goldman Sachs and Morgan Stanley sold a large amount of block of shares during the Class Period while in possession of material, non-public information about Archegos after confidentially learning it was likely failing to meet margin calls. As a result of these sales, Defendants Goldman Sachs and Morgan Stanley avoided billions in losses combined.

 

TO LEARN MORE ABOUT THE VIPS CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Vipshop you have until December 13, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

EAR Class Action: Learn About the Eargo Lawsuit

Levi & Korsinsky, LLP

October 11, 2021

Levi & Korsinsky, LLP announces that an EAR class action lawsuit has been filed on behalf of investors who purchased Eargo, Inc. (EAR) securities between October 16, 2020, and September 22, 2021. For more on the EAR Lawsuit please contact us today.

 

Levi & Kowsinsky Securities Class Action Lawyers

 

According to the Eargo lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Eargo had improperly sought reimbursements from certain third-party payors; (2) the foregoing was reasonably likely to lead to regulatory scrutiny; (3) as a result and because the reimbursements at issue involved the Company’s largest third-party payor, Eargo’s financial results would be adversely impacted; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE EAR CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Eargo you have until December 6, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

NNOX Class Action: Learn About the Nano-X Lawsuit

Levi & Korsinsky, LLP

October 7, 2021

Levi & Korsinsky, LLP announces that an NNOX class action lawsuit has been filed on behalf of investors who purchased Nano-X Imaging Ltd.(NNOX) securities between June 17, 2021, and August 18, 2021. For more on the NNOX Lawsuit please contact us today.

 

 

 

According to the Nano-X lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Nano-X’s 510(k) application for the Nanox.ARC was deficient; (ii) accordingly, it was unlikely that the Food and Drug Administration would approve the 510(k) application for the Nanox.ARC in its current form; (iii) as a result, NanoX had overstated the Nanox.ARC’s regulatory and commercial prospects; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE NNOX CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Nano-X you have until December 6, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

HYZN Class Action: Learn About the Hyzon Motors Lawsuit

Levi & Korsinsky, LLP

October 6, 2021

Levi & Korsinsky, LLP announces that an HYZN class action lawsuit has been filed on behalf of investors who purchased Hyzon Motors Inc. f/k/a Decarbonization Plus Acquisition Corporation (HYZN) securities between February 9, 2021, and September 27, 2021. For more on the HYZN Lawsuit please contact us today.

 

 

 

According to the Hyzon Motors lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Hyzon was misrepresenting the nature of its “customer” contracts and severely embellished its “deals” and “partnerships” with customers; (2) Hyzon could not deliver its announced vehicles in 2021, on its stated timeline; and (3) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE HYZN CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Hyzon Motors you have until November 29, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

 


Class Action Reports

APPH Class Action: Learn About the AppHarvest Lawsuit

Levi & Korsinsky, LLP

October 1, 2021

Levi & Korsinsky, LLP announces that an APPH class action lawsuit has been filed on behalf of investors who purchased AppHarvest, Inc.  (APPH) securities between May 17, 2021, and August 10, 2021. For more on the APPH Lawsuit please contact us today.

 

 

 

According to the AppHarvest lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) AppHarvest lacked sufficient training for its recently expanded labour force; (2) as a result, the Company could not produce Grade No. 1 tomatoes consistently; (3) as a result, the Company’s financial results would be adversely impacted; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE APPH CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in AppHarvest you have until November 23, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & Korsinsky Securities Class Action Law Firm

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

HNST Class Action: Learn About the The Honest Company Lawsuit 

Levi & Korsinsky, LLP

September 21, 2021

Levi & Korsinsky, LLP announces that an HNST class action lawsuit has been filed on behalf of investors who purchased The Honest Company, Inc.  (HNST) This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Honest common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s May 2021 initial public offering. For more on the HNST Lawsuit please contact us today.

 

 

 

According to The Honest Companylawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) prior to the Initial Public Offering (“IPO”), the Company’s results had been significantly impacted by a multimillion-dollar COVID-19 stock-up for products in the Diapers and Wipes category and Household and Wellness category; (2) at the time of the IPO, the Company was experiencing decelerating demand for such products; (3) as a result, the Company’s financial results would likely be adversely impacted; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE HNST CLASS ACTION LAWSUIT, CLICK HERE 

 

If you suffered a loss in The Honest Company  you have until November 15, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  

Levi & Korsinsky Securities Class Action Lawfirm

CONTACT: 


Levi & Korsinsky, LLP  

Joseph E. Levi, Esq.  

55 Broadway, 10th Floor  

New York, NY 10006  

jlevi@levikorsinsky.com  

Tel: (212) 363-7500  

Fax: (212) 363-7171  

www.zlk.com


Class Action Reports

WDH Class Action: Learn About the Waterdrop Lawsuit 

Levi & Korsinsky, LLP

September 17, 2021

Levi & Korsinsky, LLP announces that a WDH class action lawsuit has been filed on behalf of investors who purchased Waterdrop Inc. (WDH) This lawsuit is on behalf of all persons or entities who purchased Waterdrop American Depositary Shares in or traceable to the Company’s May 2021 initial public offering. For more on the WDH Lawsuit please contact us today.   

 

 

 

According to the Waterdrop lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (a) Waterdrop had achieved a substantial portion of its historical revenue growth through illicit means that ran afoul of Chinese rules and regulations governing the insurance industry; (b) Waterdrop had been ordered by the Chinese government to shut down its mutual aid platform because of its failure to comply with Chinese law; (c) Waterdrop was under investigation by regulatory authorities for continued violations of Chinese law; (d) as a result of (a)-(c) above, there existed a material undisclosed risk and substantial likelihood that Waterdrop would face severe adverse actions by regulatory authorities following the IPO; (e) Waterdrop’s operating losses had increased more than four-fold in the first quarter of 2021 as a result of the cessation of its mutual aid business and rapidly growing customer acquisition costs; and (f) as a result of (a)-(e) above, the Registration Statement’s representations regarding Waterdrop’s historical financial and operational metrics and purported market opportunities did not accurately reflect the actual business, operations, and financial results and trajectory of the Company in the lead up to the IPO, were materially false and misleading, and lacked a factual basis.

 

TO LEARN MORE ABOUT THE WDH CLASS ACTION LAWSUIT, CLICK HERE  

 

If you suffered a loss in Waterdrop you have until November 15, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  

 

Levi and Korsinsky

CONTACT: 


Levi & Korsinsky, LLP  

Joseph E. Levi, Esq.  

55 Broadway, 10th Floor  

New York, NY 10006  

jlevi@levikorsinsky.com  

Tel: (212) 363-7500  

Fax: (212) 363-7171  

www.zlk.com  


Class Action Reports

SAM Class Action: Learn About the The Boston Beer Company Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a SAM class action lawsuit has been filed on behalf of investors who purchased The Boston Beer Company, Inc. (SAM) securities between April 22, 2021, and September 8, 2021. For more on the SAM Lawsuit please contact us today.

 

 

 

According to the Boston Beer Company lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Boston Beer’s hard seltzer sales were decelerating; (2) as a result, Boston Beer was reasonably likely to incur inventory write-offs; (3) the Company was reasonably likely to incur shortfall fees payable to third party brewers; (4) as a result of the foregoing, Boston Beer’s financial results would be adversely impacted; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE SAM CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in The Boston Beer Company you have until November 15, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & Korsinsky Securities Class Action Lawfirm

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SPPI Class Action: Learn About the Spectrum Pharmaceuticals Lawsuit

Levi & Korsinsky, LLP

September 3, 2021

Levi & Korsinsky, LLP announces that an SPPI class action lawsuit has been filed on behalf of investors who purchased Spectrum Pharmaceuticals, Inc. (SPPI) securities between December 27, 2018, and August 5, 2021 For more on the SPPI Lawsuit please contact us today.

 

 

 

According to the Spectrum Pharmaceuticals lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the ROLONTIS, an investigational granulocyte-colony stimulating factor analogue, manufacturing facility maintained deficient controls and/or procedures; (ii) the foregoing deficiencies decreased the likelihood that the Food and Drug Administration would approve the ROLONTIS biologics license application (“BLA”) in its current form; (iii) Spectrum had therefore materially overstated the ROLONTIS BLA’s approval prospects; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE SPPI CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Spectrum Pharmaceuticals you have until November 1, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & Korsinsky Securities Class Action Lawfirm

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

KPLT Class Action: Learn About the Katapult Holdings Lawsuit

Levi & Korsinsky, LLP

August 31, 2021

Levi & Korsinsky, LLP announces that a KPLT class action lawsuit has been filed on behalf of investors who purchased Katapult Holdings, Inc. (KPLT) securities between December 18, 2020, and August 10, 2021 For more on the KPLT Lawsuit please contact us today.

 

 

According to the Katapult Holdings lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Katapult was experiencing declining e-commerce retail sales and consumer spending, (2) despite Katapult’s assertions that it was clear and compelling value proposition to both consumers and merchants, transforming the way nonprime consumers shop for essential goods and enabling merchant access to this underserved segment, Katapult lacked visibility into its consumers’ future buying behaviour; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE KPLT CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Katapult Holdings you have until October 26, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SAVA Class Action: Learn About the Cassava Lawsuit

Levi & Korsinsky, LLP

August 30, 2021

Levi & Korsinsky, LLP announces that a SAVA class action lawsuit has been filed on behalf of investors who purchased Cassava Sciences, Inc.(SAVA) securities between February 2, 2021, and August 24, 2021 For more on the SAVA Lawsuit please contact us today.

 

 

 

According to the Cassava lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (a) the quality and integrity of the scientific data supporting Cassava’s claims for simufilam’s, a small molecule drug designed to treat Alzheimer’s disease, efficacy had been overstated; (b) the scientific data supporting Cassava’s claims for simufilam’s efficacy were biased; and (c) as a result of the foregoing, Defendants’ positive statements during the Class Period about the Company’s business metrics and financial prospects and the likelihood of Food and Drug Administration approval was false and misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE SAVA CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Cassava you have until October 26, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Kowsinsky Securities Class Action Lawyers

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

HYRE Class Action: Learn About the HyreCar Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an HYRE class action lawsuit has been filed on behalf of investors who purchased HyreCar Inc. (HYRE) securities between May 14, 2021, and August 10, 2021. For more on the HYRE Lawsuit please contact us today.

 

 

 

According to the HyreCar lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (a) HyreCar had materially understated its insurance reserves; (b) HyreCar had systematically failed to pay valid insurance claims incurred prior to the Class Period; (c) HyreCar had incurred significant expenses transitioning to its new third-party insurance claims administrator and processing claims incurred from prior periods; (d) HyreCar had failed to appropriately price risk in its insurance products and was experiencing elevated claims incidence as a result; (e) HyreCar had been forced to dramatically reform its claims underwriting, policies and procedures in response to unacceptably high claims severity and customer complaints; and (f) as a result, HyreCar’s operations and prospects were misrepresented because the Company was not on track to meet the financial estimates provided to investors during the Class Period, and such estimates lacked a reasonable basis in fact, including HyreCar’s purported gross margin, EBITDA (earnings before interest, taxes, depreciation, and amortization), and net loss trajectories.

 

TO LEARN MORE ABOUT THE HYRE CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in HyreCar you have until October 26, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

AHCO Class Action: Learn About the AdaptHealth Lawsuit

Levi & Korsinsky, LLP

August 24, 2021

Levi & Korsinsky, LLP announces that an AHCO class action lawsuit has been filed on behalf of investors who purchased AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. (AHCO) securities between November 11, 2019, and July 16, 2021 For more on the AHCO Lawsuit please contact us today.

 

Levi & Korsinsky

 

According to the AdaptHealth lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (i) AdaptHealth had misrepresented its organic growth trajectory by retroactively inflating past organic growth numbers without disclosing the changes, in violation of Securities and Exchange Commission regulations; (ii) accordingly, the Company had materially overstated its financial prospects; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE AHCO CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in AdaptHealth you have until September 27, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SESN Class Action: Learn About the Sesen Bio Lawsuit

Levi & Korsinsky, LLP

August 23, 2021

Levi & Korsinsky, LLP announces that a SESN class action lawsuit has been filed on behalf of investors who purchased Sesen Bio, Inc.  (SESN) securities between December 21, 2020, and August 17, 2021 For more on the SESN Lawsuit please contact us today.

 

 

 

According to the Sesen Bio lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Sesen Bio’s clinical trial for its cancer treatment product, Vicineum, had more than 2,000 violations of trial protocol, including 215 classified as “major”; (2) three of Sesen Bio’s clinical investigators were found guilty of “serious noncompliance,” including “back-dating data”; (3) Sesen Bio had submitted the tainted data in connection with the Biologics License Application (“BLA”) for Vicineum; (4) Sesen Bio’s clinical trials showed that Vicineum leaked out into the body, leading to side effects including liver failure and liver toxicity, and increasing the risks for fatal, drug-induced liver injury; (5) as a result of the foregoing, the Company’s BLA for Vicineum was not likely to be approved; (6) as a result of the foregoing, there was a reasonable likelihood that Sesen Bio would be required to conduct additional trials to support the efficacy and safety of Vicineum; and (7) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE SESN CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Sesen Bio you have until October 18, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & Korsinsky Securities Class Action Law Firm

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ATIP Class Action: Learn About the ATI Physical Therapy Lawsuit 

Levi & Korsinsky, LLP

August 20, 2021

Levi & Korsinsky, LLP announces that an ATIP class action lawsuit has been filed on behalf of investors who purchased ATI Physical Therapy, Inc. f/k/a Fortress Value Acquisition Corp. II (ATIP) This lawsuit is on behalf of investors who: (a) purchased or otherwise acquired ATI securities between April 1, 2021, and July 23, 2021, inclusive and/or (b) held FVAC Class A common stock as of May 24, 2021, and were eligible to vote at FVAC’s June 15, 2021, special meeting. For more on the ATIP Lawsuit please contact us today.   

 

 

 

According to the ATI Physical Therapylawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) ATI was experiencing attrition among its physical therapists; (2) ATI faced increasing competition for clinicians in the labour market; (3) as a result of the foregoing, the Company faced difficulties retaining therapists and incurred increased labour costs; (4) as a result of the labour shortage, the Company would open fewer new clinics; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE ATIP CLASS ACTION LAWSUIT, CLICK HERE  

 

If you suffered a loss in  ATI Physical Therapy  you have until  October 15, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  

Levi & Korsinsky Securities Class Action Lawfirm

 

CONTACT: 


Levi & Korsinsky, LLP  

Joseph E. Levi, Esq.  

55 Broadway, 10th Floor  

New York, NY 10006  

jlevi@levikorsinsky.com  

Tel: (212) 363-7500  

Fax: (212) 363-7171  

www.zlk.com 


Class Action Reports

VIEW Class Action: Learn About the View Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a VIEW class action lawsuit has been filed on behalf of investors who purchased View, Inc. f/k/a CF Finance Acquisition Corp. II  (VIEW) securities between November 30, 2020, and August 16, 2021. For more on the VIEW Lawsuit please contact us today.

 

 

 

According to the View lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) View had not properly accrued warranty costs related to its product; (2) there was a material weakness in View’s internal controls over accounting and financial reporting related to warranty accrual; (3) as a result, the Company’s financial results for prior periods were misstated; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE VIEW CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in View you have until October 18, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ANVS Class Action: Learn About the Annovis Bio Lawsuit

Levi & Korsinsky, LLP

August 19, 2021

Levi & Korsinsky, LLP announces that an ANVS class action lawsuit has been filed on behalf of investors who purchased Annovis Bio, Inc.  (ANVS) securities between May 21, 2021, and July 28, 2021. For more on the ANVS Lawsuit please contact us today.

 

 

According to the Annovis Bio lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Annovis’s ANVS401 (Posiphen), an orally administrated drug that purportedly inhibited the synthesis of neurotoxic proteins that are the main cause of neurodegeneration, did not show statistically significant results across two patient populations as to factors such as orientation, judgement, and problem solving; and (2) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE ANVS CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Annovis Bio you have until October 18, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & Korsinsky Securities Class Action Lawfirm

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

LIVE Class Action: Learn About the Live Ventures Incorporated Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a LIVE class action lawsuit has been filed on behalf of investors who purchased Live Ventures Incorporated (LIVE) securities between December 28, 2016, and August 3, 2021. For more on the LIVE Lawsuit please contact us today.

 

 

According to the Live Ventures Incorporated lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: 1) Live’s earnings per share for FY 2016 was actually only $6.33 per share; (2) the Company used an artificially low share count to boost the earnings per share by 40%; (3) Live had overstated pretax income for fiscal 2016 by 20% by including $915,500 of “other income” related to certain amendments that were not negotiated until after the close of the fiscal year; (4) Live’s acquisition of Appliance Smart did not close during first quarter 2017; (5) using December 30, 2017 as the “acquisition date” and recognizing income therefrom did not conform to generally accepted accounting principles; (6) by falsely stating that the acquisition closed during the quarter, Live recognized bargain purchase gain, which enabled the Company to report positive net income in what would otherwise have been an unprofitable quarter; (7) between fiscal 2016 and fiscal 2018, Live’s CEO received approximately 94% more in compensation than was disclosed to investors; and (8) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE LIVE CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Live Ventures Incorporated you have until October 12, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky Securities Class Action Law Firm

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

YALA Class Action: Learn About the Yalla Group Lawsuit

Levi & Korsinsky, LLP

August 18, 2021

Levi & Korsinsky, LLP announces that a YALA class action lawsuit has been filed on behalf of investors who purchased Yalla Group Limited (YALA) securities between September 30, 2020, and August 9, 2021. For more on the YALA Lawsuit please contact us today.

 

 

 

According to the Yalla Group lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the filed complaint: the Company overstated its user metrics and revenue and, as a result, the Company’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE YALA CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Yalla Group you have until October 12, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

PHG Class Action: Learn About the Philips Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a PHG class action lawsuit has been filed on behalf of investors who purchased Koninklijke Philips N.V. (PHG) securities between February 25, 2020, and June 11, 2021. For more on the PHG Lawsuit please contact us today.

 

 

 

According to the Philips lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Philips had deficient product manufacturing controls or procedures; (ii) as a result, the Company’s Bi-Level PAP and CPAP devices and mechanical ventilators were manufactured using hazardous materials; (iii) accordingly, the Company’s sales revenues from the foregoing products were unsustainable; (iv) the foregoing also subjected the Company to a substantial risk of a product recall, in addition to potential legal and/or regulatory action; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE PHG CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Philips you have until October 15, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & korsinsky

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SLQT Class Action: Learn About the Selectquote Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an SLQT class action lawsuit has been filed on behalf of investors who purchased Selectquote, Inc. (SLQT) securities between February 8, 2021, and May 11, 2021. For more on the SLQT Lawsuit please contact us today.

 

 

 

According to the Selectquote lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) SelectQuote’s 2019 cohort was underperforming; (2) as a result, the Company’s financial results would be adversely impacted; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE SLQT CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Selectquote you have until October 15, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky Securities Class Action Lawfirm

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ITRM Class Action: Learn About the Iterum Therapeutics Lawsuit

Levi & Korsinsky, LLP

August 10, 2021

Levi & Korsinsky, LLP announces that an ITRM class action lawsuit has been filed on behalf of investors who purchased Iterum Therapeutics Plc (ITRM) securities between November 30, 2020, and July 23, 2021 For more on the ITRM Lawsuit please contact us today.

 

 

 

According to the Iterum Therapeutics lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the sulopenem New Drug Application (“NDA”) lacked sufficient data to support approval for the treatment of adult women with UTIs caused by designated susceptible microorganisms proven or strongly suspected to be nonsusceptible to a quinolone; (ii) accordingly, it was unlikely that the Food and Drug Administration would approve the sulopenem NDA in its current form; (iii) Defendants downplayed the severity of issues and deficiencies associated with the sulopenem NDA; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE ITRM CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Iterum Therapeutics you have until October 4, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ZY Class Action: Learn About the Zymergen  Lawsuit 

Levi & Korsinsky, LLP

August 9, 2021

Levi & Korsinsky, LLP announces that a ZY class action lawsuit has been filed on behalf of investors who purchased Zymergen Inc. (ZY)This lawsuit is on behalf of investors who purchased ZY common stock pursuant and/or traceable to the documents issued in connection with the Company’s April 2021 initial public offering. For more on the ZY Lawsuit please contact us today.

 

 

According to the Zymergen lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:(1) during the qualification process for Hyaline, key customers had encountered technical issues, including product shrinkage and incompatibility with customers’ processes; (2) through the qualification process was critical to achieving market acceptance for Hyaline and generating revenue, Zymergen lacked visibility into the qualification process; (3) as a result, the Company overestimated demand for its products; (4) as a result of the foregoing, the Company’s product delivery timeline was reasonably likely to be delayed, which in turn would delay revenue generation; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE ZY CLASS ACTION LAWSUIT, CLICK HERE  

 

If you suffered a loss in Zymergen you have until October 4, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  

Levi & Korsinsky

 

CONTACT: 


Levi & Korsinsky, LLP  

Joseph E. Levi, Esq.  

55 Broadway, 10th Floor  

New York, NY 10006  

jlevi@levikorsinsky.com  

Tel: (212) 363-7500  

Fax: (212) 363-7171  

www.zlk.com  


Class Action Reports

ATVI Class Action: Learn About the Activision Blizzard Lawsuit

Levi & Korsinsky, LLP

August 4, 2021

Levi & Korsinsky, LLP announces that an ATVI class action lawsuit has been filed on behalf of investors who purchased Activision Blizzard, Inc. (ATVI) securities between August 4, 2016 – July 27, 2021. For more on the ATVI Lawsuit please contact us today.

 

 

 

 

According to the Activision Blizzard lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Activision Blizzard discriminated against women and minority employees; (2) Activision Blizzard fostered a pervasive “frat boy” workplace culture that continues to thrive; (3) numerous complaints about unlawful harassment, discrimination and retaliation were made to human resources personnel and executives which went unaddressed; (4) the pervasive culture of harassment, discrimination, and retaliation would result in serious impairments to Activision Blizzard’s operations; (5) as a result of the foregoing, the Company was at greater risk of regulatory and legal scrutiny and enforcement, including that which would have a material adverse effect; (6) Activision Blizzard failed to inform shareholders that the California Department of Fair Employment and Housing had been investigating Activision Blizzard for harassment and discrimination; and (7) as a result, Defendants’ statements about Activision Blizzard’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

 

TO LEARN MORE ABOUT THE ATVI CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Activision Blizzard you have until October 4, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ARDX Class Action: Learn About the Ardelyx Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an ARDX class action lawsuit has been filed on behalf of investors who purchased Ardelyx Inc. (ARDX) securities between August 6, 2020, and July 19, 2021.  For more on the ARDX Lawsuit please contact us today.

 

 

According to the Ardelyx lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the filed complaint: Defendants made materially false and misleading statements regarding tenapanor and the likelihood that it would be approved by the Food and Drug Administration (“FDA”). Defendants possessed, were in control over, and as a result, knew that the data submitted to support the New Drug Application was insufficient in that it showed a lack of clinical relevance of the drug’s treatment effect, making it foreseeably likely that the FDA would not approve the drug.

 

TO LEARN MORE ABOUT THE ARDX CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Ardelyx you have until September 28, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

PLL Class Action: Learn About the Piedmont Lithium Lawsuit

Levi & Korsinsky, LLP

July 27, 2021

Levi & Korsinsky, LLP announces that a PLL class action lawsuit has been filed on behalf of investors who purchased Piedmont Lithium Inc. (PLL) securities between March 16, 2018, and July 19, 2021 For more on the PLL Lawsuit please contact us today.

 

 

 

According to the Piedmont Lithium lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Piedmont has not, and would not, follow its stated steps or timeline to secure all proper and necessary permits; (2) Piedmont failed to inform relevant people and governmental authorities of its actual plans; (3) Piedmont failed to file proper applications with relevant governmental authorities (including state and local authorities); (4) Piedmont and its lithium business do not have “strong local government support”; and (5) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

 

TO LEARN MORE ABOUT THE PLL CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Piedmont Lithium you have until September 21, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

OTLY Class Action: Learn About the Oatly Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an OTLY class action lawsuit has been filed on behalf of investors who purchased Oatly Group AB (OTLY) securities between May 20, 2021, and July 15, 2021. For more on the OTLY Lawsuit please contact us today.

 

 

According to the Oatly lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (a) Oatly overinflated its gross margins, revenue, capital expenditure, and market share financial metrics; (b) the Company overstated its sustainability practices and impact; (c) the Company exaggerated its growth in China; and (c) as a result of the foregoing, Oatly’s statements about its operations, business, and prospects were misleading during the Class Period.

 

TO LEARN MORE ABOUT THE OTLY CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Oatly you have until September 24, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi & Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

COIN Class Action: Learn About the Coinbase Global Lawsuit 

Levi & Korsinsky, LLP

July 26, 2021

Levi & Korsinsky, LLP announces that a COIN class action lawsuit has been filed on behalf of investors who purchased Coinbase Global, Inc.(COIN) This lawsuit is on behalf of all persons and entities that purchased or otherwise acquired Coinbase Class A common stock pursuant and/or traceable to the Company’s registration statement and prospectus for the resale of up to 114,850,769 shares of its Class A common stock, whereby Coinbase began trading as a public company on or around April 14, 2021. For more on the COIN Lawsuit please contact us today. 

 

 

According to the Coinbase Globallawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company required a sizeable cash injection; (2) the Company’s platform was susceptible to service-level disruptions, which were increasingly likely to occur as the Company scaled its services to a larger user base; and (3) as a result of the foregoing Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE COIN CLASS ACTION LAWSUIT, CLICK HERE  

 

If you suffered a loss in Coinbase Global you have until September 20, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  

 

Levi and Korsinsky

CONTACT: 


Levi & Korsinsky, LLP  

Joseph E. Levi, Esq.  

55 Broadway, 10th Floor  

New York, NY 10006  

jlevi@levikorsinsky.com  

Tel: (212) 363-7500  

Fax: (212) 363-7171  

www.zlk.com  


Class Action Reports

CRMD Class Action: Learn About the CorMedix Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CRMD class action lawsuit has been filed on behalf of investors who purchased CorMedix Inc. (CRMD) securities between July 8, 2020, and May 13, 2021. For more on the CRMD Lawsuit please contact us today.

 

 

According to the CorMedix lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) deficiencies existed with respect to DefenCath’s manufacturing process and/or at the facility responsible for manufacturing DefenCath; (ii) In light of the foregoing deficiencies, the Food and Drug Administration (“FDA”) was unlikely to approve the DefenCath new drug application (“NDA”) for catheter-related bloodstream infections (“CRBSIs”) in its present form; (iii) Defendants had downplayed the true scope of the deficiencies with DefenCath’s manufacturing process and/or at the facility responsible for manufacturing DefenCath; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE CRMD CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in CorMedix you have until September 20, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

BLCT Class Action: Learn About the Bluecity Holdings Lawsuit

Levi & Korsinsky, LLP

July 23, 2021

Levi & Korsinsky, LLP announces that a BLCT class action lawsuit has been filed on behalf of investors who purchased Bluecity Holdings Holdings (BLCT) This lawsuit is on behalf of all persons and entities, other than Defendants, who purchased or otherwise acquired BlueCity American Depositary Shares pursuant and/or traceable to the Offering Documents issued in connection with the Company’s initial public offering conducted on or about July 8, 2020. For more on the BLCT Lawsuit please contact us today.  

According to the Bluecity Holdings lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Defendants had overstated BlueCity’s business and financial prospects; (2) the Company was ill-equipped to absorb the costs of becoming a publicly-traded company, including IPO- and growth-related costs; (3) as a result of all the foregoing, Defendants had misrepresented the Company’s capability for sustainable growth; and (4) as a result, the Offering Documents were materially false or misleading and/or failed to state information required to be stated therein.

 

TO LEARN MORE ABOUT THE BLCT CLASS ACTION LAWSUIT, CLICK HERE 

 

If you suffered a loss in Bluecity Holdings you have until September 17, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. 

Levi & korsinsky

 

CONTACT: 

Levi & Korsinsky, LLP 

Joseph E. Levi, Esq. 

55 Broadway, 10th Floor 

New York, NY 10006 

jlevi@levikorsinsky.com 

Tel: (212) 363-7500 

Fax: (212) 363-7171 

www.zlk.com 


Class Action Reports

RCAR Class Action: Learn About the Renovacare Lawsuit

Levi & Korsinsky, LLP

July 19, 2021

Levi & Korsinsky, LLP announces that an RCAR class action lawsuit has been filed on behalf of investors who purchased Renovacare, Inc.(RCAR) securities between August 14, 2017 – May 28, 2021 For more on the RCAR Lawsuit please contact us today.

According to the Renovacare lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) at the direction of Harmel Rayat, RenovaCare engaged in a promotional campaign to issue misleading statements to artificially inflate the Company’s stock price; (2) when the OTC Markets inquired, RenovaCare and Mr Rayat issued a materially false and misleading press release claiming that no director, officer, or controlling shareholder had any involvement in the purported third party’s promotional materials; (3) as a result of the foregoing, the Company’s disclosure controls and procedures were defective; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE RCAR CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Renovacare you have until September 14, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SRAC Class Action: Learn About the Stable Road Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an SRAC class action lawsuit has been filed on behalf of investors who purchased Stable Road Acquisition Corp.(SRAC) securities between October 7, 2020, and July 13, 2021. For more on the SRAC Lawsuit please contact us today.

 

 

According to the Stable Road lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (a) Stable Road’s acquisition target, Momentus’s 2019 test of its key technology, a water plasma thruster, had failed to meet Momentus’s own public and internal pre-launch criteria for success, and was conducted on a prototype that was not designed to generate commercially significant amounts of thrust; (b) the U.S. government had conveyed that it considered Momentus’s Chief Executive Officer a national security threat, jeopardizing his continued leadership of Momentus and Momentus’s launch schedule and business prospects; (c) consequently, the revenue projections and business and operational plans provided to investors regarding Momentus and the commercial viability and timeline of its products were materially false and misleading and lacked a reasonable basis in fact; and (d) Stable Road had failed to conduct appropriate due diligence of Momentus and its business operations and defendants had materially misrepresented the due diligence activities being conducted by Stable Road executives and its sponsor in connection with the merger.

 

TO LEARN MORE ABOUT THE SRAC CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Stable Road you have until September 13, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

QFIN Class Action: Learn About the 360 DigiTech Lawsuit

Levi & Korsinsky, LLP

July 16, 2021

Levi & Korsinsky, LLP announces that a QFIN class action lawsuit has been filed on behalf of investors who purchased 360 DigiTech (QFIN) securities between April 29, 2021, and July 7, 2021. For more on the QFIN Lawsuit please contact us today.

 

According to the 360 DigiTech lawsuits, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company had been collecting personal information in violation of relevant People’s Republic of China laws and regulations; (ii) accordingly, 360 DigiTech was exposed to an increased risk of regulatory scrutiny and/or enforcement action; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE QFIN CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in 360 DigiTech you have until September 13, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

YMM Class Action: Learn About the Full Truck Alliance Lawsuit 

Levi & Korsinsky, LLP

July 14, 2021

Levi & Korsinsky, LLP announces that a YMM class action lawsuit has been filed on behalf of investors who purchased Full Truck Alliance Co. Ltd.(YMM) This lawsuit is on behalf of persons who purchased or otherwise acquired Full Truck’s securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Full Truck’s June 2021 initial public offering. For more on the YMM Lawsuit please contact us today. 

According to the Full Truck Alliance  lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Full Truck’s apps Yunmanman and Huochebang would face an imminent cybersecurity review by the Chinese government; (2) the Chinese government would require Full Truck to suspend new user registration; (3) FTA needed to conduct a “comprehensive self-examination of any cybersecurity risks”; (4) Full Truck needed to “continue to improve its cybersecurity systems and technology capabilities”; and (5) as a result, Defendants’ public statements were materially false and misleading at all relevant times and negligently prepared.

 

TO LEARN MORE ABOUT THE YMM CLASS ACTION LAWSUIT, CLICK HERE  

 

If you suffered a loss in Full Truck Alliance you have until September 10, 2021,to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  

 

Levi and Korsinsky

 

CONTACT: 


Levi & Korsinsky, LLP  

Joseph E. Levi, Esq.  

55 Broadway, 10th Floor  

New York, NY 10006  

jlevi@levikorsinsky.com  

Tel: (212) 363-7500  

Fax: (212) 363-7171  

www.zlk.com  


Class Action Reports

BZ Class Action: Learn About the Kanzhun Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a BZ class action lawsuit has been filed on behalf of investors who purchased Kanzhun Limited (BZ) securities between June 11, 2021, and July 2, 2021. For more on the BZ Lawsuit please contact us today.

 

According to the Kanzhun lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) Kanzhun would face an imminent cybersecurity review by the CAC; (2) the CAC would require Kanzhun to suspend new user registration on its BOSS Zhipin app; (3) Kanzhun needed to “to conduct a comprehensive examination of cybersecurity risks”; (4) Kanzhun needed to “enhance its cybersecurity awareness and technology capabilities”; and (5) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE BZ CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Kanzhun you have until September 10, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

LOTZ Class Action: Learn About the CarLotz Lawsuit

Levi & Korsinsky, LLP

July 13, 2021

Levi & Korsinsky, LLP announces that a LOTZ class action lawsuit has been filed on behalf of investors who purchased CarLotz, Inc.(LOTZ) securities between December 30, 2020, and May 25, 2021. For more on the LOTZ Lawsuit please contact us today.

According to the CarLotz lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) due to a surge in inventory during the second half of fiscal 2020, CarLotz was experiencing a “logjam” resulting in slower processing and higher days to sell; (2) as a result, the Company’s gross profit per unit would be negatively impacted; (3) to minimize returns to the corporate vehicle sourcing partner responsible for more than 60% of CarLotz’s inventory, the Company was offering aggressive pricing; (4) as a result, CarLotz’s gross profit per unit forecast was likely inflated; (5) this Company’s corporate vehicle sourcing partner would likely pause consignments to the Company due to market conditions, including increasing wholesale prices; and (6) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE LOTZ CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in CarLotz you have until September 7, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

JRVR Class Action: Learn About the James River Group Holdings Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a JRVR class action lawsuit has been filed on behalf of investors who purchased James River Group Holdings, Ltd. (JRVR) securities between August 1, 2019 – May 5, 2021. For more on the JRVR  Lawsuit please contact us today.

 

According to the James River Group Holdings lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) James River had not adequately reserved for its Uber policies; (2) James River was using an incorrect methodology for setting reserves that materially understated the Company’s true exposure to Uber claims; (3) as a result, James River was forced to increase its unfavourable reserves in subsequent quarters even after cancelling the Uber policies; and (4) as a result of the foregoing, Defendants’ statements about James River’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE JRVR CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in James River Group Holdings you have until September 7, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

DIDI Class Action: Learn About the Didi Global Inc. F/K/A Xiaoju Kuaizhi Lawsuit 

Levi & Korsinsky, LLP

July 9, 2021

Levi & Korsinsky, LLP announces that a DIDI class action lawsuit has been filed on behalf of investors who purchased Didi Global Inc. F/K/A Xiaoju Kuaizhi Inc. (DIDI) This lawsuit is on behalf of persons and entities that purchased or otherwise acquired DiDi American Depositary Shares pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s June 2021 initial public offering. For more on the DIDI Lawsuit please contact us today. 

 

According to the Didi Global Inc. F/K/A Xiaoju Kuaizhi lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) DiDi’s apps did not comply with applicable laws and regulations governing privacy protection and the collection of personal information; (2) as a result, the Company was reasonably likely to incur scrutiny from the Cyberspace Administration of China; (3) the CAC had already warned DiDi to delay its IPO to conduct a self-examination of its network security; (4) as a result of the foregoing, DiDi’s apps were reasonably likely to be taken down from app stores in China, which would have an adverse effect on its financial results and operations; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE DIDI CLASS ACTION LAWSUIT, CLICK HERE  

 

If you suffered a loss in Didi Global Inc. F/K/A Xiaoju Kuaizhi you have until September 7 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  

 

Levi and Korsinsky

CONTACT: 


Levi & Korsinsky, LLP  

Joseph E. Levi, Esq.  

55 Broadway, 10th Floor  

New York, NY 10006  

jlevi@levikorsinsky.com  

Tel: (212) 363-7500  

Fax: (212) 363-7171  

www.zlk.com  


Class Action Reports

DKNG Class Action: Learn About the DraftKings Inc. Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a DKNG class action lawsuit has been filed on behalf of investors who purchased DraftKings Inc. f/k/a Diamond Eagle Acquisition Corp.  (DKNG) securities between December 23, 2019, and June 15, 2021. For more on the DKNG Lawsuit please contact us today.

 

 

According to the DraftKings Inc. lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) SBTech Global Limited (“SBTech”), a company acquired by DraftKings, had a history of unlawful operations; (ii) accordingly, DraftKings’ merger with SBTech exposed the Company to dealings in black-market gaming; (iii) the foregoing increased the Company’s regulatory and criminal risks with respect to these transactions; (iv) as a result of all the foregoing, the Company’s revenues were, in part, derived from unlawful conduct and thus unsustainable; (v) accordingly, the benefits of the Business Combination were overstated; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE DKNG CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in DraftKings Inc. you have until August 31, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

REKR Class Action: Learn About the Rekor Systems, Inc. f/k/a Novume Solutions Lawsuit

Levi & Korsinsky, LLP

July 1, 2021

Levi & Korsinsky, LLP announces that a REKR class action lawsuit has been filed on behalf of investors who purchased Rekor Systems, Inc. f/k/a Novume Solutions, Inc. (REKR) securities between April 12, 2019 – May 25, 2021, For more on the REKR Lawsuit please contact us today.

 

 

According to the Rekor Systems, Inc. f/k/a Novume Solutions lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Rekor’s ALPR technology and UVED-related business are outclassed by global competitors with an established, dominant market share; (ii) it was unlikely that states would pass legislation authorizing deals similar to Rekor’s Oklahoma UVED partnership because of, inter alia, state and local privacy laws and related public concerns; (iii) Rekor’s UVED partnership was not as profitable as Defendants had led investors to believe because of known impediments to enrollment rates and costs associated with the partnership; (iv) accordingly, Rekor had overstated its potential revenues, profitability, and overall ALPR- and UVED-related business prospects; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE REKR CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Rekor Systems, Inc. f/k/a Novume Solutions you have until August 30, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

RKT Class Action: Learn About the Rocket Companies Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an RKT class action lawsuit has been filed on behalf of investors who purchased Rocket Companies, Inc.  (RKT) securities between February 25, 2021, and May 5, 2021. For more on the RKT Lawsuit please contact us today.

According to the Rocket Companies lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (a) Rocket’s gain on sale margins were contracting at the highest rate in two years as a result of increased competition among mortgage lenders, an unfavorable shift toward the lower margin Partner Network operating segment and compression in the price spread between the primary and secondary mortgage markets; (b) Rocket was engaged in a price war and battle for market share with its primary competitors in the wholesale market, which was further compressing margins in Rocket’s Partner Network operating segment; (c) the adverse trends identified above were accelerating and, as a result, Rocket’s gain on sale margins were on track to plummet at least 140 basis points in the first six months of 2021; (d) as a result of the above, the favorable market conditions that had preceded the Class Period and allowed Rocket to achieve historically high gain on sale margins had vanished as the Company’s gain on sale margins had returned to levels not seen since the first quarter of 2019; (e) rather than remaining elevated due to surging demand, Rocket’s Company-wide gain-on-sale margins had fallen materially below recent historical averages; and (f) as a result of the foregoing, defendants’ positive statements about the Company’s business operations and prospects were materially misleading and/or lacked a reasonable basis.

TO LEARN MORE ABOUT THE RKT CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Rocket Companies you have until August 30, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  RKT Stock News and  Rocket Companies Stock information.

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ATHA Class Action: Learn About the Athira Pharma Lawsuit

Levi & Korsinsky, LLP

June 29, 2021

Levi & Korsinsky, LLP announces that a ATHA class action lawsuit has been filed on behalf of investors who purchased Athira Pharma, Inc. (ATHA) securities between September 18, 2020 and June 17, 2021 For more on the ATHA Lawsuit please contact us today.

 

According to the Athira Pharma lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) the research conducted by Defendant Kawas, which formed the foundation for Athira’s product candidates and intellectual property, was tainted by Kawas’ scientific misconduct, including the manipulation of key data through the altering of Western blot images; and (2) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and omitted material facts necessary in order to make the statements made not misleading.

 

TO LEARN MORE ABOUT THE ATHA CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Athira Pharma you have until August 24, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

HMPT Class Action: Learn About the Home Point Capital Lawsuit 

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an HMPT class action lawsuit has been filed on behalf of investors who purchased Home Point Capital Inc.(HMPT) common stock pursuant and/or traceable to the Company’s January 29, 2021, initial public offering. For more on the HMPT  Lawsuit please contact us today.

 

According to the Home Point Capitallawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Home Point’s aggressive expansion of its broker partners would dramatically increase the Company’s expenses; (ii) the mortgage industry was anticipating industry-wide decreased gain-on-sale margins as a result of rising interest rates in 2021 and Home Point would be subject to the same competitive pressures; (iii) accordingly, the Company had overstated it’s business and financial prospects; and (iv) as a result, the Offering Documents were materially false and/or misleading and failed to state information required to be stated therein.

 

TO LEARN MORE ABOUT THE HMPT CLASS ACTION LAWSUIT, CLICK HERE  

 

If you suffered a loss in Home Point Capital you have until  August 20, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.  

 

Levi and Korsinsky

CONTACT: 


Levi & Korsinsky, LLP  

Joseph E. Levi, Esq.  

55 Broadway, 10th Floor  

New York, NY 10006  

jlevi@levikorsinsky.com  

Tel: (212) 363-7500  

Fax: (212) 363-7171  

www.zlk.com  

 


Class Action Reports

OCGN Class Action: Learn About the Ocugen Lawsuit

Levi & Korsinsky, LLP

June 21, 2021

Levi & Korsinsky, LLP announces that an OCGN class action lawsuit has been filed on behalf of investors who purchased Ocugen, Inc. (OCGN) securities between February 2, 2021, and June 10, 2021, For more on the OCGN Lawsuit please contact us today.

 

According to the Ocugen lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the information submitted to the U.S. Food and Drug Administration (“FDA”) was insufficient to support an Emergency Use Authorization (“EUA”), (ii) Ocugen would not file a EUA with the FDA, (iii) as a result of the foregoing, the Company’s financial statements, as well as Defendants’ statements about Ocugen’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE OCGN CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Ocugen you have until August 17, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

RLX Class Action: Learn About the RLX Lawsuit

Levi & Korsinsky, LLP

June 17, 2021

Levi & Korsinsky, LLP announces that an RLX class action lawsuit has been filed on behalf of investors who purchased RLX American Depository Shares pursuant or traceable to the documents issued in connection with RLX’s January 2021 initial public stock offering. For more on the RLX Lawsuit please contact us today.

 

According to the RLX lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the filed complaint: the Company’s then-existing exposure to China’s ongoing campaign to establish a national standard for e-cigarettes, which would bring them into line with ordinary cigarette regulations, and that RLX’s reported financials were not nearly as robust as the offering materials projected, nor were they indicative of future results. As a result, investors purchased RLX shares at artificially inflated prices.

 

TO LEARN MORE ABOUT THE RLX CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in RLX you have until August 9, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

NTNX Class Action: Learn About the Nutanix Lawsuit

Levi & Korsinsky, LLP

June 15, 2021

Levi & Korsinsky, LLP announces that an NTNX class action lawsuit has been filed on behalf of investors who purchased Nutanix, Inc. (NTNX) securities between November 30, 2017, and May 30, 2019. For more on the NTNX Lawsuit please contact us today.

 

This securities fraud class action arises from misrepresentations and omissions made by Defendants during the class period intended to misrepresent and/or conceal from investors Nutanix’s rapidly declining sales pipeline and revenue. Among other things, Defendants: 1) knowingly concealed from investors that Nutanix’s purported strong sales hiring was woefully inadequate because a large portion of the Company’s hiring was to replace sales representatives who were leaving, rather than growing the sales force needed to achieve targeted revenue growth; 2) made the undisclosed decision to keep critical spending for lead generation activities “flat” so that Nutanix could divert those funds to the research and development of its public cloud product; and 3) told investors that Nutanix had “experienced record sales productivity”, despite their knowledge to the contrary.

 

TO LEARN MORE ABOUT THE NTNX CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Nutanix you have until August 10, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

FREQ Class Action: Learn About the Frequency Therapeutics Lawsuit

Levi & Korsinsky, LLP

June 7, 2021

Levi & Korsinsky, LLP announces that a FREQ class action lawsuit has been filed on behalf of investors who purchased Frequency Therapeutics, Inc.  (FREQ) securities between November 16, 2020 – March 22, 2021. For more on the FREQ Lawsuit please contact us today.

 

According to the Frequency Therapeutics lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: According to the filed complaint, during the class period, Frequency Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: the Company’s Phase 2a trial results failed to live up to the Company’s expectations as the results revealed no discernable difference between FX-322 and the placebo. In spite of the disappointing results, the Company continued to conduct the Phase 2a study while releasing positive statements in earnings calls, press releases, SEC filings, and pharmaceutical presentations about FX-322’s potential. These statements materially misled the market and artificially inflated the value of Frequency’s common stock.

 

TO LEARN MORE ABOUT THE FREQ CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Frequency Therapeutics you have until August 2, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SPCE Class Action: Learn About the Virgin Galactic Lawsuit

Levi & Korsinsky, LLP

June 2, 2021

Levi & Korsinsky, LLP announces that an SPCE class action lawsuit has been filed on behalf of investors who purchased Virgin Galactic Holdings, Inc. (SPCE) securities between October 26, 2019, and April 30, 2021. For more on the SPCE Lawsuit please contact us today.

 

According to the Virgin Galactic lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) for accounting purposes, Social Capital Hedosophia Holdings Corp.’s (“SCH”) warrants were required to be treated as liabilities rather than equities; (ii) Virgin Galactic had deficient disclosure controls and procedures and internal control over financial reporting; (iii) as a result, the Company improperly accounted for SCH warrants that were outstanding at the time of the business combination; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE SPCE CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Virgin Galactic you have until July 27, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

WPG Class Action: Learn About the Washington Prime Group, Inc. Lawsuit

Levi & Korsinsky, LLP

May 26, 2021

Levi & Korsinsky, LLP announces that a WPG class action lawsuit has been filed on behalf of investors who purchased Washington Prime Group, Inc.  (WPG) securities between November 5, 2020, and March 4, 2021. For more on the WPG Lawsuit please contact us today

 

According to the Washington Prime Group, Inc. lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:  (1) WPG’s financial condition was deteriorating substantially; (2) as a result, there was substantial uncertainty about the Company’s ability to meet its capital structure obligations as they become due; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE WPG CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Washington Prime Group, Inc. you have until July 23, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

PRVB Class Action: Learn About the Provention Bio Lawsuit

Levi & Korsinsky, LLP

May 25, 2021

Levi & Korsinsky, LLP announces that a PRVB class action lawsuit has been filed on behalf of investors who purchased Provention Bio, Inc. (PRVB) securities between November 2, 2020 – April 8, 2021. For more on the PRVB Lawsuit please contact us today.

 

According to the Provention Bio lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the teplizumab Biologics License Application (“BLA”) was deficient in its submitted form and would require additional data to secure U.S. Food and Drug Administration approval; (ii) accordingly, the teplizumab BLA lacked the evidentiary support the Company had led investors to believe it possessed; (iii) the Company had thus overstated the teplizumab BLA’s approval prospects and hence the commercialization timeline for teplizumab; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE PRVB CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Provention Bio you have until July 20, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

UI Class Action: Learn About the Ubiquiti Lawsuit

Levi & Korsinsky, LLP

May 24, 2021

Levi & Korsinsky, LLP announces that a UI class action lawsuit has been filed on behalf of investors who purchased Ubiquiti Inc. (UI) securities between January 11, 2021, and March 20, 2021. For more on the UI Lawsuit please contact us today.

 

According to the Ubiquiti lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company had downplayed the data breach in January 2021; (2) attackers had obtained administrative access to Ubiquiti’s servers and obtained access to, among other things, all databases, all user database credentials, and secrets required to forge single sign-on (SSO) cookies; (3) as a result, intruders already had credentials needed to remotely access Ubiquiti’s customers’ systems; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE UI CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Ubiquiti you have until July 19, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

WISH Class Action: Learn About the Contextlogic Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a WISH class action lawsuit has been filed on behalf of investors who purchased Contextlogic Inc.(WISH) securities between December 16, 2020, and May 12, 2021. For more on the WISH Lawsuit please contact us today.

 

According to the Contextlogic lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: In the registration statement and prospectus used to conduct the initial public offering and throughout the class period, defendants made materially false and misleading statements about the strength of ContextLogic’s business operations and financial prospects by overstating its then-present monthly active users (“MAUs”) and MAU growth trends.

 

TO LEARN MORE ABOUT THE WISH CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Contextlogic you have until July 16, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ARRY Class Action: Learn About the Array Tech Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an ARRY class action lawsuit has been filed on behalf of investors who purchased Array Technologies, Inc. (ARRY) securities between October 14, 2020, and May 11, 2021, For more on the ARRY Lawsuit please contact us today.

 

According to the Array Tech lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: Defendants repeatedly and consistently painted a materially misleading picture of the Company’s business and prospects that did not reflect rising steel and freight costs. After the October 2020 initial public offering, the December 2020 offering and the March 2021 offering, and subsequent to the class period, Array disclosed that it was experiencing increases in steel prices and substantial increases in the cost of both ocean and truck freight that in turn were having a material impact on its margins for the foreseeable future. This caused Array to miss profit expectations and withdraw its full-year outlook. As a result of Defendants’ wrongful acts and omissions and the precipitous decline in the market value of the Company’s securities, shareholders have suffered significant losses and damages.

 

TO LEARN MORE ABOUT THE ARRY CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Array Tech you have until July 13, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

DNMR Class Action: Learn About the Danimer Scientific Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a DNMR class action lawsuit has been filed on behalf of investors who purchased Danimer Scientific, Inc. (DNMR) securities between October 5, 2020, and May 4, 2021. For more on the DNMR Lawsuit please contact us today.

 

 

According to the Danimer Scientific lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Danimer had deficient internal controls; (ii) as a result, the Company had misrepresented, inter alia, its operations’ size and regulatory compliance; (iii) Defendants had overstated Nodax’s biodegradability, particularly in oceans and landfills; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE DNMR CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Danimer Scientific you have until July 13, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ATER Class Action: Learn About the Aterian Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an ATER class action lawsuit has been filed on behalf of investors who purchased Aterian, Inc.(ATER) securities between December 1, 2020, and May 3, 2021. For more on the ATER Lawsuit please contact us today.

 

According to the Aterian lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the Company’s organic growth is plummeting; (ii) the Company’s recent, self-lauded acquisitions were overpayments for flawed assets from questionable sources; (iii) Aterian’s purported artificial intelligence software is a flawed product that lacks customer interest; (iv) Aterian uses rebate programs and paid or artificial reviews to pump up their product offerings; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE ATER CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Aterian you have until July 12, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

PCT Class Action: Learn About the PureCycle Lawsuit

Levi & Korsinsky, LLP

May 17, 2021

Levi & Korsinsky, LLP announces that a PCT class action lawsuit has been filed on behalf of investors who purchased PureCycle Technologies, Inc. (PCT) securities between November 16, 2020, and May 5, 2021. For more on the PCT Lawsuit please contact us today.

 

According to the PureCycle lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the technology PureCycle licensed from Procter & Gamble is not proven and presents serious issues even at lab scale; (ii) the challenges posed by the availability and competition for the raw materials necessary to commercialize the licensed technology are significant; (iii) PureCycle’s financial projections are baseless; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE PCT CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in PureCycle you have until July 12, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SKLZ Class Action: Learn About the Skillz Inc Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an SKLZ class action lawsuit has been filed on behalf of investors who purchased Skillz Inc. f/k/a Flying Eagle Acquisition Corp. (SKLZ) securities between December 16, 2020, and April 19, 2021. For more on the SKLZ Lawsuit please contact us today.

 

According to the Skillz Inc lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose those: Representations relating to certain of Skillz’s business operations, performance metrics and ultimate valuation, including, among others, Skillz’s ability to attract new end-users, future profitability, the shrinking popularity of its hosted games that accounted for 88% of its revenue, and the Company’s valuation. For example, one of the Company’s objectively unrealistic promises included the unsupportable claim that the Company was valued at $3.5 billion, based on revenue projections in excess of $550 million for 2022. However, the Company failed to inform investors that downloads of the games that account for a majority share of its revenue have been declining since at least November 2020. In reality, the Company’s prospects for attaining that revenue scale was far from realistic given its size, market share, reliance on third-party app stores, declining downloads of its most popular games and, critically, the enormous amount of incentive Bonus Payments that Skillz routinely provides to its gamer customers, a fact that investors were misled about. These Bonus Payments are routinely provided to its customers, who are expected to use them for game entry fees, which, in turn, artificially inflates Skillz revenue.

 

TO LEARN MORE ABOUT THE SKLZ CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Skillz Inc you have until July 7, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CCIV Class Action: Learn About the Churchill Capital Lawsuit

Levi & Korsinsky, LLP

May 10, 2021

Levi & Korsinsky, LLP announces that a CCIV class action lawsuit has been filed on behalf of investors who purchased Churchill Capital Corp IV (CCIV) securities between January 11, 2021, and February 22, 2021. For more on the CCIV Lawsuit please contact us today.

 

According to the Churchill Capital lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Lucid was not prepared to deliver vehicles by spring of 2021; (2) Lucid was projecting production of 557 vehicles in 2021 instead of the 6,000 vehicles touted in the run-up to the merger with Churchill; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

 

TO LEARN MORE ABOUT THE CCIV CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Churchill Capital you have until June 18, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

CCXI Class Action: Learn About the ChemoCentryx Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that a CCXI class action lawsuit has been filed on behalf of investors who purchased ChemoCentryx, Inc. (CCXI) securities between November 26, 2019, and May 3, 2021. For more on the CCXI Lawsuit please contact us today.

 

According to the ChemoCentryx lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) the study design of the Phase III ADVOCATE trial presented issues about the interpretability of the trial data to define a clinically meaningful benefit of avacopan and its role in the management of ANCA-associated vasculitis; (2) the data from the Phase III ADVOCATE trial raised serious safety concerns for avacopan; (3) these issues presented a substantial concern regarding the viability of ChemoCentryx’s New Drug Application (“NDA”) for avacopan for the treatment of ANCA-associated vasculitis; and (4) as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE CCXI CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in ChemoCentryx you have until July 6, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

PTON Class Action: Learn About the Peloton Lawsuit

Levi & Korsinsky, LLP

May 5, 2021

Levi & Korsinsky, LLP announces that a PTON class action lawsuit has been filed on behalf of investors who purchased Peloton Interactive, Inc.  (PTON) securities between September 11, 2020, and April 16, 2021. For more on the PTON Lawsuit please contact us today.

 

According to the Peloton lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) in addition to the tragic death of a child, Peloton’s Tread+ had caused a serious safety threat to children and pets as there were multiple incidents of injury to both; (2) safety was not a priority to Peloton as defendants were aware of serious injuries and death resulting from the Tread+, yet did not recall or suggest a halt of the use of the Tread+; (3) as a result of the safety concerns, the U.S. Consumer Product Safety Commission (“CPSC”) declared that the Tread+ posed a serious risk to public health and safety and urgently recommended that consumers with small children cease using the Tread+; (4) the CPSC also found a safety threat to Tread+ users if they lost their balance; and (5) as a result of the foregoing, defendants’ statements about Peloton’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

 

TO LEARN MORE ABOUT THE PTON CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Peloton you have until June 28, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

VRUS Class Action: Learn About the Verus International Lawsuit

Levi & Korsinsky, LLP

April 27, 2021

Levi & Korsinsky, LLP announces that a VRUS class action lawsuit has been filed on behalf of investors who purchased Verus International, Inc. (VRUS) securities between June 17, 2019, and November 8, 2020. For more on the VRUS Lawsuit please contact us today.

 

According to the Verus International lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Verus lacked the requisite resources, infrastructure and/or expertise to exploit its Big League Foods brand and its MLB license; (ii) the Company issues in production ramp-up were not fully resolved to enable the Company to fulfil customer orders; (iii) as a result, the Company’s prospects and outlook were not as represented; (iv) the Company’s internal controls for financial reporting and accounting were not sufficient with specific respect to stock-based compensation and classification of equity instruments; (v) as a result, the Company’s financial results, outlook and prospects were materially worse than represented; and (vi) as a result of the foregoing, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE VIRUS CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Verus International you have until June 22, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

SOS Class Action: Learn About the SOS Limited Lawsuit

Levi & Korsinsky, LLP

April 23, 2021

Levi & Korsinsky, LLP announces that an SOS class action lawsuit has been filed on behalf of investors who purchased SOS Limited (SOS) securities between July 22, 2020 – February 25, 2021. For more on the SOS Lawsuit please contact us today.

 

According to the SOS Limited lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) SOS had misrepresented the true nature, location, and/or existence of at least one of the principal executive offices listed in its SEC filings; (ii) HY and FXK were either undisclosed related parties and/or entities fabricated by the Company; (iii) the Company had misrepresented the type and/or existence of the mining rigs that it claimed to have purchased; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

 

TO LEARN MORE ABOUT THE SOS CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in SOS Limited you have until June 1, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

RMO Class Action: Learn About the Romeo Power Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an RMO class action lawsuit has been filed on behalf of investors who purchased Romeo Power, Inc. (RMO) securities between October 5, 2020, and March 30, 2021. For more on the RMO Lawsuit please contact us today.

 

According to the Romeo Power lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Romeo had only two battery cell suppliers, not four, (ii) the future potential risks that Defendants warned of concerning supply disruption or shortage had already occurred and were already negatively affecting Romeo’s business, operations and business prospects, (iii) Romeo did not have the battery cell inventory to accommodate end-user demand and ramp up production in 2021, (iv) Romeo’s supply constraint was a material hindrance to Romeo’s revenue growth, and (v) Romeo’s supply chain for battery cells was not hedged, but in fact, was totally at risk and beholden to just two battery cell suppliers and the spot market for their 2021 inventory. Given the supply constraint that Romeo was experiencing during the Class Period, Defendants had no reasonable basis to represent that the Company had the ability to meet customer demand and that it would support growth in revenue in 2021.

 

TO LEARN MORE ABOUT THE RMO CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Romeo Power you have until June 15, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi and Korsinsky

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

EBS Class Action: Learn About the Emergent Bio Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an EBS class action lawsuit has been filed on behalf of investors who purchased Emergent Biosolutions Inc. (EBS) securities between July 6, 2020, and March 31, 2021. For more on the EBS Lawsuit please contact us today.

 

According to the Emergent Bio lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Emergent’s Baltimore plant had a history of manufacturing issues increasing the likelihood for massive contaminations; (ii) these longstanding contamination risks and quality control issues at Emergent’s facility led to a string of FDA citations; (iii) the Company previously had to discard the equivalent of millions of doses of COVID-19 vaccines after workers at the Baltimore plant deviated from manufacturing standards; and (iv) as a result of the foregoing, Defendants’ public statements about Emergent’s ability and capacity to mass manufacture multiple COVID-19 vaccines at its Baltimore manufacturing site were materially false and/or misleading and/or lacked a reasonable basis.

 

TO LEARN MORE ABOUT THE EBS CLASS ACTION LAWSUIT, CLICK HERE

 

If you suffered a loss in Emergent Bio you have until June 18, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

 

 

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com


Class Action Reports

ACAD Class Action: Learn About the Acadia Lawsuit

Levi & Korsinsky, LLP

Levi & Korsinsky, LLP announces that an ACAD class action lawsuit has been filed on behalf of investors who purchased Acadia Pharmaceuticals Inc. (ACAD) securities between June 15, 2020, and April 4, 2021. For more on the ACAD Lawsuit please contact us today.

 

According to the Acadia lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) the materials submitted in support of the pimavanserin sNDA contained statistical and design deficiencies; (ii) accordingly, the pimavanserin sNDA lack